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Abstract 
This thesis explores the feasibility of testing for drugs from a fingerprint. Previous publications 
have reported drug detection in fingerprints from either drug users or after contact with a substance. 
There are possibilities to exploit these findings either for forensics (where a finger-mark is 
deposited at a crime scene to give intelligence about a donor) or for drug testing (where fingerprints 
are deposited under controlled conditions). In forensic science, it may be sufficient to know that a 
drug has been either handled or ingested within a specific time frame. In contrast, for drug testing, 
it may be necessary to exclude handling of drugs as a possible source. In either case, it is necessary 
to understand the significance of detecting a drug or its metabolite in a fingerprint.  
This thesis explored the significance of detecting a selection of illicit drugs in fingerprints. In 
Chapter 4 and Chapter 5, a rapid analysis method based on paper spray high resolution mass 
spectrometry is developed and validated for cocaine and its metabolite, benzoylecgonine (BZE), 
and the method is applied to the fingerprints of non-drug users and drug users respectively. As a 
result, cocaine and BZE were found in samples from both non-drug users (set as environmental 
cut-off) and drug users. The detection rate from drug users was above 90 % and there were no false 
positive using this method. Moreover, handwashing involvement became indicative of either 
ingestion of cocaine OR recent contact with cocaine. In Chapter 6 and 7, imaging mass 
spectrometry techniques were employed to determine whether contact and ingestion scenarios can 
be distinguished via spatial distribution of analytes. Those results supported the hypothesis that 
hot spots would be formed in fingerprints after contact whereas analytes would be evenly 
distributed in fingerprints after ingestion. The presence of BZE was also used to in distinguishing 
fingerprint samples from the two scenarios. In Chapter 8 and 9, the paper spray mass spectrometry 
methodology was expanded to a selection of novel psychoactive substances (NPS) relevant to a 
prison environment using fingerprints for the first time. The method was applied to the fingerprints 
of prisoners before and after participants washed their hands. As a result, NPS substances were not 
detected from any participants, in agreement with their urine testing. Finally, in Chapter 10, the 
data collected in Chapter 4 and 5 was analysed retrospectively for detection of heroin and 6-AM 
in fingerprints to explore the possibility of carrying out an untargeted analysis. The sensitivity of 
the method was not as good as for cocaine and benzoylecgonine (BZE), which led to the lower 
detection rate of heroin and 6-AM than that of cocaine and BZE. However, this study proved that 
the paper spray method could still provide qualitative and quantitative results of heroin detection 
in fingerprints. 
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This study demonstrates that in the future with a suitable, deployable high resolution mass 
spectrometer, paper spray mass spectrometry could be used to detect cocaine, its metabolites and 
NPS for evidential purposes within the confines of a police station.    
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Glossary  
Cut-off value It is the dividing points where the test results are divided into different 
category: positive or negative. In this case, among levels of target analytes 
above limits of detection (LOD) from non-drug users’ fingerprint samples 
using paper spray mass spectrometry, the highest level of target analytes 
from them were set as cut-off values, so when the level of target analytes 
from drug users’ fingerprint samples are lower than that, they are not 
considered deriving from drug administration or contact.     
Retrospective study It is a research method used for previous event, and the outcome of it is 
already known.   
Taylor cone It refers to the cone shaped drop at the tip of capillary observed the 
electrospray processes from which a jet of charged particles emanates above 
a threshold voltage. At onset voltage, the pressure of charges accumulating 
at the tip is higher than the surface tension, the shape of the drop changes at 
once to a Taylor cone and small droplets are released. 
Ambient surface it refers to a surface that can be analysed in the atmospheric environment. It 
is usually referred to being compared against one that can be analysed in the 
vacuum environment. 
Mass Resolution It is level of separating two narrow mass spectral peaks which seem 
duplicated. 
Mass analyser It takes ionized masses and separates them based on m/z and outputs them 
to detector. 
Mass detector It detects ions and later converts them to a digital output. 
Spatial resolution It refers to the number of pixels used in construction of a digital/elemental 
image. 
Pixel It is the smallest unit of a digital image which can be displayed on a display 
device. It is combined to form a complete image on a display.    
PPM Abbreviation of parts per million. It is a value of a whole number in units of 
1/1000000. It was used for mass accuracy of element and target analytes after 
calibration using time of flight secondary ions mass spectrometry (ToF-
SIMS). For example, if a peak of ion is 100 ppm off, it is 0.0001 (u) away 
from its ideal peak location. 
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Chapter 1 Introduction  
For numerous types of crimes, the chain of the criminal justice system (composed of law 
enforcement, forensic services and judiciary) was established. Each agency has a role to play. Law 
enforcement agencies investigate a reported crime scene, establish the facts, and seek to identify 
and arrest criminal suspects based on the analysed evidence. The judiciary is composed of 
attorneys, judges, magistrates, and courts. It deals with adjudicating punishment of criminal 
defendants. Corrections consists of those agencies responsible for handling the probation, 
incarceration, rehabilitation, treatment, parole, and execution of convicted criminals [1].  
From a crime scene to the court room, the forensic scientist plays a significant role. They not only 
deal with examination and interpretation of evidence collected from the crime scene to implicate 
people for investigations, but also communicate with and educate law enforcement agencies and 
legal officials and provide fair testimony based on the scientific knowledge and information 
regarding the evidence. This results in helping the decision making of the justice system [1].  
However, it is impossible for a piece of evidence presented in a perfect condition to be examined 
and interpreted properly. The evidence can be too small physically or contain too small sample 
size, so it requires additional analytical equipment such as a microscope (for physical 
characteristics) or mass spectrometry (for chemical characteristics). These small amounts of 
evidence could provide information to determine the factual circumstances of what actions took 
place at the time that the crime occurred (detection/identification). Evidence can be affected or 
distorted by external forces or circumstances to relocate, change, or contaminate evidence. This is 
called evidence dynamics. Even under the best circumstances, evidence exposure to uncontrollable 
influences is inevitable regardless of intent. Because the multiple factors that affect evidence are 
unpredictable since they are not shown as certain and precise records of actions and events, 
consideration of them should be kept in mind for analysing evidence to ensure it does not confuse, 
mislead, and confound (significance study) [2].  
Previously, many studies introduced techniques and methods to detect minute amount of physical 
(paint [3], glass [4], or soil [5]) and chemical (drug [6] or explosives [7]) trace evidence. Detecting 
and identifying these trace evidences is still very valuable to associate a person with a crime and 
crime scene. However, it cannot always be a conclusive solution. Uncontrollable external 
interference on evidence can stem from natural causes (weather related matters) or human made 
causes (external force, secondary transfer, or persistence) which can modify the result of 
메모 포함[민장1]: I put the separated introduction section 
introducing general roles of forensic scientist, definition of 
evidence dynamic, and necessity of analysis of trace 
evidences.  
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examination and further narrative of testimony. It means that wrongful verdict or adjudication can 
still be possible. 
Among types of trace evidence, this thesis deals with illicit substances. Drug abuse is still one of 
the most frequently committed crimes with links to collateral crimes such as violence, sexual 
assault, and robbery which committed with a high percentage of drug administration according to 
United Nations Office Drugs and Crime (UNODC). Moreover, the rate of false conviction of drug 
related cases doubly increased compared to 2011 [8]. Nevertheless, the attempt to research 
regarding consideration of evidence dynamic of illicit substances has not been investigated. This 
study will not only introduce techniques and methods to detect minute amount of illicit substances 
in a single fingerprint, but also investigate a significance study considering evidence dynamic of 
detecting them by focusing on the effect of handwashing, persistence, and distinguishing between 
drug contact and drug administration for the first time. 
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Chapter 2 Literature Review 
This chapter introduces a few studies considering evidence dynamic focusing on transfer and 
persistence of trace physical evidence (sediments, pollen particulates, fluorescent powder, flint 
particles, and gunshot residue) and trace chemical evidence (explosives) and illicit substances used 
in this study and fingerprint. 
2.1 Trace physical evidence 
Bull et al [9] investigated the relevant transfer and persistence of small sedimentary particles such 
as pollen, fluorescent powder, and flint particles from several different types of clothing.  
First, the persistence of pollen grains (lily, sambucus, pine, and hydrangea) on five different 
materials (cotton, acrylic, wool, nylon tights and polyester) was studied. These pollen grains were 
selected due to size difference (lily: 100 μm, sambucus: 25 μm, pine: 50 μm, and hydrangea: 10 
μm) under scanning electron microscopy at x70, effecting a 500 μm2 viewing area. After the types 
of pollen were dried, they were brushed on each material. As a result, the decay curve trend was 
larger for the material types than for the pollen types. It means that the kind of material used for 
making clothes is more significant for controlling the decay rate of pollen grains. All four types of 
pollen grains were still found on all materials after 647 hours. As an extended study, the effect of 
washing (procedures of dry-cleaning, machine washing, and hand washing) was also investigated. 
After three runs of washing, pollen grains were still present in a low amount.  
In the second study, persistence of fluorescent powder was explored over 24 hours (1 hour interval). 
Fluorescent powder was applied to materials (nylone, wool, PVC, and a viscose/nylon/lycra mix). 
The powder was mixed with flour to be evenly distribute across each material. In order to find 
trace, a photograph was taken under UV light. As a result, 12, 39.7, and 12.4 % of recovery of 
pollen grains on PVC, wool, and the viscose/nylon/lycra mix, respectively was present after 24 
hours. The decay curves of each of the four materials were similar again and showed that the 
controlling factor is the type of material rather than the particulates used.  
In the third study, persistence of lighter flint particles on a viscose material and a nylon material 
was explored. Each material had triplicates. Lighter flint particles were applied from flicking a 
clipper lighter on each material. Lots of debris can be found from this action, but only the rounded 
cerium and lanthanum were counted. Then, they were worn for designated time periods. As a result, 
between 20 % and 30 % of cerium and lanthanum still remained on both viscose and nylon after 
18 hours of wear. Again, the decay curve of lighter flint particles proved that the persistence of 
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them was dependent on the type of material rather than particulates as the two previous studies 
showed.           
Morgan et al [10] explored the quantities of materials left on the soles of footwear over time, and 
the persistence of pollen particulates on the top of shoes over even longer periods of time using 
visual identification method (UV powder). In order to quantify the amount of trace sediment, a 
UV powder (less than 15 μm) was mixed with soil and applied to the soles of shoes. A participant 
walked at a different intervals (0, 100, 250, 350, and 450 m) wearing the shoes on a smooth 
concrete surface. This was repeated three times. As a result, a general regression trend was seen 
until 100 m of walking, and the remaining material was spread out by the pressure. However, the 
amount of slit-sized material increased after 250 m of walking due to decay of larger 
conglomerated materials from initial stages of walking and subsequently decreased after 350 m of 
walking. However, trace material was still found on some parts of the soles even after 450 m of 
walking. The second study investigated the transfer and persistence of pollen particulates on the 
top of different types of footwear: suede shoes and cotton plimsolls. The participant brushed each 
pair of shoes with flowing shrub and wore them for seven days undertaking normal daily activities 
(time intervals: 0, 2, 4, 6, 8, 10, 12, 24, 36, and 168 hours). The trace was observed by the location 
of pollen grains present and scanned by electron microscope at x330. As a result, the loss of pollen 
was rapid during the first 4 hours with subsequently less rapid loss until 10 hours, followed by 
periods of much slower loss of pollen. After 168 hours, 4.8 and 1.5 % of pollen remained on the 
suede shoes, whereas, 1.8 and 1.0 % remained on the cotton plismolls. Although pollen particulates 
were collected from small region of the shoe upper (0.5 cm2), they persisted for a very long time.  
Persistence and transfer of gunshot residue (GSR) was investigated as well. According to 
Rosenberg et al. [11], GSR can persist for days rather than hours. In order to determine persistent 
period of time of GSR, laser induced breakdown spectroscopy (LIBS) was used targeting barium 
(detection limits: 19.3 % laser pulses testing positive for GSR). After a gun shot, samples were 
collected using tape lifts from shooter’s hands up to 9 days (a day interval). As a result, detectable 
amounts of GSR were present on the shooter’s hands over 5 days (5.27 days) after firearm 
discharge. For the transfer study of GSR, French et al. investigated possibility of secondary transfer 
of GSR to an individual who was not present at the time of firing using SEM-EDX. There were 
three scenarios. In the first one, a shooter fired five rounds before sample collected. This was to 
measure the GSR that was transferred to the hands of the shooter during firearm discharge. In the 
second one, the shooter after shooting shook hands with a second participant who was not at the 
scene of firing mimicking a situation when a shooter contacted with an unconnected individual 
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after shooting. His hands were also sampled.  In the third one, the second participant whose hands 
were washed and controlled contacted the pistol briefly after it was discharged. Each scenario was 
triplicated. As a result, GSR particles were still identified from handshaking and the second gun 
handler. However, the amount of transfer between shooter and handshaking (scenario 2) was found 
to be higher than that of between the fired gun and the second handler (scenario 3).  
The study regarding persistence and transfer of trace physical evidence using visual identification 
techniques can be an important implication to identify where a crime takes place and reduce the 
possibility of false plosive or negative association in the forensic examination of trace physical 
evidence. However, evidence dynamic of chemical evidence which cannot be quantified or 
detected using visual identification techniques must also be considered.    
2.2 Trace chemical evidence      
Twibel et al. [12] investigated the persistence of explosives (nitroglycerine (NG) based) using gas 
chromatography with electron capture detection (GC-ECD, detection limits: 5 ng) and gas 
chromatography mass spectrometry (GC-MS, detection limits: 12 ng) in order to measure both 
quantities of NG transferred to hands from commercial cartridges and quantities of NG persistence 
at various time points after handling. For the transfer study, there were three ways to handle 
explosives with hands: 1) A participant picked up a well wrapped cartridge with the right hand and 
passed it to the left hand before putting it down. This single process was compared to nine times 
repeated processes (series A). The second was similar to the series A (one pass) except with a 
poorly wrapped cartridge, which is showing the sign of sweating and liquid droplets on the 
cartridge (Series B). In the third, a participant played with raw explosives using the palm and finger, 
and the palm, fingers, and nail fragments of a participant’s hand were analysed to determine 
distribution of explosives over their hands. Because GC-ECD offered better specificity and 
detection limits compared to GC-MS, the method of GC-ECD was used for this study. For the 
experiment of series A, 60 ng of NG was detected from a single well-wrapped cartridge of 
explosive. On the other hand, between 1 and 32 μg of NG was detected from nine different 
cartridges. It means that as the number of transfer increased, the amount of NG was considerably 
accumulated. For the experiment of series B, between 25 and 83 μg of NG was detected from 
handling of single poorly wrapped cartridges. After touching raw NG (series C), 20 mg of NG was 
detected on a hand. The participant washed his hands due to stickiness after touching it. After 
handwashing, 2 mg of NG was detected.  
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For the persistence study, 1, 100, and 1000 μg of NG in 100 μL of toluene was pipetted and 
distributed evenly on palm area for 3 hours. After standards were dried, the pipetted area was 
swabbed with a cotton wool. Five replications of samples were analysed. A rapid loss of NG was 
found in the first 15 minutes for all standards, and the subsequent rate of loss became slower. The 
more standard was applied to the hand, the longer NG remained. However, none of them lasted 
more than 3 hours. As an extended study, 1 mg of raw NG was applied to participants’ hands over 
20 hours. Despite handwashing, normal daily activities, and swabbing, it was still detected on both 
left (170 ng) and right (41 ng) hands over 20 hours.  
Studies regarding persistence and transfer of trace physical evidence are various and updated, and 
their number is relatively large compared to that of trace chemical evidence. On the other hand, 
studies regarding those of trace chemical evidence are still deficient, and data gained for it is 
outdated, as shown in Section 2.2. Currently commercialised mass spectrometry techniques used 
to identify and characterise chemical analytes can provide better sensitivity, specificity, and 
resolving powder. With the new techniques, data on persistence and transfer of trace chemical 
evidence can be updated. In order to minimise the false accusation, considering evidence dynamic 
of both physical and chemical evidence is very significant. The combination and harmony of 
enough information on both sides can make crime solving methodology more robust.  
As described in Chapter 1, illicit substances are selected for this study, since drug abuse is 
constantly one of the most frequently committed crimes and other crimes derive from drug 
administration in a high percentage. Therefore, consideration of evidence dynamic of illicit 
substances becomes more significant and accumulated gathered data of it can be used to have a 
great implication for forensic and toxicological analysis.  
This project explores the efficacy of drug testing from a single fingerprint. The first part of this 
research was to develop a methodology suitable for exploring the robustness of cocaine and heroin 
detection from a fingerprint, and then apply this methodology to a wider exploration of novel 
psychoactive substances, as requested by Her Majesty’s Prison and Probation Service. The second 
part of this research was to explore the evidence dynamic of drugs focusing on the effect of 
handwashing and various removal methods, persistence, and distinguish between fingerprints of 
drug use and fingerprints of drug contact. This chapter provides a summary of the drugs of interest 
in the study, the metabolism, detection in other matrices, as well as a summary of the efforts that 
have been made so far to test for drugs of abuse in a fingerprint.  
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2.3 Introduction to Conventional Illicit Drugs 
This section introduces two conventional illicit drugs, cocaine and heroin. According to the survey 
of Home Office in 2018 [13], these are still the most commonly consumed drugs despite stronger 
regulation of them for several decades. As a result, heroin overdose became the main cause of drug 
related death with misuse of fentanyl in 2016, and the rate of cocaine related deaths has gradually 
increased since 1993 [14]. Because of the widespread use in the society, they are readily detected 
as environmental contaminants – for example, cocaine residue is found in 11 % of UK banknotes 
[15], and both are detected in waste water [16]. Therefore, this research uses cocaine and heroin 
as target drugs and seeks to explore novel testing methods. 
The following sections explain the chemistry, metabolism, and detection window of cocaine and 
heroin in different biological matrices. 
2.3.1 Cocaine  
2.3.1.1 Chemistry of cocaine 
Cocaine is a drug extracted from the leaves of the coca plant [17]. It stimulates the central nervous 
system by inducing dopamine production, and this type of drug is called a stimulant. Historically, 
cocaine hydrochloride was isolated from the plant and used as an anaesthetic material until a 
synthetic anaesthetic was developed.  
Today, the 1970 Controlled Substances Act (CSA) classifies cocaine as a Schedule II drug, which 
means that the drug has a high potential for abuse, but the drug can be accepted for medical use 
under a doctor’s permission [18].  
Generally, there are two forms of cocaine: cocaine base and cocaine hydrochloride powder. 
Cocaine base as known as “crack” is more abused due to providing immediate and intense effects 
[19]. It takes two steps to produce cocaine base: (I) making coca paste by either solvent or acid 
extraction from coca leaf, (II) converting coca paste to cocaine base by purification. With the 
cocaine base, cocaine hydrochloride (HCl) can be produced. Cocaine base is dissolved in a solvent 
(ethyl acetate or acetone) and heated in a water bath. During the heating process, methyl or ethyl 
ketone is added into the boiling solution along with hydrochloric acid which leads to crystallisation 
of the cocaine base by the nitrogen atom of cocaine base accepting a hydrogen atom. After 
removing solvents by putting it inside of the oven, only crystallised products remain, which are 
chunks of cocaine hydrochloride (powder cocaine). In order to produce cocaine base (crack 
cocaine) from cocaine hydrochloride, cocaine hydrochloride is dissolved in a mixture of water and 
baking soda (sodium bicarbonate) by boiling. Once the solution is heated enough, oily substances 
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(deprotonated amine) start to be formed at the bottom of the solution. Oily substances then 
transform to the hard-solidified substances after cooling down and solvent removed. The rock-like 
products are crack cocaine [20].          
 
Figure 1 Chemical structure of crack cocaine (A) and cocaine hydrochloride powder (B)[21]. 
Most of street cocaine contains adulterants in order to bulk its volume and enhance the mimicking 
pharmacological effects [22]. Therefore, street cocaine has widely varying purity [23]. Adulterants 
such as caffeine, lidocaine, and levamisole account for highest portions of street cocaine [24]. Even 
flour can be added into the cocaine mixture because of the white colour. According to Kudlacek 
et al, those main adulterants were found in almost 70% of street cocaine samples seized between 
2012 and 2015. In particular, levamisole was the most commonly found adulterant [25]. 
Cocaine hydrochloride is usually administered through injection or snorted, but not smoked. That 
is because, the melting point is very high (190 °C) due to presence of hydrochloride. In contrast, 
crack cocaine is usually smoked due to lower melting point (90°C) [26].  
2.3.1.2 Metabolism of cocaine 
Once a drug is administered, it is irreversibly transferred to the systematic circulation and 
distributed to the various body sites such as the liver, kidneys, and the brain [27]. Then, the drug 
is bio-transformed into its metabolites, which become more water soluble with polarity increase 
to be readily excreted by the kidneys (renal excretion) and the liver (biliary excretion) [28].  
The drug pathway through the body is different depending on the administration method. The 
greatest difference is the location of metabolism in the body.  
If orally ingested, drug metabolites are formed primarily through enzymatic hydrolysis in the liver 
and butyl-cholinesterase in plasma or through oxidative metabolic processes in liver. The liver 
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hepatocytes contain all the necessary enzymes for drug metabolism. The main enzymes are 
cytochrome P450 (CYP) group, which are also involved in cocaine metabolism [29]. 
If inhaled, drug metabolites are formed in the lungs. However, different CYP drug metabolising 
enzymes are expressed in the lungs compared with the liver, and the expression levels are generally 
lower. Therefore, the metabolizing capacity of the lungs is generally lower than that of the liver 
[30].    
Once cocaine is administered into a body, the major cocaine metabolites, benzoylecgonine (BZE) 
and other metabolites are produced. These become eventually ecgonine through hydrolysis 
metabolised reaction. BZE is formed by both enzymatic and non-enzymatic hydrolysis in liver and 
lung. Because both are produced by hydrolysis action, pure cocaine powder could contain both 
BZE and EME if it is stored near a humid space. Figure 2 depicts the metabolic pathway of cocaine 
administered into the body. The half-lives of BZE and EME are both much longer than the half-
life of cocaine. If 100 mg of cocaine is snorted, BZE may be detected for 4 to 6 hours, and EME 
may be detected up to 4 hours in blood. If 20 mg of cocaine injected, the half-lives of both 
metabolites increase by a factor of 1.5 to 2.1 than if it is snorted [31].    
 
Figure 2 Structure of cocaine and its metabolic pathway including the main metabolite, BZE (red squared). BZE is produced by 
the enzymatic and non-enzymatic metabolic actions of cocaine in liver and lung [32]. 
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2.3.1.3 Detection window of cocaine 
The detection window is defined as the time that a drug can be detected in biological matrices 
above the designated cut-off level [33]. For example, if the detection starts at t=14 hour and ends 
at t=48 hours, the detection window is 34 hours.  
The detection window of a given substance is also different depending on the matrix which is 
analysed and the concentration of biological matrix. The formed metabolites, as well as the non-
metabolised parent drug are primarily excreted into urine or bile, so using urine samples for drug 
testing has been a conventional test and is still applied in current drug testing systems [34, 35]. 
However, cocaine can also be detected in oral fluid [36, 37], blood [38, 39], hair [40, 41], and 
sweat [42]. Other factors which influence the detection window can be the route of administration, 
the duration of use, target substances, and sensitivity of the applied method [43].   
Generally, detection windows follow the following order, with the longest detection time first, hair, 
urine, sweat, oral fluid, and blood [43].  
Hair analysis can allow the observation of changes in drug use over time, a non-invasive sample 
collection as well as widest detection window of drug. However, recent drug use (within 7 days) 
cannot be detected, and interpretation of drug analysis in hair is sometimes unreliable due to 
complexities of hair structure and stability of drugs in hair [44]. In hair, deuterated cocaine 
(cocaine-D5) remained for 2 to 6 months with concentration of 0.1 to 5 ng/mg hair when a single 
dose (0.6 to 4.2 mg/kg) of it was consumed by participants (n=25). On the other hand, its 
metabolite, BZE-D5 was detected with a sixth of the concentration (less than 1 ng/mg hair) [45]. 
For chronic users, cocaine was able to stay in hair up to 8 months although the donor stopped 
taking the drug [46]. 
Urine testing can provide enough quantities of sample matrix for confirmation testing and retesting, 
as well as the presence of both the parent drug and its metabolites in high concentration. However, 
the sample of urine can be adulterated easily [44]. In urine, BZE, the main metabolite of cocaine, 
tends to be more sensitive because it remains for longer than cocaine in urine. In one study, 
participants who administered cocaine orally (22.4 mg, n=6), intravenously (25 mg, n=6), and by 
smoking (42 mg, n=3) were monitored. The detection time (at the time which substances start to 
be detected), of BZE in urine was usually approximately one day, but in some cases extended up 
to 55 hours. In case of cocaine, the longest detection time in urine was less than 36 hours [47]. 
Cocaine and BZE could remain in urine up to 21 days from the chronic users or following a heavy 
binge [34]. 
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Sweat testing can provide a non-invasive sample collection process. The collection of sweat can 
last over several days or weeks using patches worn on the skin, so that it can obtain a cumulative 
and effective drug-use surveillance [48]. On the other hand, concentrations of drugs in the patch 
are lower than urine, and there is a possibility of environmental contamination present before patch 
application and after removal [44]. In one study, sweat was collected by means of sweat patch 
from participants who had a history of cocaine or heroin abuse by means of sweat patch up to for 
several days. These samples were analysed by gas chromatography mass spectrometry (GC-MS). 
After cocaine was administered to the participants, cocaine lasted in sweat from within 1 to 2 hours 
to weeks and highest concentration observed within 24 hours with the detectable amounts on the 
patch as small as 1 to 5 mg, which is below the dose needed for drug-induced effects. Moreover, 
smaller amounts of respective metabolites, BZE and EME were detected as well [49].          
Oral fluid testing can also provide a non-invasive sample collection process and presence of higher 
concentrations of parent drug than for a urine test, so it can provide an advantage for drug 
identification. On the other hand, oral fluid samples can be easily contaminated because of food 
ingestion or smoking [44].  In oral fluid, detection windows of cocaine and BZE are typically 
shorter than for hair and urine. For example, in one study, participants (n=10), who smoked or 
used intravenously (IV) injected cocaine for at least 6 months, administered a single dose of 25 
mg IV cocaine on three separate days (Days 1, 5, and 10). The earliest detection window for 
cocaine in oral fluid was 0.17 hours, which is about 10 minutes after IV cocaine administration. 
On the other hand, the earliest detection window for BZE was 0.5 hours. The average detection 
window for cocaine and BZE in oral fluid was 6.5 and 28 hours respectively at 1 μg/L of the cut 
off of their concentration [50]. As mentioned previously, depending on the oral fluid collection 
device, the detection window and cut-off level of drugs will be variable. 
Blood testing targets parent drugs, so it is effective for drug identification. Additionally, donors 
cannot falsify their blood samples to pass the test because collection is supervised. However, a 
blood test is very invasive method of sample collection and the detection window is limited [51]. 
In blood, the half-life of cocaine and BZE are approximately 1 hour and 6 hours, respectively. This 
refers to the time that it takes for the blood concentration of a substance to become half of the 
concentration of the initial value at maximum blood plasma concentration. For chronic users, the 
half-life is longer due to accumulation of drugs inside of the body. In a recent research study, the 
participants administered intranasal cocaine with dose between 20 and 100 mg. The detection 
window of cocaine in blood was 4 to 6 hours in 20 mg dose and to 12 hours in 100 mg dose [43]. 
Another study showed that low dose of cocaine administration (70 mg/75 kg) provided the average 
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of 11.5 hours (from 4.0 to 24.1 hours) of detection window of cocaine in blood plasma. On the 
other hand, a high dose of cocaine administration (150 mg/75kg) resulted in detecting during 
average of 9.8 hours (from 4.0 to 47.6 hours) of it. The detection window of BZE and EME were 
an average of 48 hours (from 24.0 to 48.0 hours post administration) and an average of 24 hours 
(from 4.0 to 48.0 hours post administration) in both low and high dose of cocaine [52]. If cocaine 
is administered intravenously or smoked, the peak level in blood occurs within 5 to 10 minutes. If 
it is inhaled, it takes less than 60 minutes to reach the peak level [17].  
Table 1 Summary of detection window of cocaine and BZE in different biological matrices. 
 Cocaine BZE 
Hair 2 to 6 month (cocaine D5) [45] 
For chronic users, up to 8 months [46] 
1 week to 1 month (BZE D5) [45] 
Urine Single dose: up to 36 hours [47] 
From chronic users or heavy binge, 21 
days [34] 
Single dose: 24 hours to 55 hours [47] 
From chronic users or heavy binge, 21 
days [34] 
Sweat within 1 to 2 hours to weeks and highest 
concentration at within 24 hours (1 to 5 
mg) [49]. 
 
Oral fluid The earliest, 0.17 h, the average, 6.5 h 
at a 1 μg/L cut off [50].   
The earliest, 0.5 h, the average, 28 h at 
a 1 μg/L cut off [50]. 
Blood 4 to 6 hours in 20 mg dose and 12 hours 
in 100 mg dose [43]. 
A low dose of cocaine administration 
(70 mg/75 kg), 11.5 hours (4.0 to 24.1 
hours). A high dose of cocaine 
administration (150 mg/75kg), 9.8 
hours (4.0 to 47.6 hours) [52]. 
If smoked or intravenously 
administered, 5 to 10 minutes. If 
inhaled, less than 60 minutes [17]. 
48 hours (24.0 to 48.0 hours post 
administration) from the low dose. 24 
hours (4.0 to 48.0 hours post 
administration) from the high dose 
[52].  
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2.3.2 Heroin 
2.3.2.1 Chemistry of heroin 
Heroin, also known as diamorphine, is one of most commonly consumed opioids which belongs 
to the category of narcotics. Heroin was first introduced by syntheses from morphine to be used as 
a replaced pain relief because the addiction rate of morphine abuse increased at that time.  
Once heroin is administered, heroin converts to morphine and binds to the opioid receptors on cells 
in the brain causing euphoria. At the same time nausea, respiratory depression and constipation 
can occur [53]. Heroin addiction has become one of the most common and serious problems in the 
society, so the Controlled Substances Act (CSA) classifies heroin as a Schedule II drug [18]. 
Production of illicit heroin takes several steps, 1) extracting morphine from the opium poppy seed 
pods, 2) producing morphine base, 3) producing heroin from morphine base. 
Once opium poppy seed pods are taken, they are placed into boiling water with lime. Then, 
morphine substances float to the top of water. After separating them off the water, the raw 
morphine substances are boiled with ammonia and filtered continuously until a brown precipitated 
paste is shown, which is morphine base. This is dried into bricks. The morphine base is dissolved 
in a solvent (chloroform or alcohol) and heated in a water bath. During the heating process, an 
acetylating solution is added in to the boiling solution along with hydrochloric acid to induce 
crystallisation of heroin [54]. The final products are mixed with adulterants such as paracetamol, 
caffeine, procaine, and codeine. Even sugar, starch, flour, and powdered milk have been found in 
street heroin [22]. 
2.3.2.2 Metabolism of heroin 
The main routes of administration of heroin are via injection into veins and smoking [43]. It can 
be also taken through by mouth or snorting. As explained in Section 1.1.1.2, the drug pathway 
through the body is different depending on the administration method.  
6-monoacetylmorphine (6-AM) is the main metabolite of heroin, and it is rapidly produced by 
metabolism of heroin through enzymatic hydrolysis. Further enzymatic hydrolysis of 6-AM 
produces morphine by eliminating the acetyl esters [55]. Morphine is also metabolised by free 
phenolic group conjugating with glucuronic acid producing morphine-3-glucuronide and 
morphine-6-glucuronide [56]. Metabolism of heroin primarily occurs in the liver with cytochrome 
P450 (CYP) group mainly involved. 90 % of metabolites are excreted through urine, with the rest 
of them being excreted through the faeces [56].   
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Figure 3 Metabolic pathway of heroin and its metabolites, heroin (A), 6-AM (B), morphine (C), morphine-3-glucuronide (D), and 
morphine-6-glucuronide (E) . 
2.3.2.3 Detection window of heroin 
In hair, heroin has a long detection widow. Hair samples (1.5 inches from the scalp) of participants 
(n=280) with heroin abuse were collected and analysed with a cut-off value of 300 pg/mg. As a 
result, heroin was detected for up to 3 months [57]. In the case of 6-AM, it is detected more stably 
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in hair compared to urine or blood samples, and it can be used to distinguish heroin from morphine 
since 6-AM is the main metabolite of heroin, which can be the biomarker of heroin use [44].   
In urine, detection windows are shorter. In one study, participants (n=52) who attended a protected 
detoxification treatment program provided their urine samples daily for 3 weeks. 6-AM was 
initially detected in urine on average of 5 hours (0.5 to 34.5 hours) after initial dose, and total 
morphine was detected in urine in average of 118.8 hours (25.3 to 270.3 hours) after initial dose 
[58].  
In another study, 7 male participants were given intravenous doses of 3, 6, and 12 mg of heroin 
hydrochloride. 6-AM was detected up to 2.3, 2.9, and 4.4 hours, respectively. Total morphine was 
detected up to 18.5, 24.8, and 35.3 hours, respectively (cut-off value: 300 ng/ml). Moreover, 4 
male participants smoked 3.5, 5.2, 7, 10.5, or 13.9 mg doses of heroin base. With low dose (below 
7 mg of doses), morphine was detected for an average of 15.7 hours (7.4 to 31.9 hours). On the 
other hand, in case of 10.5 and 13.9 mg of doses, it was detected for an average of 34.4 hours (10.7 
to 53.5 hours) [59].  
Urine samples of 63 male heroin addicts for 3 years were collected. The earliest detection time of 
morphine from the last heroin administration was 8.5 hours. Morphine stayed in the body for 7 
days with the decreasing rate: 88.4, 74.2, 64.2, 57.1, 63.3, and 44.8 % for after 1 day to 6 days 
respectively [60].        
In sweat testing for heroin, sweat samples were collected from heroin users using sweat patches. 
Heroin and 6-AM were detected with highest concentration within 24 hours (LOD: 1 ng/patch). 
One thing to note was that 6-AM appeared rapidly after heroin administration and the 
concentration of it increased as that of heroin decreased over time. It suggests that heroin was 
undergoing the hydrolysis metabolic process in the sweat patch, but morphine was not detected 
[49].      
In oral fluid testing, detection windows are considerably shorter than for urine or hair. Oral fluid 
samples from 6 participants, 3 for intravenous doses (5, 10, and 20 mg of heroin hydrochloride 
and 2.6, 5.2, and 10.5 mg of heroin base) and rest of them for smoking (3, 6, and 12 mg of heroin 
hydrochloride and 3.5, 7.0, and 10.5 mg of heroin base) were collected periodically. The earliest 
detection time of heroin in oral fluid was 2 minutes by both routes. The detection window of heroin 
in oral fluid through both routes was up to 24 hours. Similarly, 6-AM was detected after 2 minutes 
at the earliest by both routes. 6-AM was detected in oral fluid for 0.5 to 8 hours and 1 to 4 hours 
after smoked and intravenous heroin administration, respectively. Morphine was also detected in 
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both routes of administration. Concentrations of morphine in oral fluid were higher (76 to 142 
ng/ml) after smoking than after intravenous administration (6 to 37 ng/ml) [61].   
Another study showed that 6-AM can be detected in oral fluid from 0.5 to 8 hours, and morphine 
can be detected from 12 to 24 hours [62]. 
The typical half-life of heroin (10 mg) in blood is less than 10 minutes. The half-lives of 6-AM 
and morphine are longer than for heroin in blood, and are 6 to 25 minutes and 2 to 3 hours, 
respectively [63]. In one study, blood samples from 6 participants, 3 for intravenous doses (5, 10, 
and 20 mg of heroin hydrochloride and 2.6, 5.2, and 10.5 mg of heroin base) and rest of them for 
smoking (3, 6, and 12 mg of heroin hydrochloride and 3.5, 7.0, and 10.5 mg of heroin base) were 
collected periodically. Heroin was detected in blood in 5 minutes at the earliest by both routes of 
administration. A higher concentration of heroin was more frequently found in blood samples after 
intravenous administration. However, the concentration rapidly declined, so that it was only 
detected up to 30 minutes after administration. 6-AM was also detected in blood after 5 minutes 
at the earliest by both routes of administration. Unlike heroin, 6-AM remained in blood for a longer 
period and was detected for up to 2 hours. Morphine was detected in blood after 10 minutes at the 
earliest by both routes of administration. The concentration of morphine decreased relatively more 
slowly than heroin and 6-AM did. It was detected up to 2 and 12 hours after smoking and 
intravenous administration, respectively [61]. 
In another study, two participants administered a single dose of morphine and codeine through 
intramuscular injection (low dose: 10 mg and high dose: 20 mg). Morphine was detected up to 24 
hours with high dose of intramuscular injection [64]. 
Table 2 Summary of detection window of heroin, 6-AM, and morphine in different biological matrices. 
 Heroin 6-AM Morphine 
Hair Up to 3 months with a cut-
off value of 300 pg/mg [57].  
  
Urine  Average of 5 hours (0.5 to 34.5 
hours) after initial dose. The cut-
off value of opiates 200 ng/ml 
[58]. 
Intravenous dose of 3 mg, 2.3 
hours. Intravenous dose of 6 mg, 
2.9 hours. Intravenous dose of 12 
Average of 118.8 hours (25.3 to 270.3 
hours) after initial dose. The cut-off 
value of opiates 200 ng/ml [58]. 
Intravenous dose of 3 mg, 18.5 hours. 
Intravenous dose of 6 mg, 24.8 hours. 
Intravenous dose of 12 mg, 35.3 hours 
(cut-off value: 300 ng/ml) [59]. 
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mg, 4.4 hours (cut-off value: 300 
ng/ml) [59]. 
 
Smoked of low dose (3.5, 5.2, and 7 
mg), an average of 15.7 hours (7.4 to 
31.9 hours). Smoked of high dose (10.5 
and 13.9 mg), an average of 34.4 hours 
(10.7 to 53.5 hours) [59].  
8.5 hours from the last heroin 
administration. Stayed in the body for 7 
days with the decreasing rate: 88.4, 
74.2, 64.2, 57.1, 63.3, and 44.8 % for 
after 1 day to 6 days respectively [60].  
 
Sweat Within 24 hours (LOD: 1 
ng/patch) [49]. 
Within 24 hours (LOD: 1 
ng/patch). 
The concentration of 6-AM 
appeared rapidly after heroin 
administration increased as that of 
heroin decreased over time [49]. 
 
Oral 
fluid 
From both Intravenous 
doses (5, 10, and 20 mg of 
heroin hydrochloride and 
2.6, 5.2, and 10.5 mg of 
heroin base) and smoking 
dose (3, 6, and 12 mg of 
heroin hydrochloride and 
3.5, 7.0, and 10.5 mg of 
heroin base), 2 minutes to 24 
hours [61].  Morphine was 
also detected in both routes 
of administration. 
Concentrations of morphine 
in oral fluid were higher (76 
to 142 ng/ml) after smoking 
than after intravenous 
administration (6 to 37 
ng/ml) 
From 2 minutes to 0.5 hours to 8 
hours (smoked). From 2 minutes 
to 1 to 4 hours (intravenous) [61].  
From 0.5 to 8 hours after 
administration [62].  
From 12 to 24 hours after 
administration [62].  
Blood Intravenous doses (5, 10, 
and 20 mg of heroin 
hydrochloride and 2.6, 5.2, 
and 10.5 mg of heroin base) 
and smoked doses (3, 6, and 
12 mg of heroin 
5 minutes at the earliest by both 
routes of administration up to 2 
hours [61]. 
10 minutes at the earliest by both routes 
of administration up to 2 (smoking) and 
12 hours (intravenous) respectively 
[61]. 
A single dose of morphine through 
intramuscular injection (low dose: 10 
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hydrochloride and 3.5, 7.0, 
and 10.5 mg of heroin base), 
5 minutes at the earliest by 
both routes of 
administration up to 30 
minutes [61].  
mg and high dose: 20 mg), Morphine 
was detected up to 24 hours with high 
dose of intramuscular injection [64]. 
 
2.4 Introduction to NPS  
As well as considering heroin and cocaine, this thesis will survey a range of novel psychoactive 
substances (NPS). NPS were originally synthesised for research and pharmacological purposes. 
These substances mimic the effects of conventional drugs of abuse, such as cocaine, heroin, 
cannabis, and ecstasy (MDMA). Because of their origin, NPS were legally allowed until they were 
first available in the market as incense or air freshener in mid-2000s [65]. Since then, 
unrecognisable psychoactive substances rapidly increased in the drug market causing severe health 
problems. Therefore, new legislation for controlling NPS are being developed and implemented 
around the world. By 2017, over 60 countries had implemented a legislation on controlling NPS. 
Internationally, the Commission on Narcotic Drugs put 27 NPS under international control [66]. 
Nevertheless, the use of these drugs are spread by online purchase by students and clubbers, and 
they are detected from prisoners [67].   
2.4.1 Chemistry of NPS 
The main method to produce NPS is to tweak the chemical structure of existing conventional illicit 
drugs in order to mimic the effects of them. Manufacturers increasingly contort the chemical 
compositions and structures of the drugs to make them “legal”, so it becomes more difficult to 
identify and detect using current techniques available to law enforcement authorities. There is no 
universally accepted way to categorise NPS, but based on the chemical structure and their 
following effects, they can be broken down into aminoindane, synthetic cannabinoid, synthetic 
cathinone, phencyclidine-type substance, phenethylamine, piperazine, plant-based substance, and 
tryptamine according to UNODC (United Nations Office on Drugs and Crime) Early Warning 
Advisory on New Psychoactive Substances [66]. Since this study has investigated substances of 
synthetic cannabinoid, it will only be introduced in this chapter.   
1.2.1.1 Synthetic cannabinoids 
Synthetic cannabinoids are human-made substances to mimic the desired effects of cannabis [67]. 
They were originally invented for research purposes, but they appeared on the market as drugs of 
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abuse in 2004 with product names such as “Spice”, “K2”, or “herbal incense”. Although they are 
labelled in “not for human consumption”, they are usually smoked in order to have similar effects 
to those of cannabis [68].  
Synthetic cannabinoids, often to be referred to as synthetic cannabinoid receptor agonists (SCRAs), 
are group of chemically unrelated structure functioning similarly to Δ 9-tetrahydrocannabinol 
(THC), which is the principal constituent of cannabis. Unlike natural cannabis, which has THC as 
a primary psychoactive substance, SCRAs have wide arrays of molecules stimulating the brain’s 
cannabinoid receptors (CB). Besides, SCRAs do not contain cannabidiol (CBD), which is natural 
cannabinoid constituent of natural cannabis [69]. There are two main CBs: CB1 and CB2 receptor. 
The CB1 receptor is mostly found in the central nervous system (CNV) and associated with 
psychoactive effects. The CB2 receptor is associated with the immune system [70]. This means 
that the more the affinity to the CB1 receptor, the higher the potency of psychoactive inducing 
compounds [69]. Based on the chemical structure, SCRA are broken down into eight categories: 
tetrahydrocannabinols analogue, cyclohexylphenol (CP), naphthoylindoles, 
naphthylmethylindoles, naphthoylpyrroles, naphthylmethylindenes, phenylacetylindoles, and 
benzoylinedoles [68]. 
Tetrahydrocannabinols based synthetic cannabinoids are analogues of THC based on a 
dibenzopyran ring, so they are so called “classical cannabinoids”. Navilone, Dronabinol, and HU-
210 are listed as examples of THC analogue. As shown in Figure 4, the molecular structures of 
them are very similar to THC. Navilone and Dronabinol can be used sparingly for therapeutic 
purposes in USA, but HU-210 is highly controlled legislatively in USA and Europe [70]. HU-210 
is a full non-selective agonist to CB1 receptor, which is 100 times more potent than THC since it 
partially agonist at CB1 [70-72].     
 
 
Figure 4 Chemical structure of THC (A), HU-210 (B), and Nabilone (C). 
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Cyclohexylphenols (CP) are usually called “non-classical” cannabinoid [66].  Their series (CP47, 
497, CP 59, 540, and CP 55, 940) was originally synthesised by Pfizer for research use and 
potential antidepressant properties in the late 1980s [70]. However, it has been found that CP 47, 
497 and its homologues (C6, C8, and C9) were one of the main ingredients in the herbal incense 
so called “Spice” or “K2”[73]. Therefore, they have become scheduled drugs in USA and Europe 
[74]. These synthetic cannabis have 3 to 28 times more affinity for the CB1 receptor than THC 
[75]. One of its homologues, cannabicyclohexanol ((C8)-CP 47, 497) has several times more 
potency than the parent compound [76].  
 
Figure 5 Chemical structure of CP 47, 497 
Naphthoylindoles, naphthylmethylindoles, naphthoylpyrroles, phenylacetylindoles, and 
benzoylindoles can be grouped into aminoalkylindoles and naphthylmethylindenes can be grouped 
into aminoalkylindenes. They contain varieties of synthetic cannabinoids which are structurally 
dissimilar to THC [66] as shown in Figure 6. Aminoalkylindolesare the most common compounds 
found in herbal products. This is because, the synthesising process of aminoalkylindoles is less 
complicated than that of classical, non-classical, or hybrid cannabinoids [66]. J.W Huffman and 
his group at Clemson University, USA synthesised a large series of naphthoylindoles, 
naphthylmethylindoles, naphthoylpyrroles, naphthylmethylindenes, and phenylacetylindoles in 
the 1990s [70]. Therefore, most of synthetic cannabinoids under those groups are named after the 
initial of J.W Huffman.  
Naphthoylindoles are defined with any compound containing a 3-(1-Naphthoyl) indole structure 
with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, 
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl 
group with naphthyl ring joined by a carbonyl group in the centre of the compound. [77, 78]. 
JWH-018 is the main example of naphthoylindoles. It is a full agonist of both the CB1 and CB2 
receptors producing THC similar effects in humans. The affinity for the CB1 receptor is five times 
greater than that of THC according to the study [79]. JWH-018 is one of the most primary 
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constituents of herbal blend, “Spice”, which is heavily abused in prisons[66]. In a case study 
comparing the consumption of THC and the JWH-018 ingredient “Spice”, a patient consumed the 
“Spice” daily for eight months. The THC-causing symptoms became more severe and the time to 
desensitisation was much shorter compared to THC [80]. There was also a case that a basketball 
player died because of drug toxicity and organ failure derived from JWH-018 [81]. Because of its 
hazardous nature, JWH-018 is currently listed as Schedule I controlled substances in USA and 
regulated in many European countries. Nevertheless, analogues of it are emerging in the 
commercial market [74]. The current marijuana immunoassay methods cannot detect the presence 
of synthetic constituents in “Spice”, so an immunoassay method to detect it has been being 
developed [82]. 
 
Figure 6 Chemical Structure of naphthoylindoles (A) and JWH-018 (B).  
Naphthylmethylindoles are defined with any compound containing a 1 H-indol-3-yl-(1- naphthyl) 
methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, 
alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-
morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and 
whether or not substituted in the naphthyl ring to any extent[77]. As shown in Figure 7, 
naphthylmethylindoles look structurally similar to naphthoylindoles except the presence of two 
double ring structures connected by a carbonyl functionality [78].  
JWH-175 is the most popular example of naphthylmethylindole drugs. Structurally, it is very 
similar to JWH-018 except ketone bridge replaced by a simpler methylene bridge, which makes 
several time weaker binding affinity at the CB1 receptor than JWH-018. JWH-175 is also quite 
less potent compared to most synthetic cannabinoid drugs in synthetic blends, so it has not been 
found for the purpose [83]. However, it is strictly controlled in United Kingdom, Australia, Russia, 
and some states in USA.  
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Figure 7 Chemical structure of naphthylmethylindoles (A) and JWH-175 (B).  
Naphthoylpyrroles are defined with any compound containing a 3-(1-naphthoyl) pyrrole structure 
with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, 
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl 
group, whether or not further substituted in the pyrrole ring to any extent and whether or not 
substituted in the naphthyl ring to any extent [77]. 
JWH-030 is one of example of a naphthoylpyrrole drug. It is a partial agonist to the CB1 receptors, 
and it has roughly half the potency of THC. Like previous JWH group drugs, it also provides 
analgesic effects [84]. A recent study regarding symptoms of synthetic cannabinoids abuse 
suggested that JWH-030 is cytotoxic and can cause adverse cardiovascular effects in case of 
abuse[85].  
 
Figure 8 Chemical structure of naphthoylpyttoles (A) and JWH-030 (B). 
Naphthylmethylindenes are defined with any compounds  containing a naphthymethylindenes 
structure, which is composed of an indene ring unlike previous aminoalkyliniodoleswhich are 
composed of an indole ring, with substitution at the 3-position of the indene ring by an alkyl, 
haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-
morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and 
whether or not substituted in the naphthyl ring to any extent[77, 78]. 
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JWH-176 is an example of naphthymethylindene drugs and analgesic drug [83]. Unlike previous 
analgesic JWH group drugs, it is structurally contrasted with consisting of only hydrocarbon 
containing no heteroatoms, especially nitrogen in this case. It results in lack of hydrogen bonding 
capability, but it still demonstrated high affinity to CB1 receptors, which proved more potent than 
THC itself. This can suggest that hydrogen bonding capability with morpholino nitrogen or 
carbonyl oxygen does not serve as crucial interaction sites to CB1 receptor. Instead, aromatic rings 
are key to interact with CB1 receptor [86].  
Studies regarding metabolism of JWH-176 have been carried out recently because of its unique 
structure with no heteroatom or carbonyl group compared to other JWH group drugs, which could 
result in different metabolic pathways. As a result, mono- and di-hydroxylated metabolites were 
identified using human hepatocyte which are found mostly from other JWH drugs [87].        
 
 
Figure 9 Chemical structure of naphtylmethylindene (A) and JWH-176 (B).  
Phenylacetylindolesare defined as any compounds containing a 3-phenylacetylindole structure, 
with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, 
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 
group, whether or not further substituted in the indole ring to any extent and whether or not 
substituted in the phenyl ring to any extent[77]. This chemical looks structurally similar 
tonaphtoylindoles except phenylacetylindoles do not contain naphthalene ring.   
JWH-250 is an analgesic substance and one example of phenylacetylindoles with comparable 
potency to THC [83]. It has high affinity for both CB1 and CB2 receptors. Because of the absence 
of naphthalene ring, this family of drugs can be regarded as a new class of cannabinoid ligands 
[88]. JWH-250 became one of new generation constituents of “Herbal blend” or “Spice” since 
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JWH-018 and (C8)-CP 47, 497 had been banned. Because of structural similarity to 
naphtoylindoles (e.g. JWH-018), it is not difficult to manufacture if manufacturer already knew 
how to synthesiseJWH-018, and the symptoms of them are very similar [70]. Therefore, JWH-250 
is also highly regulated in Australia and many European countries. In the USA, it has been 
designated as a Schedule I drug [89].      
 
Figure 10 Chemical structure of Phenylacetylindoles (A) and JWH-250 (B).  
Benzoylinedoles are defined as any compound containing a 3-(benzoyl)indole structure with 
substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, 
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl 
group whether or not further substituted in the indole ring to any extent and whether or not 
substituted in the phenyl ring to any extent[77]. It is structurally very similar to 
phenylacetylindoles except absence of methylene group between the benzene ring and the 
connecting carbonyl moiety [78]. 
RCS-4, also sold as OBT-199, RT-19, BTM-4, and Eric-4, represents the first benzoylindoles 
identified as synthetic cannabinoid designer drugs. It has high affinity for both CB1 and CB2 
receptors and it is potent. It is one of the most common constituents identified in “herbal highs” 
internationally. Therefore, it has been already designated as a Schedule I drug in the US and is 
highly regulated in multiple centuries. Besides, because of its popularity, research regarding 
development of analytical methods for detection and quantification of RCS-4 [90] and its 
metabolism study in hair [91], urine [92], serum [93],  and oral fluid [94] have been investigated. 
Furthermore, homologues of RCS-4: RCS-2, RCS-3, and RCS-4-C4 were also identified in order 
to replace RCS-4 in “herbal highs” these days, and they are not regulated yet. However, the affinity 
of those substances at both CB1 and CB2 receptors still high enough to cause adverse effects to 
human body, so the possibility to be sold in the black market has emerged [95].       
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Figure 11 Chemical structure of benzoylindoles (A) and RCS-4 (B).  
Cannabis is the most widely used for recreational purposes [67]. There are various kinds of SCRAs 
existed in this world, and still unidentified substances keep emerging in the market due to more 
severe regulations. Although SCRAs produce similar effect to those of THC, they should not be 
treated the same. As described in this section, SCRAs mostly have higher affinity for both CB1 
and CB2 receptors than THC, and many of them are more potent than THC. Because of a lack of 
information regarding their detailed pharmacological actions, potential adverse effects from 
SCRAs are still unknown, and they may have different biological actions from those of THC [69, 
70].  
2.4.2 Metabolism of NPS 
Compared to conventional drugs, very little research concerning the pharmacokinetics and 
pharmacodynamics of NPSs has taken place, because new synthetic substances mimicking the 
psychoactive effects of conventional drugs are constantly produced in order to avoid regulation 
against them. From a forensic perspective, acknowledging the mechanisms of metabolism of a 
drug is very significant. Metabolites may often exist higher concentration than their parent drugs 
and so increase the window detection for drug testing. Depending on the period of abuse, the half-
life of drugs and their metabolites can be extended. 
Most of experimental work on NPS have been conducted in vitro using recombinant cytochrome 
P450 (CYP) enzymes, which are the most common cytochrome enzyme group to metabolise 
potentially toxic compounds to the human body such as drugs and endogenously metabolised 
products. Besides, human liver microsomal incubations (as vesicles of the hepatocyte endoplasmic 
reticulum) are sometimes used to show the outline of phase I metabolism with phase I enzyme 
namely CYPs, flavine-containing monooxygenases (FMO), esterases, amides, and epoxide 
hydrolases [96]. They are not present in healthy and living cells, but they contain CYP so that they 
are very useful to analyse the metabolic activity of CYP [97]. However, as NPS becomes 
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structurally diverse with new substituents and the addition of new functional group, other CYP 
enzymes or non-CYP enzymes may potentially play a role in the biotransformation of them [98].  
This section presents the metabolic pathway of each designated NPS and their respective metabolic 
products.       
UR-144 and XLR-11 
UR-144 ((1-pentylindol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone)and its fluorinated 
analogue, XLR-11 ([1-(5-fluoropentyl) indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl) methanone), 
are synthetic cannabinoid receptor agonist (SCRA) which is explained in Section 1.2.1.2. In 2015, 
they were the most frequently seized synthetic cannabinoids in worldwide [99].   
The metabolism of UR-144 (H+: m/z 312.2322) has not been systematically studied. No ADME 
(absorption, distribution, metabolism, and elimination) study of UR-144 was not available at the 
time of writing. However, mono-hydroxylated metabolites (UR-144 N-OH) were produced most 
abundantly with cytochrome P450 (CYP) enzymes, CYP3A4 and CYP 2B6 in vitro and in vivo 
[100]. Another study also investigated the reaction of UR-144 with different CYP enzymes 
(CYP1A2, 2B6, 2C8, 2C9, 2C18, 2C19, 2D6, 3A4, and 2E1) in order to identify specific CYP 
enzymes involved in the metabolism of UR-144 using human liver microsomes (HLM). As a result, 
CYP3A4 had an extensive influence on metabolising UR-144 at the tetramethylcyclopropyl 
(TMCP) moiety [101]. 
The other tool for metabolism studies is using the fungus called Cunninghamella elegans. 
According to Watanabe et al., UR-144 was incubated with the fungus, and products of metabolism 
were identified using liquid chromatography-mass spectrometry. UR-144 was metabolised by 
hydroxylation, dihydroxylation, trihydorxylation, aldehyde formation (RCOH), ketone formation 
(RCOR), carboxylation (COOH), and N-dealkylation (-N alkyl group) [102]. In this study, a 
standard of UR-144 5-Hydroxypentyl metabolite (m/z 328.2271) and UR-144 5-Pentanoic acid 
metabolite (m/z 342.2064) which are primary urinary metabolites according to the Sigma-Aldrich 
were applied as a tool for method validation.  
For XRL-11, drug incubation with human hepatocytes (major cell of the parenchymal tissue in the 
river, which carry out most function of metabolism) was carried out in order to determine the 
metabolic profiles using LC-MS. More than 25 metabolites were produced with mechanism of 
hydroxylation, carboxylation, hemiketal and hemiacetal formation, internal dehydration, and 
further glucuronidation from oxidative metabolites. Besides, defluorination occurred producing 
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UR-144 metabolites. There were three main sites of metabolic modifications found: the terminal 
position of the pentyl side chain, the teteramethylcycloporpyl (TMCP) ring, and α-carbon atom 
next to the carbonyl function. Based on the peak intensity, the main metabolites of XLR-11 turned 
out to be 2′-carboxy-XLR-11 (+2O, -2H), UR-144 pentanoic acid (-F, -H, +2O), 5-hydroxy-UR-
144 (-F, +O, +H), 2′-carboxy-UR-144 pentanoic acid (-F, -3H, +4O), and the 3 hydroxy-XLR-11 
glucuronides (+O, +C6H8O6)[103]. A standard of XLR-11 4-hydroxypentyl metabolite was used 
for method validation of its metabolite in this study.  
 
Figure 12 Mass spectra of UR-144 parent drug (a) and its most abundant fungal metabolites (b) [102]. 
PB-22 and 5F-PB-22 
PB-22 (1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid) and its fluoro analogue, 5F-PB-
22, 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid, are synthetic cannabinoid 
receptor agonist (SCRA). They were first detected in 2013 and emerged from then to 2014 in the 
USA. They are usually administered by smoking, but there is no reliable data available about 
dosage [104].  
Few metabolic studies of PB-22 and 5F-PB-22 have been conducted in vivo and in vitro. One study 
analysed specimens of drug incubation with human hepatocytes using HPLC-MS in order to 
determine the metabolic profiles of them. The predominant metabolic transformation was 
hydrolysis of the ester group, yielding wide variety of pentylindole-3-carboxylic acid (PI-COOH) 
and 5-fluoropentylindole-3-carboxylic acid (5F-PI-COOH) metabolites. Oxidation at different 
positions of PI-COOH also occurred as phase I biotransformation, while glucuronidation at them 
occurred as phase II biotransformation. For PB-22, the five most abundant metabolites were 
generated by ester bond cleavage and subsequent biotransformation: pentylindole-3-carboxylic 
acid (PI-COOH, M17), which had exclusively high intensity, PI-COOH glucuronide (M9), several 
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hydroxylated PI-COOH metabolites (M8, M4 and M10) and keto-PI-COOH (M3) as shown in 
Figure 13[105].A standard of PB-22 4-hydroxypentyl metabolite (m/z 375.1698) and PB-22 5-
pentanoic acid metabolite (m/z 389.1496)which are primary urinary metabolites of PB-22 
according to the Sigma Aldrich was applied for method validation for PB-22 in this study. Table 
3 shows the formula, protonated mass, and reaction of PB-22 and its metabolites. 
5-F PB-22 was found to have similar outcomes to those of PB-22. The hydrolysis of ester group 
was still predominant, and several different metabolic steps were undergone: hydroxylation, 
dihydroxylation, oxidative defluorination, carboxylation, epoxide hydrolysis, and conjugation 
with glucuronic acid or cysteine. Based on the intensity of peaks, there were five most abundant 
metabolites found. Three of them derived from hydrolysis of the ester group: 5′-
fluoropentylindole-3-carboxylic acid (5F-PI-COOH, M17), which was the most dominant, 5F-PI-
COOH glucuronide (M9), and hydroxy-5F-PI-COOH (M5). The remaining two still had a 
quinolone ring (heterocyclic aromatic organic compound, C9H7N) with defluorination [105]. 
These M-labelled metabolites can be found in Figure 14. A standard of 5-Fluoro PB-22 3-
carboxyindole metabolite (m/z 250.1238) which is primary urinary metabolite was applied for 
method validation for 5F-PB-22 metabolite in this study. Table 4 shows the formula, protonated 
mass, and reaction of 5F-PB-22 and its metabolites. 
Table 3 Major metabolites of PB-22, with their formula, H+ m/z for protonated molecular ion, and reaction. 
Formula M+H+ 
(m/z) 
Reaction 
C23H22N2O2 359.1756 Parent ion 
C14H17NO2 232.1337 Ester hydrolysis to PI-COOH 
C20H25NO8 408.1659 Ester hydrolysis + glucuronidation at PI-COOH 
C14H17NO3 248.1283 Ester hydrolysis + oxidation at indole moiety 
C20H23NO9 246.1124 Ester hydrolysis + ketone formation at PI-
COOH + glucuronidation 
C23H22N2O3 375.1698 Oxidation at pentyl side chain 
C23H24N2O4 393.1813 Epoxide hydrolysis 
C29H30N2O9 551.2023 Oxidation at indole moiety + Glucuronidation 
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Figure 13 Metabolic pathways and products of PB-22 in human hepatocytes. Parentheses indicate intermediate metabolites which 
were not detected on their own [105]. 
Table 4 Major metabolites of 5-F-PB-22, with their formula, H+ m/z for protonated molecular ion, and reaction. 
Formula M+H+ (m/z) Reaction 
C23H21N2O2F 377.1665 Parent ion 
C14H16NO2F 250.1238 Ester hydrolysis, 5F-PI-COOH 
C23H20N2O4 389.1493 Oxidative defluorination to carboxylic acid 
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C29H30N2O9 551.2021 Oxidative defluorination + glucuronidation 
C20H24NO8F 426.1550 Ester hydrolysis + glucuronidation at 5F-PI-
COOH 
C14H16NO3F3 266.1186 Ester hydrolysis + oxidation at 5F-PI-COOH at 
indole moiety 
 
 
Figure 14 Metabolic pathways and products of 5F-PB-22 in human hepatocytes. Parentheses indicate intermediate metabolites 
which were not detected on their own [105]. 
AB-PINACA 
AB-PINACA (N-[(2S)-1-amino-3methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3 carboxamide) 
is a synthetic cannabinoid receptor agonist (SCRA), which was first reported in 2012 and its 
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forensic detection was emerged since then. In 2014, it was one of the most common substances in 
the USA in 2014. With small concentration (nano-molar) binding to the cannabinoid receptor, it 
can still induce a number of biological responses caused by Δ9 –THC [106].  
There are some studies of the metabolism of AP-PINACA in vitro. Incubation of human 
hepatocytes identified 23 metabolites of AB-PINACA using LC-MS/MS via a mechanism of 
carboxamide hydrolysis, hydroxylation, ketone formation, carboxylation, epoxide formation with 
subsequent hydroxylation, and internal corboxamide hydrolysis. Among them, the most intense 
metabolites of AB-PINACA were AB-PINACA carboxylic acid (COOH), carbonyl AB-PINACA 
(COOR, ketone function on N-pentyl chain), hydroxypentyl AB-PINACA (C5H11OH), carbonyl 
AB-PINACA carboxylic acid and a hydroxypentyl AB-PINACA carboxylic acid isomer. Amide 
hydrolysis catalysed by carboxylesterase 1 and oxidation reactions catalysed by CYP450 
monooxygenases can occur at the same time producing a combination of carboxylic acid and 
hydroxylated metabolites [107]. In this study, a standard of AB-PINACA 5-hydroxypentyl 
metabolite (m/z 347.2078) and AB-PINACA 5-pentanoic acid metabolite (m/z 361.187) which are 
major urinary metabolite according to Sigma-Aldrich was applied for method validation process. 
Table 5 shows the formula, protonated mass, and reaction of AB-PINACA and its metabolites.    
Table 5 Major metabolites of AB-PINACA, with their formula, H+ m/z for protonated molecular ion, and reaction. 
Formula M+H+ (m/z) Reaction 
C18H26N4O2 331.2133 Parent ion 
C18H25N3O3 332.1974 Amide hydrolysis 
C18H24N4O3 345.1928 Ketone formation 
C18H26N4O3 347.2089 Oxidation 
C18H23N3O4 346.1771 Amide hydrolysis + ketone formation 
C18H25N3O4 348.1926 Amide hydrolysis + oxidation 
 
APINACA (AKB-48) 
APINACA is a SCRA and has similar effects to that of THC. There is very little information 
pharmacodynamics and pharmacokinetics and dependence potential of APINACA [108]. Despite 
the presence of unknown factors, there were 443 reports of AKB-48 related cases registered in the 
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National Forensic Laboratory Information System (USA) from 2010 to 2013. Therefore, it was 
classified as a Schedule I drug in USA in 2013.  
In 2013, a study characterising the metabolism of APINACA for the first time was published. 
Again, the drug was incubated with human hepatocytes and metabolic profiles were established 
using HPLC-MS. A total of 17 metabolites were found with mechanism of mono, di, try-
hydroxylation on the aliphatic adamantine ring or N-pentyl side chain. Glucuronide conjugation 
of mono and dihydroxylated metabolites occurred as well. Oxidation and dihydroxylation on the 
adamantine ring and N-pentyl side chain formed a keton. Among 17 products, 11 of them were 
identified and considered as major metabolites of AKB-48 based on the peak area (>e5). 
Theseincluded (see Figure 15) monohydroxylated (C23H31N3O, M17), dihydroxylated 
(C23H31N3O3, M5,7,10, and 15), trihydroxylated (C23H31N3O4, M1, 4, and 9), and mono- and 
dihydroxylated glucuronide conjugates (C29H39N3O8, M13 and 16) and dihydroxylated with ketone 
formation at the N-pentyl side chain (C23H29N3O4, M3)[109].A standard of APINACA 5-
hydroxypentyl metabolite which is an important biomarker for identifying intake of APINACA 
and a product resulting from mono-hydroxylation, was used for method validation. Table 6 shows 
the formula, protonated mass, and reaction of APINACA and its metabolites. 
Table 6 Major metabolites of APINACA, with their formula, H+ m/z for protonated molecular ion, and reaction. 
Formula M+H+ (m/z) Reaction 
C23H31N3O 366.2547 Parent ion 
C23H31N3O2 382.2487 Monohydroxylation 
C23H29N3O3 396.2284 Dioxidation 
C23H31N3O3 398.2443 Dihydroxylation 
C29H39N3O8 558.2799 Monohydroxylation and glucuronide conjugation 
C23H31N3O4 414.2387 Trihydroxylation 
C23H29N3O3 396.2279 Monohydroxylation and ketone formation 
C29H39N3O9 574.2753 Dihydroxylation and glucuronide conjugation 
C23H29N3O4 412.2232 Dihydroxylation and ketone formation 
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Figure 15 Metabolic pathways and products of APINACA in human hepatocytes [109]. 
AB-FUBINACA 
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide) is an indazole SCRA. It was originally developed as an analgesic for animals, but 
began to be used as an ingredient in synthetic cannabinoid blends. Although it is identified in drug 
seizures, little information of metabolism studies is available [110]. Like AB-PINACA, which is 
structurally related, one study analysed specimens of drug incubation with human hepatocytes 
using HPLC-MS/MS in order to determine the metabolic profiles of AB-FUBINACA by 
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comparing to those of authentic urine specimens. As a result, 11 and 10 metabolites were yielded 
from human hepatocytes and authentic human urine, respectively (see Figure 16) with major 
metabolic pathways of terminal amide hydrolysis, acyl glucuronidiation and hydroxylation at the 
aminooxobutane moiety, but with no defluorination. AB-FUBINACA carboxylic acid (M11), 
hydroxy-aminooxobutane AB-FUBINACA (M6), and AB-FUBINACA carboxylic acid 
glucuronide (M8) had the most intense peak in spectra in human hepatocytes. In authentic urine 
specimens, AB-FUBINACA carboxylic acid (M11), hydroxy-aminooxobutane AB-FUBINACA 
carboxylic acid (M7), and AB-FUBINACA carboxylic acid glucuronide (M8) were the three most 
common metabolites found, which could be suggested as suitable urinary markers for AB-
FUBINACA intake [111]. Unfortunately, there was no reference metabolite standard of AB-
FUBINACA found in order to use for method validation in this study. Table 7 shows the formula, 
protonated mass, and reaction of AB-FUBINACA and its metabolites. 
Table 7 Major metabolites of AB-FUBINACA with their formula, H+ m/z for protonated molecular ion, and reaction.  
Formula M+H+ (m/z) Reaction 
C20H21N4O2F 369.1721 Parent ion 
C20H21N4O3F 385.1683 Monohydroxylation 
C20H20N3O3F 370.1562 Amide hydrolysis (M11) 
C20H20N3O4F 386.1510 Amide hydrolysis + hydroxylation (M 7) 
C26H28N3O9F 546.1875 Amide hydrolysis + glucuronidation (M 8) 
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Figure 16 Metabolic pathways and products of AB-FUBINACA in human hepatocytes. Parentheses indicate intermediate 
metabolites which were not detected on their own [111]. 
2.5 Introduction to Fingerprints 
As a biological matrix to detect illicit substances, a fingerprint is selected. It is an individual 
characteristic; each person has thier own fingerprint pattern. Even identical twins who share same 
DNA have different fingerprint patterns. Moreover, a fingerprint pattern remains unchanged for 
the life of an individual unless enough physical force to transform the pattern is impacted on the 
finger. 
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2.5.1 Rationale for drug testing from a fingerprint  
Nowadays, a fingerprint can be used for more than just personal identification. Recently, a number 
of papers have demonstrated that fingerprint can be used as a tool to detect biomarkers for clinical 
[112-114], geochemical [115, 116], and forensic purposes. Especially, in the perspective of 
forensic toxicology, it has been proposed that a fingerprint can offer a rapid and convenient method 
of screening for drugs, wherein the ridge detail of the fingerprint encapsulates the donor’s identity 
unlike drug test using oral fluid or urine.  
A fingerprint mostly consists of a mixture of sweat from various glands in the skin. When an illicit 
drug is administered into the body, the drug is bio-transformed into its metabolites in liver or lung. 
The drug and its metabolites are then excreted in multiple ways, including via sweat. Therefore, 
to detect drug use from a fingerprint, the drug and its metabolites are the main targets.  
2.5.2 Chemical composition of fingerprints 
There are three types of sweat glands found on the human body: eccrine, sebaceous, and apocrine. 
Fingerprints consist of a mixture of endogenous compounds secreted by the eccrine glands (located 
in the palms and fingertips) and sebaceous glands (located most abundantly on the scalp and face). 
As shown in Table 8, sebaceous glands secrete compounds called sebum which comprise lipid 
compounds. Sebum is the major components in a fingerprint produced by contact transfer from 
the face [117]. The resulting chemical mixture includes organic compounds such as amino acids 
(e.g. serine, glycine, and ornithine) and lipids or inorganic compounds such as metal salts (e.g. 
zinc, cobalt, and copper) [118]. The list of compounds secreted from each type of gland is shown 
in the Table 8 [119]. 
Table 8 Chemical compounds typically found in eccrine and sebaceous gland secretions [119].  
Eccrine Gland Sebaceous Gland 
Organic constituents Inorganic 
constituents 
Organic constituents Inorganic 
constituents 
proteins 
polypeptides 
lactic acids 
choline 
ammonium 
calcium 
sulphide 
magnesium 
free fatty acids 
wax esters 
diglycerides 
triglycerides 
N/A 
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amino acids 
urea 
creatinine 
uric acid 
phenol 
vitamins 
chlorides 
sodium 
potassium 
ammonia 
 
monoglycerides 
cholesterol esters 
squalene 
squalene oxidation products 
cholesterol 
Key: 1) NA=no inorganic constituents reported. 2) After handwashing, sebum is expected to be 
lost from the fingerprint. It consists mainly of eccrine sweat.  
Recently, there has been growing momentum for offering fingerprints as a drug testing matrix. 
Drug testing has been carried out with urine [37, 120, 121], hair [41, 122-124], or blood [125] for 
a long time, and they are still widely used by prison, probation services, hospitals, and workplaces. 
For blood and urine, the procedure for collecting these samples, as well as transporting and storing 
them is complicated because they are biohazards [126]. For hair, as discussed previously, the 
detection window is long and therefore cannot be used in a situation where short term drug use is 
to be probed. On the other hand, a fingerprint is non-invasive to human skin and offers a simple 
and rapid sample collection and storage. Additionally, the ridge detail of the fingerprint 
encapsulates the donor’s identity. 
2.5.3 Techniques used for the detection of drugs in fingerprints 
Sweat is another form of excretion for non-metabolised parent drugs and their metabolites through 
mechanisms of passive diffusion. They are excreted in smaller quantities through eccrine and 
sebaceous glands. Sweat testing has been proposed as an alternative matrix for drug testing [6, 127, 
128]. Therefore, drugs and their metabolites can be detected in a fingerprint [129]. 
2.5.3.1 Time of flight secondary Ion mass spectrometry (ToF-SIMS) 
Time of Flight Secondary ion mass spectrometry (ToF-SIMS) is a surface mass spectrometry 
technique which uses a primary ion beam to remove molecules from the most surface layer of the 
sample. It is known that time of flight secondary ion mass spectrometry (ToF-SIMS) can be used 
to visualise the spatial distribution of substances in a fingerprint [130]. Fingerprints generated from 
donors who have touched cocaine [131] and amphetamine [132] have been previously investigated 
using ToF-SIMS to show that fingerprints can be images alongside a drug, showing that a donor 
has touched an illicit substance. However, high fragmentation, which is characteristic of SIMS, 
prevented the discrimination of cocaine parent ions from its metabolites in this study [131]. 
66 
 
2.5.3.2 Liquid chromatography mass spectrometry (LC-MS) 
Liquid chromatography mass spectrometry (LC-MS) is an analytical technique that is used for the 
identification of analytes by separating components and based on the partitioning of the solutes 
between the mobile and stationary phase before injection into MS to measure m/z [133]. The core 
of an LC-MS system is the column where chromatographic separation occurs. The injected sample 
is mixed with the mobile phase before reaching to the column, where the stationary phase is found. 
The affinity of chemicals to the stationary phase determines separation of analytes. The greater the 
affinity, the longer it takes for the analytes to pass through the column. Chemicals elute at certain 
time from the column, which is called the retention time. The retention time is characteristic for a 
given analyte under specific conditions (such as type of column, mobile phase and flow rate). Then, 
eluted analytes move into the mass spectrometer [134]. Our group previously developed a novel 
method for testing for cocaine and heroin from single fingerprint and proposed an environmental 
cut-off level using LC-MS [127]. To establish an environmental cut-off level, fingerprint samples 
of 50 non-drug users (two fingerprints each) were collected and measured. Fingerprint samples of 
drug users who testified to take cocaine (n=32) and heroin (n=24) were also collected and were 
compared to the fingerprint samples of non-drug users. A different cut-off level derived from non-
drug user population was applied depending on the analyte, and presentation of the fingers (either 
as presented or after handwashing). After application of these cut-off values, the detection rate of 
cocaine and heroin after handwashing was 87.5 and 100 % respectively after handwashing [127].  
2.5.3.3 Paper spray mass spectrometry (PS-MS) 
PS-MS is a direct mass spectrometry technique derived from electrospray (ESI) and is useful for 
fast, qualitative, and quantitative analysis of complex mixtures. The detail of an operating principle 
will be explained in Section 3.2 a method to detect cocaine and its metabolites using paper spray 
mass spectrometry (PS-MS) was previously developed by our group. Two fingerprint samples of 
40 non-drug users and 60 drug users who testified administered cocaine in last 24 hours, 
respectively were collected. Based on the value of limits of detection for cocaine (5 pg), BZE (10 
pg), and EME (155 pg) using the PS-MS method, the test returned a 99 % true positive rate and a 
2.5 % of false-positive rate. The test was based on the detection of one of cocaine, BZE or EME. 
The signals detected in the fingerprints of non-drug users were probably environmental 
contamination [135].      
2.5.3.4 Desorption electrospray ionisation mass spectrometry (DESI-MS) 
DESI is an ambient ionisation technique that can be coupled with mass spectrometry for chemical 
analysis [131]. It has been used previously for trace analysis of drugs, identification of 
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pharmaceuticals and explosives [136]. Bailey et al., [131] developed a method for the detection of 
excreted metabolites from fingerprints (DESI-MS). Fingerprints were collected from five 
individuals attending a drug and alcohol treatment service to be treated for drug abuse onto clean 
glass slides. A corresponding oral fluid sample was also collected from each patient and analysed 
by gas chromatography mass spectrometry. As a result, from four donors whose oral screening 
tests were positive, cocaine, benzoylecgonine (BZE), and ecgonine methyl ester (EME) were 
present in their fingerprints (BZE was not shown from one of the replicates). The MS/MS spectra 
confirmed the presence of each compound by detecting relevant fragment ions of each. The authors 
claimed that the presence of the metabolites of drugs of abuse could be used to confirm the drug 
had been ingested rather than arising as a result of contact with a drug. However, this research did 
not actually test fingerprints from contact with a drug to prove this point. 
2.5.3.5 Matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) 
MALDI is a soft ionisation technique used in mass spectrometry allowing the analysis and imaging 
of biomolecules and large organic compounds [137]. Groeneveld et al., [138] detected and mapped 
drugs and metabolites in latent fingerprints using matrix assisted laser desorption ionisation mass 
spectrometry (MALDI-MS). There were four different standard mixtures of drugs: (1) 
Amphetamine (AMP), 3,4-methylenedioxy-methamphetamine (MDMA), and 3,4-
Methylenedioxyamphetamine (MDA); (2) cocaine, BZE, and EME; (3) heroin, 6-
Monoacetylmorphine (6-MAM), and morphine; and (4) delta-9-tetrahydrocannabinol (Delta 9-
THC) and tetrahydrocannabinolic acid (THCA). The authors prepared fingerprints spiked with 
these exogenous compound mixtures to compare two scenarios: handling vs. abuse, with 
theoretically derived concentrations of drugs and metabolites. It was also assumed in this study 
that metabolites would not be present in fingerprints produced by contact. Clean and ungroomed 
fingertips were prepared. Each standard mixture was spotted onto a pre-cleaned glass slides and 
then evaporated under ambient conditions. In the handling scenario, a high concentration, 
10 μg/mL of those four drug standard mixtures (equivalent to 500 ng of pure compound for each 
standard), was spotted. Then, in order to transfer as much analyte as possible, the solvent was 
dragged via a fingertip side to side on the glass slide. The fingertip was deposited on a pre-cleaned 
aluminium sheet to make a drug-spiked, ungroomed fingerprint. For the abuse scenario, the 
concentration was equivalent to the determined limit of detection of each drug standard. The two 
scenarios were analysed by MALDI mass spectrometry imaging (MSI). In the handling scenario, 
the intensities of both parent ion and ion-source fragments for most compounds were high enough 
to generate molecular images with fingerprint ridge details. However, a partial fingerprint image 
was obtained from MDA and Delta 9-THC, and no image was obtained from THCA. In the abuse 
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scenario, cocaine, BZE, and heroin could be suitably mapped on the ridges, whereas partial and or 
discontinuous ridge detail was obtained for EME and 6-AM. No images were recovered for 
morphine, MDA, Delta 9-THC, and THCA. Groeneveld et al., [138] proved that MALDI is 
capable of providing a profile and image of a wide range of drugs and their metabolites in a 
fingerprint. However, this theoretical scenario, using spiked fingerprint, to compare handling and 
abuse does not answer the question of whether ingestion and contact can be distinguished. 
2.5.4 Other techniques used for the detection of drugs in fingerprints 
2.5.4.1 Immunolabelling 
Hazarika et al.,[139] developed a method to detect drugs in fingerprints based on immunolabelling. 
Immunolabelling is a technique using fluorescent labelling of a specific biological target sample, 
an antigen, via an antibody conjugated with a fluorescent material called fluorophore. In this 
research, the drug molecule was an antigen binding with drug antibodies.   
Fingerprints were collected on pre-cleaned microscope glass slides from drug users. A 
hydrophobic pen was used to draw an outline around a fingerprint to retain the antibody. Then, a 
solution of a primary antibody was spotted on the fingerprint and incubated. After incubation, the 
fingerprint was washed off with a phosphate butter. Then, a solution of a secondary antibody, 
which is conjugated with a fluorophore, was spotted on the fingerprint to bind with the primary 
antibody and incubated again. After incubation, the sample was observed under a florescence 
microscope. The sample showed a florescence image, which resulted in drug detection in the 
fingerprint [139]. 
This study also tried to develop a method for multiplexed drug detection in a fingerprint. Recently, 
according to Hudson et al. [140], they developed a method to detect multiple drugs at once using 
a fluorescence based lateral flow competition assay. They were successfully able to detect four 
classes of drugs at once: THC (cut-off: 190 pg/fingerprint), cocaine (through the detection of BZE, 
cut off: 90 pg/fingerprint), opiates (through the detection of morphine, cut-off: 68 pg/fingerprint), 
and amphetamine (cut-off: 80 pg/fingerprint) in the sweat of a fingerprint from UK coroner areas 
with sensitivity of 100, 90, 95, and 66.7 % respectively.  
2.5.4.2 Raman spectroscopy 
Raman spectroscopy is a type of vibrational spectroscopy used to determine information on 
chemical structure of a substance qualitatively or semi-quantitatively [141]. Day et al. [142] 
developed a method to detect exogenous substances in latent fingerprints using Raman 
spectroscopy. There were two different scenarios for fingerprint treatment: sweat-rich and sebum-
rich latent fingerprints. Sweat rich fingerprints were prepared by allowing substances on the finger 
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for 30 minutes to induce sweat to accumulate on the fingertip after touching them. On the other 
hand, sebum rich fingerprints were prepared by wiping the fingertip across the forehead and side 
of the nose to collect some sebum before touching substances. Participants handled five drugs of 
abuse, codeine phosphate, cocaine hydrochloride, amphetamine sulphate, barbital, and nitrazepam 
with five of their adulteration of drugs such as caffeine, aspirin, paracetamol, starch, and talc. After 
all preparation procedures, they deposited the fingerprint on pre-cleaned steel slides. Then, the 
corresponding Raman spectra were obtained. As a result, all substances including drugs of abuse 
and adulterants were successfully detected in Raman spectroscopy in both scenarios. However, the 
sweat rich fingerprint yielded better quality of spectra which is more similar to the reference 
spectra of substances compared to the sebum rich fingerprint. Although all substances were 
detected in the sebum rich fingerprint, it contained higher fluorescence background levels and 
interfering Raman bands derided from the fingerprint oil [142].  
2.6 Summary 
In order to study the evidence dynamic of illicit substances, cocaine and heroin were selected, as 
these are still the most commonly consumed illicit drugs and have been for several decades despite 
the strong regulation. As a result, many research methods using different biological matrices in 
order to detect them have been successfully developed and are currently applied to the real time 
situations in the toxicological and forensic fields. More recently, NPS use has surged due to the 
high regulation of conventional drugs and pursuit of stronger psychoactive effects. However, as 
the NPS have been newly recognised, only a small amount of research regarding chemistry and 
metabolism has been investigated. Moreover, NPS use is a particular problem in UK prisons [143].   
Administered drugs in the human body system can be detected from different biological matrices 
with a different detection window. Among these matrices, sweat of a fingerprint can offer a rapid, 
non-invasive, less complex in sample preparation, and convenient method of screening for drugs. 
Also, a fingerprint contains ridge detail which encapsulates the donor’s identity. 
Several studies have already developed methods to detect illicit substances in a fingerprint. 
However, studies regarding the significance of detecting them in a fingerprint have never been 
investigated. For example, detecting drugs in a fingerprint cannot distinguish between if they 
derive from administration or from accidental touch. Therefore, this research focused on not only 
developing methods to detect drugs in a fingerprint, but also investigating significance of them in 
a fingerprint. A more detailed aim and objectives are present in the following section.     
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2.7 Aim and Objectives 
The aim of this research is to consider the significance of detecting drugs in the fingerprints of 
drug users, by considering for the first time the similarities and differences between user and non-
drug user fingerprints, together with the contact with drugs and persistence of drug residues in 
fingertips. This research will therefore to develop a rapid method based on paper spray high 
resolution mass spectrometry to detect drugs, particularly cocaine, heroin (retrospective), and NPS 
substances in a fingerprint.  
The study also investigates the influence of hand washing and cleaning with physical and chemical 
methods as well as the persistence of cocaine and heroin powder residue after contact with 
fingertips. This has been done by developing a rapid chemical profiling technique, paper spray 
mass spectrometry as well as using mass spectrometry imaging techniques to explore spatial 
correlations between drugs metabolites and the circumstances surrounding the deposition of a 
fingerprint. This could be a future solution to prevent a false accusation of innocent people who 
accidently touched cocaine.  
2.7.1 Objectives 
The objectives of this study were as follows: 
- Development and validation of a high resolution mass spectrometry detection method for 
cocaine and benzoylecgonine in fingerprints, based on Costa et al. [135] for paper spray 
high resolution mass spectrometry. 
- Collection and analysis of fingerprints and oral fluid samples from drug users receiving 
treatment in a rehabilitation clinic and from background populations (a negative control 
group) 
- Comparison of two different fingerprint sampling strategies: as presented and after 
handwashing. 
- Determination of heroin and 6-acetylmorphine in the fingerprint samples above using 
retrospective analysis of the high resolution mass spectrometry data.  
- Determination of the persistence of cocaine, benzoylecgonine, heroin, and 6-
acetylmorphine on the fingers after contact cocaine and heroin powder by non-drug users. 
- Application of time of flight secondary ion mass spectrometry (ToF-SIMS), matrix assisted 
laser desorption/ionisation time of flight mass spectrometry (MALDI-ToF-MS), and 
desorption electrospray ionisation (DESI-MS) for fingerprint imaging analysis to image 
fingerprint samples. 
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- Optimisation and validation of a method for novel psychotic substances and their 
respective metabolites in fingerprints using paper spray mass spectrometry, and application 
to fingerprint samples from offenders from Rochester prison and background (non-drug 
user) population.  
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Chapter 3 Mass Spectrometry and Applied Ionisation Techniques 
This chapter describes the principles of operation and functions of the mass spectrometers and 
conjugated ionisation techniques that were applied in this research for analysis of drugs and 
metabolites in fingerprints. Paper spray mass spectrometry was used to detect and identify various 
parent drugs and their metabolites in fingerprints that were deposited on paper substrates under 
various conditions. This technique can provide a qualitative and quantitative information of target 
analytes but cannot offer any spatial resolution in order to analyse the image of fingerprint. 
Desorption electrospray ionisation mass spectrometry, matrix assisted laser desorption/ionisation 
mass spectrometry, and time of flight secondary ion mass spectrometry were therefore used to 
obtain molecular images for fingerprint samples after drug contact and drug use.  
3.1 Mass Spectrometry 
Mass spectrometry is an analytical technique which is capable of providing both qualitative and 
quantitative information from ionised analyte molecules. The ionised molecules first pass through 
the ionisation source of the mass spectrometer. The instrument can be set up to detect either 
positive or negative charges. Then, the charged ions move through the mass analyser and arrive at 
different parts of the detector according to their mass to charge (m/z) ratio. Once each charged ion 
is detected, signals are generated, and they are recorded by a linked computer system. The signals 
are displayed as a mass spectrum showing the relative abundance of each m/z value [144]. This 
chapter will introduce Orbitrap and Q-ToF mass spectrometer since this study have used only those 
two instruments. 
3.1.1 Orbitrap mass spectrometer 
Figure 17 shows a schematic diagram of the Orbitrap mass spectrometer used in this research in 
conjunction with paper spray and electrospray ionisation (ESI). Each component in the diagram is 
described in the following paragraphs in this section.   
Analyte ions travel through the ion transfer tube into the progressively spaced stacked-ring ion 
guide, called the S-lens. The S lens is a radio frequency (RF) device which captures and efficiently 
focuses the ions into a tight beam. The diameter of the ring electrodes at the entrance of the S-lens 
is larger in order to capture as many ions as possible. The diameter of the ring electrodes becomes 
progressively smaller, so an ion beam can be more focused on the exit lens. As well as providing 
significantly increased instrument sensitivity, the S-lens helps to eliminate analytes which do not 
belong to the selected mass range [145].  
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The transfer multipole is called the quadrupole mass analyser or quadrupole mass filter. It consists 
of four parallel cylindrical rods. A RF voltage and direct current (DC) offset voltage are applied 
between one pair of rods and the other, so that ions can travel between the rods to the detector. 
However, depending on the given voltages, ions of certain mass to charge ratio can pass through 
the rods and reach the detector, which allows selection of target ions with a range of target m/z 
[144].  
Once ions pass the quadrupole mass analyser, they arrive at the C-trap. The C-trap is essentially 
an ion guide with four curved electrodes of rectangular cross section and a slot in the electrode 
closest to the Orbitrap. Ions are ejected through the inside portion of bent rods. Ions of designated 
m/z range are trapped simultaneously in the C-trap. The C-trap is operated with nitrogen which 
makes the ions lose their kinetic energy and allows effective cooling of them in its RF field.  If the 
ions sufficiently cool down in the C-trap, the amplitude of RF decreases. Then, the ions are ejected 
from the C-trap by DC potentials to avoid collision with trap electrodes. The ions are then pushed 
toward the Orbitrap and subsequently accelerated [146]. 
The higher-energy C-trap dissociation (HCD) cell is interfaced to the C-trap and is used only for 
MS/MS scans. The main function of HCD cell is to fragment ions after they are cooled down and 
stored in the C-trap. The high RF voltage in HCD cell is capable of retaining fragment ions. Ions 
are then pushed into and separated in the Orbitrap for analysis [147, 148]. 
 
Figure 17 Schematic diagram of Q-Exactive Plus Orbitrap mass spectrometer. 
The Orbitrap mass analyser detects and analyses ions by measuring their oscillation frequencies. 
The Orbitrap is an ion trap mass analyser that consists of three electrodes; two outer electrodes 
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and a central electrode. Ions are injected into the volume between the central and outer electrodes. 
With voltage applied between the central and outer electrodes, a radial electric field strongly 
attracts ions to the central electrode. With a correct choice of parameters, the ions remain on a 
nearly circular spiral inside the trap. At the same time, the axial electric field caused by the conical 
shape of electrodes pushes ions toward the widest part of the trap initiating harmonic axial 
oscillations. Outer electrodes are then used as receiver plates for image current detection of these 
axial oscillations. Different ions oscillate at different frequencies, resulting in their separation. The 
Orbitrap mass analyser uses a Fourier Transform mass analyser to convert Fourier-Transformed 
time domain into the frequency domain using an enhanced Fourier Transform (eFT) algorithm. In 
the same way, Fourier Transform of frequency signal converts to a mass spectrum of 
corresponding trapped ions [149]. 
3.1.2 Q-ToF mass spectrometer  
Figure 18 is a schematic diagram of Q-TOF mass spectrometer which was a conjugated with a 
DESI source used for fingerprint analysis. The mass spectrometer is Synapt G2-Si High Definition 
Mass Spectrometry (Waters, UK). Each component is described in the following paragraph in this 
section.       
 
Figure 18 Schematic diagram of the Q-TOF mass spectrometer used at NPL for fingerprint imaging studies. 
The step wave ion guide is a unique ion transfer device designed to maximise ion transmission 
from the ion source to the mass analyser with a DC offset potential. It transfers ions from the lower 
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to the upper stage and into the subsequent low-pressure regions of the mass spectrometer for 
analysis. Neutral contaminants and excess solvent are left in the lower stage and removed by the 
vacuum system, which helps increase the sensitivity [150].  
The operation of quadrupole type mass analyses is already explained in Section 2.1.1.  
The triwave (T-Wave) is a type of stacked ring ion guide. It consists of three travelling wave 
devices: trap, ion mobility separations (IMS), and transfer. They are used to guide to trap, 
accumulate, release, separate, and fragment ions. It is uniquely designed to maximise sample 
separation in an analytical workflow using IMS. The IMS is achieved by ions moving through a 
neutral buffer gas with an electric field. The ions interact with the buffer gas resulting in slowing 
themselves down as they move forward. This causes separation of ions of different size, shape, 
charge, and m/z to transit through a mobility device at different rates, which cannot be observed in 
the conventional mass spectrometer. Because of those advantages, the addition of IMS can provide 
information on conformation and structure of target analytes and deliver the more detailed 
structural characterisation with novel fragmentation routines [151, 152]. 
The ions then travel into the time of flight (ToF) mass analyser. This consists of high field pusher, 
dual stage reflectron, ion detector, and analogue to digital conversion (ADC) system. Ions are first 
accelerated into the high field pusher where a 2 kV pulse is applied. The rapid acceleration of ions 
minimises the time spread due to initial velocity spread of the ions in the pushout region. This is 
called “turn around” time. This should be minimised to maximise the resolution of the ToF 
instrument. Once the ions have left the pushout region, they have velocity based on the m/z, which 
means they start to separate. Then, they enter the dual stage reflectron. The dual stage reflectron 
uses a multi pass mode operation called W mode. The ions take two passes of the same flight tube 
in W mode, which increases the time of flight without increasing the size of the analyser. Once the 
ions leave the dual stage reflectron, they turn around back toward ion detector due to being 
spatially focused. The ion detector amplifies the signal as ions arrive, where their arrival times are 
accurately measured. ADC records the intensity of ions detected over time. It allows the detector 
to produce the fast signals correctly and to calculate the arrival time of ions and their intensity 
accurately [153].  
3.1.3 Comparison of mass spectrometer system 
The following sections in this chapter describe the ionisation sources that space were conjugated 
to each mass spectrometer explained above.  
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In imaging applications, Q-ToF detectors are generally preferred due to their faster acquisition 
speed. Additionally, in MS/MS mode, the resolving power of Q-TOF systems are normally the 
same as in full scan mode. This can be an advantage over the Orbitrap mass analyser, whose 
resolving power in MS/MS mode is often sacrificed due to speed. For non-imaging application, 
Q-ToF detectors have some drawbacks. Q-ToFs are somewhat limited in resolution in the mass 
range of small molecules, which can cause false identification. Therefore, using Orbitrap mass 
analyser provides greater selectivity for illicit substances which are regarded as small molecules 
[149, 154]. 
3.2 Paper Spray Mass Spectrometry (PS-MS) 
Mass spectrometry (MS) is a tool for the analysis of complex mixtures and provides information 
regarding molecular weights and chemical structures of analytes by measuring the mass to charge 
ratio (m/z). MS has been coupled with gas chromatography (GC-MS) [118, 120, 155-157] and 
liquid chromatography (LC-MS) [6, 127, 158-160]in order to minimise suppression effects on 
ionisation and to pre-concentrate the analytes. LC-MS is preferred for use in toxicology because 
of the high resolution separation and better sensitivity [161].On the other hand, chromatography 
techniques require sample preparation, and this can be time consuming due to sample extraction. 
Direct analysis methods such as desorption electrospray ionisation mass spectrometry (DESI-MS), 
direct analysis in real time mass spectrometry (DART-MS), and paper spray mass spectrometry 
(PS-MS)  have recently been developed to compensate the disadvantages of chromatography 
techniques, namely rapid and direct analysis of complex mixtures with no sample preparation 
[161]. 
PS-MS is a direct mass spectrometry technique derived from electrospray (ESI) and is useful for 
fast, qualitative, and quantitative analysis of complex mixtures. The concept of direct analysis is 
to remove and ionise analytes directly from the substrate, so sample pre-treatment is not required. 
PS-MS also has been widely demonstrated for direct chemical analysis and can detect large array 
of molecules from various fields including food safety [162], bio-medicine [163], forensics [135], 
and so on. 
As suggested by the name of the technique, paper is used as a substrate. Paper is an important 
medium in chemical separation. A hydrophilic and porous paper allows liquid to transport over 
the surface and through the inside micro-channels by capillary action, which utilises chemical 
separation [164].The paper substrate has multiple functions including sample loading, analyte 
extraction, transportation and droplet generation.  
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The basic steps to operate PS-MS for fingerprint analysis is shown in Figure 19: 
1. A sample (standard or fingerprint) is loaded on a triangular paper substrate 
2. Spray solvent is added on the paper 
3. High voltage is applied 
4. Extracted analytes move toward the mass spectrometer (MS) inlet 
5. MS is used to measure the mass to charge ratio (m/z) of analytes extracted from the sample.  
 
Figure 19 Principle of paper spray mass spectrometry operation (HV: high voltage). 
3.2.1 Sample loading 
The sample is preloaded (usually spotted or wiped) on a piece of triangular paper which contains 
a sharp tip. After a deposited sample is loaded on a paper, extraction of analytes occurs as soon as 
the spray solvent is applied to the paper. The solvent extraction parameters can be tuned towards 
an analyte of interest, which results in simple and effective sample purification. The extracted 
analytes are then transported by solvent wicking through the paper [161].There are two distinct 
ways for solvent to be applied on the paper, a dumping mode and a wicking mode. In the dumping 
mode, a certain amount (10 to 100 µL) of spray solvent is applied all at once. In the wicking mode, 
spray solvent is continuously applied on the paper via capillary action. In dumping mode, the ion 
intensity for analytes is relatively consistent over time. In wicking mode, the ion intensity quickly 
reaches a maximum and then decreases gradually to a low but constant value. The variation of the 
signal intensity between two modes does not affect the precision due to internal standard use. Since 
one of the goals of this research is rapid detection, dumping mode which can provide a consistent 
higher signal for a short time was applied in this study [164]. 
3.2.2 Droplet generation 
After the spray solvent is applied on the paper, a high voltage (3 to 4.5 kV) is turned on. Then, 
charged droplets are generated at the sharp tip of the triangular paper because of generation of high 
local electric fields around the corners. The droplets then carry the extracted analytes towards the 
mass spectrometer inlet as shown in Figure 20. 
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Figure 20 A photo showing the main components of paper spray mass spectrometry. 
3.2.3 Electrospray ionisation (ESI) interface 
Electrospray ionisation (ESI) was used to optimise the Orbitrap mass spectrometry settings in this 
research. 
ESI is a soft ionisation technique extensively using electrical energy to assist the transfer of ions 
from solution into production of gas phase ions without fragmentation prior to mass spectrometric 
analysis. The starting point of the ionisation process is based on the liquid dispersion due to the 
high applied capillary voltage (2.5 to 6 kV), which causes highly charged droplets. Then, solvent 
is evaporated under a stream of carrier gas (nitrogen) and heat, which leads highly charged droplets 
to shrink until they contain only one analyte molecule. At onset voltage, the pressure of the charges 
accumulating at the tip is higher than the surface tension, the shape of the drop changes at once to 
a Taylor cone and small droplets are released. The emitted ions are then accelerated into the mass 
analyser for subsequent analysis of molecular mass and measurement of ion intensity [144, 165]. 
3.3 Desorption Electrospray Ionisation Mass Spectrometry (DESI-MS) 
DESI is an extended method of ESI and is a mass spectrometry ionisation technique that allows 
examination of compounds directly in the solid state from ambient surfaces as paper spray does. 
It can provide minimal sample preparation and allow sample manipulation during analysis. Besides, 
DESI does not damage polymeric or metallic surfaces. However, soft sample materials like 
biological substrates can be damaged [166].  
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DESI-MS is also capable of 2D mapping of chemical entities from a surface. Compared to 
secondary ion mass spectrometry (SIMS) and matrix assisted laser desorption ionisation (MALDI), 
the spatial resolution of DESI-MS is relatively poor, but can be as low as 40 µm [167]. However, 
DESI-MS does not have any interferences from matrix ions observed from MALDI-MS (see next 
section: Section 2.4). Moreover, morphological characteristics of analytes during analysis cannot 
be damaged because of its non-destructive nature, which means only minute destruction of a 
sample. Therefore, possibility of information loss is very low [168].    
The basic steps to operate DESI-MS for imaging mass spectrometry is shown in Figure 21. 
1. A sample (standard or fingerprint) is loaded on a glass slide. 
2. Solvent is applied with a nebulising gas. 
3. High spray voltage (3 to 4 kV) is applied. 
4. Droplets move target surface. 
5. Charged droplets are produced and collide with the surface. 
6. The smaller charged droplets after collision move through atmospheric pressure DESI 
capillary interface and into the mass spectrometer. 
7. MS is used to measure the mass to charge ratio (m/z) of extracted analytes.  
8. The sample stage is moved to a new location to provide imaging of the sample. 
 
Figure 21 Schematic diagram of DESI-MS. 
The mechanism of DESI can be mainly distinguished by two steps, surface wetting and transferring 
droplets to the mass spectrometer.  
3.3.1 Surface wetting  
Electrically charged optimised solvent is aimed at the target region of the surface with a nebulising 
gas after high voltage (3 to 4 kV) is applied. Then, the solvent dissolves the analyte from the 
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sample surface. Once the analyte in solution is on the wetted surface, following droplets have an 
impact on the surface causing a splash effect [168]. 
3.3.2 Droplets transfer to MS    
The splash effect allows secondary analyte containing charged droplets to be ejected from the 
surface, and they head toward the MS inlet. No matter what type the surface is, the analyte 
containing droplets are still charged. Therefore, free gas-phase ions are still generated and analysed 
through mass spectrometer [168]. 
3.3.3 Mass spectrometer 
DESI analysis was conducted using a Q-ToF mass spectrometry at National Physical Laboratory 
(NPL) as described in Section 2.1.  
3.4 Time of Flight Secondary Ionisation Mass Spectrometry (ToF-SIMS) 
Time of Flight Secondary ion mass spectrometry (ToF-SIMS) is a surface analytical technique 
which uses a primary ion beam to remove molecules from the top-most surface layer of the sample. 
In the process, secondary ions are produced via a sputtering process and extracted from the surface 
of the sample. The secondary ions are then accelerated into the time of flight mass spectrometer, 
which measures mass to charge ratio of each secondary ion. There are three operational modes in 
ToF-SIMS: surface spectroscopy, surface imaging, and depth profiling [169, 170]. Figure 22 
shows a schematic diagram, illustrating how the instrument operates and analyses a sample.  
 
Figure 22 Schematic diagram of ToF-SIMS. 
The ToF-SIMS analysis of fingerprint samples were carried out on the ToF.SIMS.5 instrument 
commercialised by IONTOF GmbH ((Munster, Germany).  
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The loadlock chamber is brought up to atmospheric pressure to load a sample and pump down to 
UHV (at pressure of at least 10-7). Once the sample is pumped down, the sample will be transferred 
into the main chamber through the preparation chamber. The main chamber (analysis chamber) 
must be maintained at ultra-high vacuum (UHV) (at pressure of at least 10-9mbar) to avoid 
collisions between primary and secondary ions with air molecules during analysis. 
3.4.1 Ion source 
There are three ways to generate primary ions in ToF-SIMS: electron ionisation, surface ionisation, 
and using a liquid metal ion gun (LMIG). The instrument used in this study uses a LMIG, which 
can produce monoatomic or cluster Bin+ and yield ion images with high spatial resolution (up to 
submicron size of a pixel). The bismuth alloy used for the LMIG source covers a tungsten tip. 
When the voltage is applied, a conical shaped metal skin is formed, and a spray process is carried 
out at the tip of the cone. The instrument also has an electron gun (flood gun) which is capable of 
firing electrons directly at the sample in order to prevent any charge to pile up on the surface of 
semi-conducting and insulating samples. In this study, a Bi3+ cluster was chosen as a beam type as 
it was previously reported to yield high spatial resolution image [171]. The flood gun was not used 
for this study as conducting silicon wafers were chosen as a substrate [172]. 
3.4.2 Ion acceleration and focussing  
When the LMIG is on, it constantly emits primary ions on the target surface. The primary ion beam 
passes through an electrostatically focusing lens, which permits the SIMS technique to have high 
spatial resolution in the x,y plane. If the focused primary ion beam is rastered over the surface with 
x, y position in a given spot, the SIMS data is converted into an elemental image [144]. However, 
the ions are not always directed at the surface, which is called pulsed beam. A pulsed beam allows 
the time of flight cycle to take place, which allows the sputtered materials and secondary ions to 
be extracted and accelerated through the flight tube before the start of the next pulse [172].  
3.4.3 Collision 
The sputtering process is the principal phenomenon of the SIMS technique. Sputtering is 
phenomenon when energetic particles bombard surface material, microscopic particles of solid 
materials are ejected from its surface. The sputtering process can be described as a cascade of 
collision of incident particles in the material being analysed. The primary ion beam energy (KeV) 
is typically much higher than the energy of a chemical bond, so when primary ions initially collide 
with the surface, it results in an extensive fragment. However, as the collision cascade spreads, the 
primary ion beam becomes less energetic, which results in less fragmentation and generating the 
emission of secondary ions and molecular fragments from the surface. The extractor collects the 
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sputtered particles based on the reverse polarity to the ions and guides them to a transport optic 
which accelerates the sputtered materials and keep each secondary ion with the same energy [173].  
3.4.4 Time of flight mass spectrometer 
Before secondary ions reach the mass spectrometer, they are separated in the detector tube based 
on their mass to charge ratio by the reflectron. Reflectron is an ion mirror used to deflect ions and 
send them back through the flight tube. The role of reflection is to increase the flight path without 
increasing the dimension of mass spectrometer, resulting in improving mass resolution and 
sensitivity and limiting the mass range. By increasing the flight path, it corrects the kinetic energy 
dispersion of the ions (possibly derived from possible external issues such as mechanical or 
environmental) leaving the source with the same m/z [144].  
The ToF detector works by accelerating ions in an electric field. Because the electric field is 
constant, and each secondary ion of the same charge has the same kinetic energy. The ions travel 
towards the detector, and flight time in the flight tube depends on the mass of each ion, based on 
Equation 1.  
𝑘𝑖𝑛𝑒𝑡𝑖𝑐 𝑒𝑛𝑒𝑟𝑔𝑦 =
1
2
𝑚𝑣2. 
Equation 1 Equation of kinetic energy, m=mass and v=velocity. 
Because the initial energy of each ion is consistent, an ion with heavier mass will take longer to 
reach the detector. On the other hand, a lighter mass ion will take a shorter time. At the detector, 
the flight time of each ion is converted into m/z, and the corresponding mass spectrum is obtained 
[174]. 
3.5 Matrix Assisted Laser Desorption/Ionisation Time of Flight Mass Spectrometry 
(MALDI-ToF-MS)   
MALDI is a soft ionisation technique triggered by a laser beam coupled to mass spectrometry 
allowing the direct analysis and imaging of various endogenous and exogenous molecules on cells 
or tissue with wide range of analytes such as proteins, lipids, drugs and their metabolites, polymers, 
and large organic molecules (> 300 KDa)[175]. MALDI-ToF-MS is able to generate intact 
molecular ions with high sensitivity (femto (10-15) to atto (10-18) molar range under ideal 
conditions), which can aid analyte identification. Also, the mass range of MALDI-ToF-MS is 
higher than ToF-SIMS. However, the resolution of MALDI-ToF-MS imaging is frequently more 
than 50 μm, which is poorer than SIMS [137]. Figure 23 shows the workflow in a MALDI-ToF-
MS.  
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Figure 23 Schematic diagram of work flow in a MALDI-ToF-MS [176]. 
3.5.1 Matrix applied 
Unlike other imaging techniques, MALDI requires a low molecular weight organic molecule, 
called the “matrix” to be coated on target sample surface. It is usually conducted by robotic 
MALDI matrix deposition sprayer system. Once the matrix is crystallised and dried, the sample is 
entrapped inside of the matrix and it is called co-crystallisation [177]. Due to the matrix compound, 
fragmentation is minimised by it absorbing energy for analytes when the laser is focused on the 
target surface [178]. Depending on the type of analyte, a different matrix is applied. The most 
common matrix compounds are 2,5-dihydroxybenoic acid (DHB) usually for lipids, peptides, < 10 
KDa proteins, α-cyano-4-hydroxycinnamic acid (CHCA) usually for peptides and small proteins 
(< 10 KDa), and sinapinic acid (SA) usually for proteins (>10 KDa) [175]. Matrices should have 
strong absorption coefficients at the chosen laser wavelength in order to initiate an effective 
desorption and ionisation process [179]. However, the presence of the matrix could offer limited 
stability because of association with specific ionising agents and relatively high background noise 
signal [178].  
3.5.2 Ionisation mechanism 
When the laser beam irradiates the target spot where the matrix-sample mixture is placed, the laser 
pulse desorbs and ionises analytes of interest. The matrix initially plays a role of a separator for 
the analyte as intermolecular forces are reduced, which is called matrix ionisation. During laser 
irradiation, the matrix capturing the analyte absorbs the majority of laser energy to prevent analytes 
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from being fragmented (soft ionisation). This is called matrix excitation. Matrix changes from 
solid phase to gas phase, and a dense gas cloud forms in the vacuum chamber through the excitation. 
Analyte captured by matrix are also released into the gas phase and get ionized by collision of the 
neutral analyte molecules and matrix ions [178].  
3.5.3 Detection modes 
In Time of Flight mass spirometry, there are two modes of techniques to detect generated ions: 
linear mode and reflection mode [178]. 
3.5.3.1 Linear mode 
Linear mode is called because the ions fly into detector in a straight line through the flight tube. 
Ideally, the ions with same m/z should arrive to the detector at the same time since the kinetic 
energy of all ions are same. However, in reality, the intensity of laser irradiation is not always the 
same due to possible external issues such as mechanical or environmental. Therefore, the kinetic 
energy could not always be consistent in each m/z. This phenomenon can lead to reducing the 
spectrum resolution of assigned m/z [180]. 
3.5.3.2 Reflection mode 
Reflection mode can compensate the lack of resolution derived from linear mode by the presence 
of ion mirrors. The reflection mode technique consists of ion mirror and uses additional electric 
fields which change the direction of the ions by repulsing them back into the drift zone and to the 
detector. Therefore, it is installed in the opposite side of the flight path.  This system helps to 
correct initial kinetic energy distribution for each m/z, which leads to improve spectrum resolution 
of it [180].   
3.6 Summary 
This chapter introduced the operating principles of mass spectrometry and the ionisation sources 
used in this work. In particular, paper spray mass spectrometry was used to quantify selected drugs. 
Desorption electrospray mass spectrometry, time of flight secondary ions mass spectrometry, and 
matrix assisted laser desorption/ionisation were used for Imaging techniques to acquire images of 
fingerprints from drug use and drug contact. The following chapters describe method optimisation 
and results to detect target analytes in fingerprints using these techniques.  
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Chapter 4 Method Optimisation and Validation of Paper Spray - 
Orbitrap Mass Spectrometry Method for the Detection of Cocaine and 
Benzolyecgonine in Fingerprints 
This chapter describes the optimisation and validation of a method for paper spray mass 
spectrometry (PS-MS). The method for PS-MS was optimised and validated to detect and quantify 
the mass of cocaine and its metabolite, BZE in a fingerprint. After the method optimisation and 
validation were completed, fingerprint samples of drug users and non-drug users were analysed 
using the method. This is described in Chapter 4. 
4.1 Introduction  
In order to gain accountable sensitivity to target analytes in fingerprints, both the source and the 
mass spectrometer parameters need to be optimised using suitable reference materials. In this case, 
the developed method should be sensitive enough to detect pg of analyte in a fingerprint and 
selective enough to separate analytes from environmental compounds.  
The paper spray mass spectrometry (PS-MS) method used in this study was partially transferred 
from the method in Costa et al, [135] which used a Micromass QToF 2 mass spectrometer (Waters 
Alliance). This chapter describes the adaption and validation of the method of Costa et al. for use 
with a Q-Exactive Plus Orbitrap mass spectrometer for the detection of cocaine and 
benzoylecgonine in fingerprints. 
The validation process of the instrumental and data processing parameters and sample preparation 
applied in this research is explained in following sections.  
4.1.1 Instrumentation 
PS-MS analysis of fingerprint samples were carried out using a custom-made paper spray (PS) 
source built at the Surrey Ion Beam Centre. The PS source was coupled with a Q-Exactive Plus 
Orbitrap mass spectrometer (Thermo Fisher Scientific, UK) in University of Surrey Ion Beam 
Centre. All spectra were analysed using Xcalibur (Thermo Fisher) [181]. The spray voltage (4kV), 
capillary temperature (250 °C), and S-lens RF level (50.0) were optimised using heated 
electrospray ionisation (HESI), according to settings that gave the highest protonated ion counts 
of analytes: cocaine (m/z 304.1539) and BZE (m/z 290.1380). MS/MS was performed to detect 
fragment ions corresponding to cocaine (m/z 304.1539>182.1178 and 82.0658) and BZE (m/z 
290.138>168.1020) to confirm peak assignment.   
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4.1.2 Materials 
Drug standards (cocaine, benzoylegonine (BZE), cocaine-D3, BZE-D3) were obtained from 
Cerilliant (Dorset, UK). Cocaine hydrochloride powder (Sigma) was obtained from Dr. Alexis 
Bailey in Faculty of Health and Medical Sciences (FHMS) in University of Surrey. To prepare all 
solution and solvent mixtures, LC-MS optima grade solvents: methanol (MeOH), acetonitrile 
(ACN), and water (H2O) were applied (Fischer Scientific, Leicestershire, UK). Ultimately, 
80:20/ACN:H2O was used as spray solvent. 0.1% v/v of formic acid (Fischer Scientific, 
Leicestershire, UK) was added to all spray solvent to enhance protonation.  
For sample preparation and collection procedures, the sample kit was composed of a 
chromatography paper (Whatman Grade 1), an aluminium foil and a regular glass slide cut into a 
thin strip. The foil and glass slide were used to prevent carryover of analytes from one analysis to 
the next. This was previously reported in Costa et al. [135]. An electronic kitchen scale (Salter) 
was used for fingerprint deposition. 
The paper substrate was made of a triangular cut Whatman Grade 1 chromatography paper. Before 
putting samples on the substrate, the cut paper was washed with 0.1% hydrochloric acid and 50:50 
(% v/v) methanol:water and air dried to remove potential contamination to the paper substrate. 
4.1.3 Sample collection 
A favourable ethical opinion for collection and analysis of samples was granted from the National 
Research Ethics Service (NRES - REC reference: 14/LO/0346). 
Fingerprint samples of non-drug users were collected for the purposes of method validation. The 
chromatography paper was cut in combination of a triangular (1.6 x 2.1 cm, base × height) and 
rectangular shape as shown in Figure 24. A fingerprint was deposited on the triangular area of the 
substrate, and the rectangular shape was used to tape the substrate to a glass slide and was removed 
prior to analysis. For fingerprint deposition, an electronic kitchen scale was used to obtain a 
consistent force of deposition. Participants were asked to push down on the scales so that reading 
of 1000 to 1200 g was reached to achieve a consistent deposition force. 
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Figure 24 Schematic of the fingerprint collection kit. 
 
 
Figure 25 Paper substrate with foil and glass slide before being loaded on PS source. 
4.1.4 Paper spray method 
In the paper spray method used in this work, a sample (either a fingerprint or 10 µL of standard) 
is spotted onto the paper and air dried for 2 minutes. Then, 10 µL of internal standard (100 ng/ml 
of cocaine-D3, BZE-D3) is deposited and then air dried for 2 minutes. The sample is then placed 
on the top of a glass slide and placed in the middle of folded aluminium foil before being mounted 
on the paper spray source as shown in Figure 25. The distance and direction of the paper tip relative 
to the MS inlet is manually controlled using a close view camera. Once the paper is set up on the 
paper spray source, 100 µL of spray solvent (80:20 (% v/v), ACN:water, 0.1% formic acid) is 
pipetted onto the paper, and a voltage (4 kV) is applied. The data acquisition is then carried out for 
a total of 0.7 minutes. The first 0.5 minutes of acquisition is carried out in the full scan mode (m/z 
66.7 to 1,000) for quantitative analysis, following by 0.2 minutes in MS/MS mode to confirm the 
identity of the target analytes. Figure 26 shows schematic diagram of the optimised paper spray 
method for this study.  
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Figure 26 Flow chart of PS-MS method for detecting cocaine and BZE in fingerprints. 
4.1.5 Mass spectrometry method 
As described in Section 3.1.1, the paper spray settings were transferred from Costa et al [135]. 
However, the mass spectrometry required optimisation. The mass spectrometer used in this study 
was an Orbitrap system, whereas the previous study used a Q-TOF detector.   
The operating parameters for full scan mode and MS/MS mode to Orbitrap are shown in Table 9. 
Those various parameter values were chosen in order to maximise the peak intensity of all analytes 
of interest (M+H)+.  
Table 9 Parameters of full scan mode (upper) and MS/MS (lower) in PS-MS. 
Scan parameters Value 
Scan range m/z 66.7 to 1,000 
Resolution 280,000 
Polarity Positive 
Micro-scan 1 
AGC target 1,000,000 
Maximum inject time 500 ms 
 
Scan parameters Value 
Resolution 17,500 
AGC  200,000 
Max inject time 50 ms 
Isolation window m/z 1.0 
NCE/stepped 45 
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4.1.6 Sample drying 
In an attempt to improve upon the repeatability cited in Costa et al, [135] an experiment to observe 
if sample drying affects the relative standard deviation (RSD) of replicates was performed. 300 pg 
of drug standard containing cocaine and BZE (30 ng/ml in ACN) was spotted on the paper and run 
using the method described in Section 4.1.1. One set of samples, 3 replicates, was run directly after 
deposition of the drug standard and internal standard (100 ng/ml in ACN). Another set of triplicates 
was carried out after those standards were given time to dry. As illustrated in Figure 26, 10 µL of 
drug standard was spotted on the paper substrate and left to dry for 2 minutes. Then, 10 µL of 
internal standard was spotted on the same paper substrate and left to dry for 2 minutes. The RSD 
for the former set (no time allowed for drying) was 34 % for both cocaine and BZE. On the other 
hand, the RSD of the latter set (with drying time) was 13 and 16 % for cocaine and BZE, 
respectively. Therefore, for all the following samples, the standard was allowed to dry for 2 
minutes before application of internal standard and drying for 2 minutes, prior to analysis to obtain 
improved precision of target analytes. 
Table 10 RSD comparison between immediate run of standard and after two minutes drying of standard. 
Types of samples Analytes RSD (%) 
No drying Cocaine 34 
BZE 34 
After 2 minutes drying Cocaine 13 
BZE 16 
 
4.2 Method Validation 
According to SWGTOX, standard practices for method validation, any qualitative 
confirmation/identification test must conduct test for carryover, interference studies, limit of 
detection, and stability [182]. In this research, a method validation was carried out that included 
the evaluation of the following parameters: limit of detection (LOD) and limit of quantification 
(LOQ), linearity, precision (intra and inter-day), carryover, stability, and matrix effects. The results 
of the validation study are reported in the following sections.  
4.2.1 Limit of detection (LOD) and limit of quantification (LOQ) 
The limit of detection (LOD) of an analyte can be described as the lowest concentration of an 
analyte in a sample that can be reliably differentiated from a blank matrix and identified by the 
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analytical method [183]. The limit of quantitation (LOQ) is defined as an estimate of lowest 
concentration of an analyte in a sample that can be reliably measured with acceptable bias and 
precision [182]. The LOD for cocaine and BZE using the paper spray method was determined by 
running different concentration standards. Each standard was prepared from a stock solution which 
contained cocaine and BZE in ACN (100%) at 1000 ng/ml. The stock solution was made with 1 
mg/ml of cocaine and BZE standards. The standards were prepared at 10, 50, 100, 200, 300 and 
400 pg in the same solvent by diluting the stock solution. 10 µL of each standard was spotted on a 
separate paper substrate and air dried for 2 minutes. 10 µL of internal standard (100 ng/ml in ACN) 
was subsequently spotted on the same paper substrate and air dried for 2 minutes before carrying 
out the paper spray mass spectrometry method. Each calibration standard was analysed in triplicate. 
The ratio analyte/internal standard (A/IS) was obtained for each measurement, and the mean value 
is plotted against concentration in Figure 27. 
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Figure 27 Calibration curve of cocaine (A) and BZE (B) with the range between 10 to 400 pg, determined using paper spray mass 
spectrometry. The possible cause of uncertainty in the concentration of standard and internal standard includes pipetting error, 
degradation of standards due to aged stock solution, or less extraction of target analytes due to distorted geometry of paper 
substrates after depositing spray solvent.    
According to Shrivasava et al., for a linear calibration curve, it is assumed that the instrument 
response y is linearly related to the standard concentration x for a limited range of concentrations. 
This model is used to compute the sensitivity (slope) and the LOD and LOQ. Therefore, the LOD 
and LOQ can be expressed as the below Equation 2 [184].  
 
𝐿𝑂𝐷 = 3𝑆𝑎/𝑏 
𝐿𝑂𝑄 = 10𝑆𝑎/𝑏 
Sa: standard deviation of the response, b: the slope of the calibration curve  
Equation 2 Equation to obtain value of LOD and LOQ of the response. 
The standard deviation of the response can be estimated by the standard deviation of either y-
residuals, or y-intercepts, of regression lines. This method can be applied in all cases, and it is most 
applicable when the analysis method does not involve background noise such as in this study.  
The values of LOD and LOQ corresponding to cocaine and BZE are shown in Table 11 alongside 
the values derived from Q-TOF method by Costa et al. [135].  
y = 0.0011x - 0.0202
R² = 0.9847
-0.1
0
0.1
0.2
0.3
0.4
0.5
0.6
0 50 100 150 200 250 300 350 400 450
R
at
io
 A
/I
S
Mass (pg)
B
92 
 
Table 11 LOD and LOQ value of cocaine and BZE in Orbitrap and Q-ToF. 
 
4.2.2 Linearity  
The linearity of the method was evaluated for the 100 to 1200 pg range for cocaine and BZE. 
Calibration standards were prepared at 100, 300, 600, 900, and 1200 pg. Each level of 
concentration was performed in triplicate. The ratios analyte to internal standard were used for 
linearity analysis. The preparation method of the standards was same as preparing standards for 
the LOD and LOQ. As shown in Figure 28, The R2 value of cocaine 0.991. The R2 value of BZE 
was 0.9863. Therefore, the method gives a linear response in the range up to 1200 pg. 
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Figure 28 Calibration curve for linearity test of cocaine (A) and BZE (B) with the range between 100 and 1200 pg using paper spray 
mass spectrometry. The possible cause of uncertainty in the concentration of standard and internal standard includes pipetting 
error, degradation of standards due to aged stock solution, or less extraction of target analytes due to distorted geometry of paper 
substrates after depositing spray solvent.     
4.2.3 Precision  
Precision was evaluated by analysis of cocaine and BZE containing standards at three quality 
control (QC) levels: low (100 pg), medium (600 pg), and high (1200pg). 
Intra-day precision (repeatability) was performed with a single day run, and inter-day precision 
(reproducibility) was evaluated over runs on three separate days. Five replicates were carried out 
for each QC level. The results were calculated with one-way ANOVA (Analysis Of Variance), 
which is provided in Microsoft Excel and used to determine whether there are any statistically 
significant differences between the means of three or more independent groups. The results of both 
precision tests were expressed by relative standard deviation (RSD). According to Silveira-Gde et 
al. acceptable criteria of RSD for precision is less than 20 % [185].  Table 12 and Table 13 present 
RSD of inter precision and intra precision, respectively. The inter-precision test was performed 
once in each week. The RSD of both cocaine and BZE in inter and intra precision test had values 
lower than 20 % for each QC level. The RSD values were considerably better than those of Q-
TOF which were up to 33 % [135].    
Table 12 Intra-day precision of cocaine and BZE (n=5). 100 pg of BZE was not applicable because it is below the value of LOQ for 
BZE. 
Analyte Concentration of QC (pg) RSD (%) 
 100 19 
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Cocaine 600 18 
1200 6 
 
BZE 
600 12 
1200 10 
 
Table 13 Inter-day precision of cocaine and BZE (n=5, 3 days). 100 pg of BZE was not applicable because it is below the value of 
LOQ for BZE. 
Analyte Concentration of QC (pg) RSD (%) 
 
Cocaine 
100 17 
600 10 
1200 12 
 
BZE 
600 15 
1200 15 
 
4.2.4 Carryover 
Carryover effect is the appearance of unintended analyte signal in subsequent samples after the 
analysis of a positive sample. It can lead to inaccurate qualitative or quantitative results. An 
analytical procedure must be able to remove any carryover. In cases when it is impossible to 
eliminate carryover, the standard operating procedure (SOP) must address how it would be 
managed [182]. For example, blank samples must be run between measurements.   
Carryover effects were determined using blank paper, immediately after the analysis of a target 
analyte containing sample. It was observed that the signal of both target analytes was still observed 
from the blank paper if the previous sample contained high concentration of them, which was 
normally above 200 pg. In that case, a new blank paper must be run multiple times until the signal 
of target analytes disappears to zero. For example, Figure 29 shows the mass spectrum of 800 pg 
and more mass of cocaine (m/z 304.1542). In order to eliminate carryover, a blank paper was used. 
However, the cocaine peak was still detected at low intensity. Therefore, another blank paper was 
used to completely eliminate the cocaine signal. In this case, the cocaine signal disappeared after 
a second blank paper was run. Then, another set of samples were allowed to run. Therefore, at 
least two blank samples were run after all fingerprint samples and relevant peaks were monitored 
until the level of analytes in the blanks were below the LOD. 
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Figure 29 Mass spectra of 800 pg of cocaine and subsequent blank samples (1 and 2) to eliminate carryover effect. 
4.2.5 Stability of drug standards 
The stability of cocaine and BZE standards spotted on paper substrates was evaluated at low and 
high QC concentration (100 and 1200 pg) under two different conditions: 5°C for three weeks and 
at room temperature (20 °C) for three weeks. This test was performed with three replicates. In 
three weeks, cocaine and BZE did not show any considerable degradation between 5°C and room 
temperature storage, and a t test confirmed that there was no significant difference between the 
two storage temperatures.  
Table 14 Ratio A/IS of cocaine and BZE (100 and 1200 pg) in 5 °C and room temperature. 
Temperature Analytes Concentration 
(pg) 
Ratio A/IS 
t=0 days 
Ratio A/IS 
t=21 days 
 
5°C 
 
Cocaine 
100 0.1 0.15 
1200 1.06 1.24 
BZE 1200 0.98 1.17 
 
Room temperature 
 
Cocaine 
100 0.1 0.095 
1200 1.06 1.30 
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BZE 1200 0.98 1.29 
 
4.2.6 Matrix effects 
Non-targeted analytes in a sample can interfere with the ability to detect and identify a target 
analyte. This is called a matrix effect [182]. In mass spectrometry, matrix effects are caused by 
ionisation suppression or enhancement of target analytes in the presence of other molecules. In 
order to determine the presence of any matrix effects caused by endogenous compounds in a 
fingerprint, a drug standard containing 500 pg of cocaine and BZE was spotted on top of a 
fingerprint deposited on paper and compared with the same drug standard in the absence of a 
fingerprint. A total of three non-drug users deposited all five their fingerprints on separate pieces 
of paper. The method described in Section 4.1.1 was used to analyse the samples.  
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Figure 30 Effect on the presence of a fingerprint matrix on the intensity of analyte, cocaine (A) and BZE (B), compared to the 
internal standard for five fingerprints from each of three donors. 
The ratio A/IS for each sample is shown in Figure 30. Compared to other samples, Donor 1 showed 
the highest variability (RSD: 17 and 28 % for cocaine and BZE respectively). This could derive 
from various factors such as the paper substrate bending due to the deposition of a fingerprint, 
non-sharp tip of paper substrate after fingerprint deposition, non-fixed paper substrate during the 
spray, or an intrinsic difference in the composition of the replicate fingerprints. However, this 
variability was not observed from the other two donors (less than 20 % for both cocaine and BZE). 
In order to evaluate if there is a matrix effect between the different donors, a t test was used to 
compare the mean A/IS ratios, and the calculation is presented in Appendix 1. As a result of the 
statistical calculation, no matrix effect was found.   
4.2.7 Stability test with fingerprint 
According to SWGTOX standard practices for method validation [182], stability experiments 
should be designed and carried out to address situations normally encountered in laboratory 
operations such as instrument issues, unforeseen delays, and so on unless analyte stability is 
already addressed through other means such as quality assurance practices, and published 
references. Therefore, a stability test was conducted in order to evaluate the length of time the 
relevant analytes were stable in the presence of a fingerprint sample at 5 °C, since all fingerprint 
samples were stored in a fridge. Unlike the conducted stability test described in Section 3.2.5 which 
considered only the stability of the analytes in solution, this stability test included the presence of 
fingerprints. In order to maximise the amount of fingerprint residue, all 5 right hand fingerprints 
from 3 donors were deposited on a separate paper substrate for each donor. As for the matrix effect 
test, a 500 pg standard of cocaine and BZE was then spotted on each fingerprint containing sample. 
Fingerprint samples were prepared and aged for 16 days. t test proved that there was no significant 
difference found for either cocaine or BZE upon 16 days of ageing in the presence of a fingerprint. 
Table 15 Stability test with standard on fingerprints aged between T=0 days and T=16 days at 5 °C. 
Analytes Donor Ratio A/IS 
t=0 days 
Ratio A/IS  
t= 16 days 
Difference 
(%) 
Cocaine 1 0.37 0.34 -8 
2 0.47 0.49 +5 
3 0.46 0.34 -26 
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BZE 1 0.34 0.34 0 
2 0.41 0.48 +17 
3 0.42 0.36 -13 
 
According to SWGTOX report, the sample can be considered stable if the signal of analytes are 
placed in the range of ±20 % [182]. As shown in Table 15, BZE was considered stable in the 
presence of fingerprints after 16 days ageing based on the signal ratio from all donors. Cocaine 
was also placed on the acceptable range for being regarded as stable with the presence of 
fingerprints of all donors. The cocaine signal ratio of Donor 3 was not in the SWGTOX range for 
this experiment. This could derive from pipetting error or distorted geometry of paper substrate 
since the stability of cocaine standard (Section 3.2.5) and matrix effect (Section 3.2.6) have proved 
that there was no significant difference after ageing standard and with presence of fingerprint. 
Therefore, it was deemed to be acceptable for the experiments to be carried out in this work.  
4.3 Quality Control (QC) 
Because all the analyses of fingerprint samples were not performed in one day, running a quality 
control (QC) sample throughout this work was necessary to assure that the method was consistent. 
Therefore, the following procedure was adopted. A set of quality control samples were run at the 
beginning of each run of fingerprint samples, and the ratio A/IS obtained for each. In order to 
validate that the test was performing appropriately, a t test was used. In this case, three QC levels 
(low (100 pg), medium (600 pg), and high (1200 pg) were applied each time a set of samples were 
run. Three replicates were applied at each QC level for the method before samples runs were 
started. This allowed a decision to be made on whether the difference between the mean of ratio 
A/IS, x̄, was significantly different from the predicted value A/IS, derived from the calibration 
curve. 
4.4 Summary 
This chapter showed the procedure and results of method optimisation and method validation 
(fulfilled the standards that SWGTOX requires) for analytes of cocaine and BZE. As a result, 
method optimisation and validation of a high-resolution mass spectrometry detection method for 
cocaine and BZE in fingerprints for paper spray high resolution mass spectrometry were successful. 
Cocaine and BZE were found to be stable to ± 30 % in a fingerprint sample, stored for short periods. 
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Chapter 5 Results of PS-MS for Cocaine and BZE 
As described in Chapter 2, cocaine and BZE can be found from environment contaminants such 
as bank note, which non-drug users can be exposed to these substances although they did not 
administer it. Therefore, it is important set a cut-off level to differentiate the level of cocaine and 
BZE in fingerprints between drug users and non-drug users. Fingerprint samples of both sides are 
analysed qualitatively and quantitatively using the developed method.  
This chapter describes the analysis of fingerprint samples collected from drug users and naïve 
users, using the PS-MS method detailed in Chapter 4. As explained in the literature review, one 
aim of this research is to evaluate the efficacy of paper spray mass spectrometry for cocaine testing. 
A previous publication from our group, Costa et al [135], demonstrated feasibility of paper spray 
mass spectrometry for fingerprint analysis but used a Q-TOF mass spectrometer with resolving 
power (W) of 7,000. The test obtained a 2.5 % false positive rate, which is undesirable. Although 
it is low percentage, having possibility of false positive rate in a method can result in false 
accusation. Use of a high resolution Orbitrap (W=280,000) mass spectrometer is explored in this 
work to determine whether the improved selectivity, afforded by the higher mass resolution can 
be used to reduce false positives, and also to investigate further the efficacy of testing for cocaine 
in a fingerprint.  
Fingerprint samples were collected from non-drug users, before and after washing hands to 
determine an environmental cut-off level. Fingerprint samples were also collected, after contact 
with cocaine powder before and after handwashing to determine a cut-off level for drug contact. 
These cut-off levels were then compared with fingerprints collected from patients at a drug 
rehabilitation centre, many of whom had testified taking cocaine. The levels of target analytes were 
expressed in ng/fingerprint by applying a ratio analyte (A) to internal standard (IS) (Ratio A/IS) to 
the calibration curve shown in Figure 27.   
5.1 Background Population 
In order to observe the background level of cocaine and BZE, two fingerprint samples (right thumb 
and right index) were collected from 28 non-drug users from the University of Surrey respectively 
for both “as presented” and “after handwashing” scenarios. For the “as presented” samples, there 
was no pre-preparation step such as wiping or hand washing before fingerprints were deposited. 
For the “after handwashing” samples, participants washed their hands and wore gloves for 10 
minutes before depositing their fingerprints to induce sweating in fingers. 
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Samples were collected using the same collection kit described in Section 3.1.3, on paper with 
force applied for 10 seconds to the fingers until a reading of 1000 to 1200 g was achieved on the 
scales. These samples were run using the PS-MS method described in the previous section. The 
ratio A/IS corresponding to cocaine and BZE is shown in Figure 31. The grey line in the figure 
represents the limits of detection (LOD) for cocaine (0.02 ng) and BZE (0.032 ng), respectively. 
A peak at the same mass as cocaine ((M+H)+) was present above the LOD in 3 out of 56 
fingerprints, and peak assignment was confirmed as a signal of cocaine using MS/MS. Similarly, 
2 of 56 fingerprints contained a signal for BZE above the LOD, but only one of them was 
confirmed as a signal of BZE with MS/MS. This means that despite the small rate, environmental 
contamination derived from cocaine and BZE can be found from non-drug users. This is similar 
to observations our group have previously published using LC-MS [127]. In this previous work, 
for 13 out of 100 fingerprint samples, cocaine was detected above its LOD level (0.01 
ng/fingerprint) (13 %). In 5 out of 100 fingerprint samples, BZE was detected above its LOD level 
(0.03 ng/fingerprint) (5%) [127]. Therefore, setting cut-off levels using samples of non-drug users 
can be significant to reduce the possibility of wrongful accusation.   
In this work, two samples could not be analysed due to a failed spray. A failed spray arises when 
the signal of internal standard is not detected. This presumably occurred either because the process 
of depositing the fingerprint had distorted the geometry of the paper or the paper tip was not cut 
sharply enough to produce a Taylor cone.  
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Figure 31 Mass per fingerprint of cocaine (A) and BZE (B) from non-drug user as presented (n=28). Only 3 fingerprint samples 
(cocaine) and 1 fingerprint sample (BZE) were detected above their LOD level. Although detection rates of cocaine and BZE are 
very low, it is still possible to detect cocaine and BZE from non-drug users’ fingerprints.  
No single donor gave a fingerprint which was positive for both cocaine and BZE. The highest level 
of cocaine observed in a fingerprint of non-drug user was 0.06 ng. The highest level of BZE 
observed in a fingerprint of non-drug user was 0.035 ng. These corresponding values will be used 
as an “environmental cut-off” to compare to the amount of cocaine and BZE detected in the 
fingerprints of drug users in the “as presented” study. Compared to our previous study, the 
detection rate of cocaine and BZE from non-drug users was similar to what this study shows. The 
detection rate for cocaine and BZE in this study was 10 and 3 % respectively. 
In the “after handwashing” study, participants washed their hands thoroughly with soap and dried 
them thoroughly prior to wearing gloves for 10 minutes to induce sweating before depositing their 
fingerprints on paper. Neither cocaine nor BZE were detected in any of the fingerprints of non-
drug users after handwashing. Therefore, an “environmental cut-off” level for cocaine and BZE 
for the “after handwashing” study can be based on the limit of detection (LOD) of the method, 
which was 0.02 and 0.032 ng respectively.   
5.2 Persistence study 
An important aspect of a fingerprint drug test should be that contact with a drug returns a different 
result compared with administration of a drug. Therefore, in this study, drug residues in 
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fingerprints after contact, as well as their persistence are considered. In order to investigate how 
long cocaine residue can stay on a fingertip with normal daily activities and obtain a clearer picture 
of the significance of detecting cocaine in a fingerprint, the longer-term persistence of cocaine 
after contact with cocaine hydrochloride powder (99 %) was studied.  
Adulterants such as caffeine, lidocaine, and levamisole account for highest portion of street 
cocaine. According to Kudlacek et al. [25], these compounds were found in almost 70% of street 
cocaine samples seized between 2012 and 2015. Levamisole was the most commonly found 
adulterant. However, these adulterants were not added to the sample for this persistence study 
(cocaine hydrochloride powder) because addition of caffeine would cause an undesirable 
contamination issue on the mass spectrometer and the addition of levamisole to human skin was 
deemed to be a potential health issue. The cocaine hydrochloride powder (Sigma Aldrich, 99 % 
purity) that was used to make contact fingerprints was confirmed to contain cocaine (m/z 304.1543) 
and BZE (m/z 290.1384) by making a solution in ACN (700 ng/ml) and running 10 μl of the 
solution with the paper spray method described in the previous chapter. The region of the mass 
spectrum for cocaine, BZE, and EME in cocaine hydrochloride solution is shown in Figure 32. 
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Figure 32 Mass spectra of cocaine hydrochloride solution corresponding to [M+H]+ of cocaine (m/z 304.1543), BZE (m/z 290.1384). 
To observe cocaine and BZE in fingerprints after contact, participants (n=3) deposited their 
fingerprints (right thumb and index) on prepared cut papers at each time point; t=3, 7, 12, 24, 30, 
and 48 hours after initial contact with cocaine hydrochloride powder with their right hand fingers 
for 10 seconds. After the initial contact with cocaine, they shook their hands to remove large 
particles. Between each time point, participants reported how much hand washing activity was 
done, but there was no control of the number of hand washes. Fingerprint samples were collected 
using the same method described in Section 4.1.3. 
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Figure 33 Mass per fingerprint of cocaine detected in right thumb and right index fingerprint, collected as presented (AP), of 3 
donors (D1, D2 and D3 respectively) (A) at short term persistence up to 48 hours after touching 2 mg cocaine of 99% purity and 
(B) at long term persistence up to 12 days after touching 0.5 mg (low dose) and 2 mg (high dose) cocaine of 99 % purity. The 
possible cause of uncertainly includes uncontrolled daily activities of participants and accidental contact with heroin before 
fingerprint deposition, or less extraction of target analytes due to distorted geometry of paper substrates after depositing spray 
solvent. RT: right thumb, RI: right index. 
Figure 33 (A) shows the mass of cocaine corresponding to each time period from three donors. 
Cocaine was detected in the fingerprint samples of Donor 1 and Donor 3 above the “environmental 
cut-off” level up to 48 hours after cocaine hydrochloride powder was touched. The signal showed 
a gradual reduction in intensity as function of time, as expected.  
In contrast, after 24 hours, cocaine was not detected from Donor 2’s fingerprints.  
In order to observe if the signal of cocaine from Donor 1 and 3 was still detected above the cut-off 
level in longer time period, their fingerprints were collected again at t= 4, 7, 12 ,14 days from their 
first touching cocaine hydrochloride. As shown in Figure 33, cocaine was not detected after the 4th 
day. It means that cocaine residue on fingertips can be detected up to 48 hours after contact in case 
of fingerprints donated “as presented” but is not readily observed over longer time windows. 
Additionally, the impact of a higher contact dose was investigated, and it is shown in Figure 33. 
Donor 1 and 3 deposited their fingerprints after touching 2 mg of cocaine hydrochloride to observe 
how long it can persist on fingertips compared to low dose (0.5 mg). Compared to the low dose, 
the persistence of cocaine was not extended. Although this study defined 2 mg of cocaine 
hydrochloride as high dose, it is still not enough to affect the time of persistence in fingertips.      
5.2.1 Handwashing 
This research also investigated the effect of handwashing with soap prior to donating a fingerprint. 
The aim was to find a method that could reduce the persistence of cocaine residue after contact 
with cocaine by non-drug users. This process was called after handwashing.  
The same three donors from Section 4.2 followed the same protocol as “as presented” scenario 
except they washed their hands and wore gloves for 10 minutes before depositing their fingerprints 
on each time period. As shown in Figure 34, the mass of cocaine in fingerprints and its regression 
pattern were not so different from the “as presented” despite hand washing. However, unlike the 
“as presented” samples, cocaine persisted on the fingertips above the cut-off level for up to 30 
hours in all donors for both the “high” and “low” initial dose of cocaine, and so the detectable 
traces persisted for a shorter duration.  
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Figure 34 Mass per fingerprint of cocaine detected in the fingerprints, collected after washing hands (AH), of 3 donors (D1, D2 and 
D3 respectively) at short term of persistence after touching 0.5 mg (A) and 2 mg (B) cocaine of 99% purity. The possible cause of 
uncertainly includes uncontrolled daily activities of participants and accidental contact with heroin before fingerprint deposition, 
or less extraction of target analytes due to distorted geometry of paper substrates after depositing spray solvent. RT: right thumb, 
RI: right index. 
Overall, the mass of cocaine observed in the fingerprints of participants reduced as time passed, 
but the level of cocaine detected at each time period was not consistent between donors, since each 
donor’s activities were not controlled. The mass of cocaine measured on the different fingerprint 
samples of the same person during the same time period was variable. After 12 hours, the level of 
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cocaine became significantly different and even the cocaine signal was found from only a single 
fingerprint.   
Clearly, there are many variables in measuring the persistence of cocaine on a fingertip. In this 
study, the dose of cocaine, chemistry of cocaine, choice of donors and deposition of fingerprint 
method was controlled, but the activities of the donor were not controlled. Therefore, although 
these results are the first to explore persistence of cocaine on fingertips, they do only give an 
insight into the persistence behaviour that would be observed across a range of possible cocaine 
chemistries, donors, activities etc. One important observation of this persistence study is that BZE 
was not detected in any fingerprints in any periods from all donors although the presence of BZE 
in the cocaine hydrochloride was confirmed.  
5.2.2 Removal of cocaine contact residue: different wiping methods 
For the persistence study, only handwashing was conducted so far. However, since handwashing 
failed to completely remove cocaine, different physical and chemical removal methods were tested 
to observe whether an alternative method could be used to remove cocaine contact residues from 
fingerprints.  
For the physical approach, taping and brushing were applied in order to observe how effectively 
each method could remove residue from a fingertip. Two non-drug users touched 0.5 mg of cocaine 
for 10 seconds with their right thumb and right index finger and then washed their hands 
thoroughly with soap followed by drying their hands. Then, a piece of adhesive tape (A&E, UK) 
was stuck on the finger and pulled off. For the other participant, hands were brushed (Tetra Scene 
of Crime, USA) after contact with cocaine. They then wore protective gloves to induce sweat for 
10 minutes before depositing their fingerprints on the prepared paper substrates.  
For the chemical approach, alcohol and alcohol-free wipe were applied. Cocaine solubility in water 
is 1 g/ 600 ml, whilst cocaine solubility in alcohol is 1 g/ 6.5 ml [186]. This means that cocaine is 
about 100 times more soluble in alcohol. As an example of this phenomenon, there is a cocaine 
metabolite called cocaethylene. This product is formed when cocaine is administered concurrently 
with ethyl alcohol with a high affinity. Therefore, using alcohol wipes could form a cocaine-
friendly environment by alcohol in the wipe conjugating with the cocaine compound on the 
fingertip, so cocaine compounds would be more effectively removed from the finger.  
Another way to support this hypothesis is by considering the partition coefficient. The concept of 
partition coefficient (P) derives from the fact that many organic substances and water do not always 
mix but develop separate layers. Therefore, the logarithm of the partition coefficient, log P was 
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investigated to determine how much of an organic substance (solute) can be dissolved in the water 
portion or the organic portion through the numerical value. If log P value is negative, it means that 
the substance has a high affinity to the water portion (more hydrophilic). On the other hand, if the 
log P value is positive, the substance has high affinity to the organic portion (more lipophilic). For 
example, if log P value is 1, it means that the substance is 10 times more soluble in the organic 
(lipid) environment than the water environment [187]. In case of cocaine, the log P value is 2.3 
[188]. It means that cocaine is over 100 times more soluble in organic solvent than in water.  
Therefore, alcohol wiping was applied to the study of cocaine persistence on the fingertip. In order 
to make an alcohol wipe, a hand gel (Enliven, UK) was pumped on the contaminated fingertip and 
wiped with a paper towel.  
Alcohol free wipes (Steroplast, Manchester composed of aqueous solution containing 0.2 % of 
certrimide and 0.02% of chlorhexidine gluconate) were applied to a separate set of fingers to 
compare to the alcohol wipe.  
Two non-drug users touched 0.5 mg of cocaine for 10 seconds with right thumb and right index 
and then washed their hands thoroughly with soap followed by drying their hands. Then, one 
participant was wiped with the alcohol wipe, and the other participant was wiped with the alcohol-
free wipe. After wiping, they wore a protective glove for 10 minutes to induce sweating. 
Fingerprints of those two fingers were separately deposited on the prepared cut paper. 
 
Figure 35 Mass per fingerprint of cocaine after 2 mg of cocaine hydrochloride touched. Physical methods (tape VS brush) and 
chemical methods (alcohol wiping VS alcohol free wiping) on right thumb and right index finger (single replicate). The average 
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mass of cocaine contact after 3 hours with only water and soap for the persistence study was also shown for the direct 
comparison. 
As shown in Figure 35, as predicted, using an alcohol wipe was more effective than an alcohol 
free wipe at removing cocaine residues from fingertips although it did not result in complete 
removal. Concerning physical methods to remove the cocaine residue, neither methods removed 
cocaine residue completely. In conclusion, using alcohol turned out the best method for removing 
cocaine residue in a fingerprint.  
In this study, all participants (drug users and non-drug users) for the after handwashing study were 
conducted by only water and soap. However, these results indicate that an alcohol wipe would 
remove any cocaine contact residues more efficiently than the method that was employed to sample 
drug users. Alcohol wiping could be applied in future work.     
5.3 Street Cocaine  
Our group also investigated drug residues in fingerprints immediately after contact with cocaine. 
Data in this sub-section of the thesis was provided by Dr Catia Costa but is used for comparison 
purposes. This data is important because it considers a cocaine source of street purity.  
Samples of cocaine seized by Irish police and stored at Forensic Science Ireland (FSI) were used 
for this work. A sample from the drug seizure had been previously analysed by FSI’s standard 
analysis protocol using gas chromatography – mass spectrometry and had been found to have a 
cocaine purity of 41%, with traces of benzoylecgonine, ecgonine methyl ester, caffeine, lignocaine 
and levamisole.  Three donors (non-drug users) were asked to touch 2 mg of the powder, spreading 
the powder over all their right-hand fingers for approximately 10 seconds. They then dusted the 
excess off to remove large particles, and deposited fingerprints (left index and middle fingers) 
before and after handwashing, as described above. 
As shown in Figure 36, cocaine was detected in all fingerprints provided as presented. Interestingly, 
BZE was also detected in fingerprints provided as presented, unlike the persistence study described 
in Section 5.2, which used pure cocaine. This shows that the detection of a drug metabolite in a 
fingerprint provided from unwashed hands does not necessarily arise from drug ingestion. 
However, BZE was no longer detected after hand washing, whereas cocaine was still detected.      
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Figure 36 Mass per fingerprint of cocaine and BZE after touching street cocaine in both as presented and after handwashing. BZE 
was still detected after contact with cocaine powder, which was not found from the persistence study using cocaine hydrochloride 
powder.  AP: as presented, AH: after handwashing. 
5.4 Fingerprints from Drug Users 
Fingerprints from drug users from Surrey and Borders NHS Trust who testified taking cocaine 
within last 24 hours were also collected for as presented and after handwashing to compare to 
cocaine and BZE levels seen in Section 5.1 from non-drug users.  
5.4.1 As presented fingerprints 
Fingerprint samples (right thumb and right index) were collected from 28 patients (56 fingerprints) 
in a rehabilitation clinic from patients who testified administration of cocaine within last 24 hours. 
The mass/fingerprint of cocaine and BZE detected in their fingerprints provided as presented is 
shown in Figure 37. Three fingerprint samples could not be analysed due to failed spray (explained 
in Section 5.1).  
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Figure 37 Mass per fingerprint of cocaine (A) and BZE (B) from drug users as presented. Cocaine was detected in all fingerprint 
samples of drug users (100 %). On the other hand, BZE was detected with 83 % of detection rate. Drug users were divided into two 
groups based on the results of confirmation oral fluid test. OF-: oral fluid test negative.  
As shown in Figure 37, cocaine was detected in all fingerprint samples above the LOD (100%). 
Also plotted is the “environmental cut-off” (from the background population samples presented in 
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Section 5.1), the highest level of cocaine observed in the contact residue experiments in Section 
5.2 (labelled “Cocaine powder”) and the highest level of cocaine contact residue observed in 
Section 5.3 (labelled “Street cocaine”). Also plotted is the oral fluid test results, either positive 
(OF+) or negative (OF-).  
For BZE, 44 out of 53 (83%) fingerprint samples were detected at levels above the LOD. One 
thing to note is that there were only 3 patients whose BZE level was below the LOD level in both 
fingerprints provided.  
The mass of cocaine and BZE detected in the fingerprints of drug users were highly variable 
between and within donors. The intra donor variability arises from the fact that the method does 
not account for the volume of fingerprint material deposited, which is expected to vary between 
different depositions of different fingers. The inter donor variability may arise from several factors. 
Although fingerprint samples were collected from only patients who testified taking cocaine within 
last 24 hours, preliminary actions of participants were not monitored, and the schedule of 
administration was not controlled. Some donors may have taken cocaine a longer time ago, others, 
on the other hand, may have had cocaine powder residue remaining on their fingertips due to 
preparation for administration before coming into the clinic. Therefore, determining the mass of 
cocaine and BZE after handwashing are very significant to this investigation and is considered in 
the next section. 
5.4.2 Fingerprints collected after handwashing 
Fingerprints were collected after participants washed their hands in order to achieve a more robust 
method for cocaine detection in fingerprints. Otherwise, the possibility of false positive test result 
still remains for a drug test using fingerprints, as shown clearly in Figure 36, where contact residues 
of cocaine in fingerprint deposited after contact can be higher than those donated by patients who 
have administered cocaine.  
“After handwashing” was defined that after the patient deposited their initial fingerprints, they 
washed their hands thoroughly with soap and completely dried them prior to wearing gloves for 
10 minutes to induce sweating. Each participant was asked to wash their hands as they normally 
do. This means that the handwashing procedure was not controlled. 42 fingerprint samples (21 
patients) were collected for this study. 2 of samples could not be analysed due to a failed spray.        
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Figure 38 Mass per fingerprint of cocaine (A) and BZE (B) from drug users after handwashing. Cocaine was still detected in all 
fingerprint samples of drug users (100 %). BZE was detected with 73 % detection rate after handwashing. Drug users are divided 
into two groups based on the results of confirmation oral fluid test. OF-: oral fluid test negative. 
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Like “as presented”, cocaine was still detected above the LOD in all fingerprint samples despite 
samples being taken after handwashing.  
BZE was detected above the LOD in 29 out of 40 (73%) fingerprint samples. The detection rate 
decreased by 10% compared to “as presented” samples. There were only 3 patients whose BZE 
was below the cut-off level in both fingerprints, like in the “as presented” study. 
Some protocols for “after handwashing” study were changed in order to observe the possibility of 
increasing the detection rate of BZE in fingerprints of drug users. According to Dr. Jerry Walker 
from Intelligent Fingerprinting, the cocaine and BZE detected in an antibody assay developed by 
their company is more readily detectable from natural sweating rather than wearing gloves. 
Therefore, 5 patients were asked to sweat naturally for at least 10 minutes and try not to touch any 
surfaces after washing their hands prior to depositing their fingerprints. The corresponding 
mass/fingerprint of cocaine and BZE is shown in Figure 38. 
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Figure 39 Mass per fingerprint for cocaine (A) and BZE (B) after handwashing, not wearing gloves. Cocaine was still detected in all 
fingerprint samples of drug users. BZE was detected with 20 % detection rate without wearing gloves after handwashing.  Drug 
users are divided into two groups based on the results of confirmation oral fluid test. OF-: oral fluid test negative.  
Cocaine was still detected above the LOD in all fingerprint samples. BZE was detected in only 2 
out of 10 (20 %) above the LOD without wearing gloves, and the result of oral fluid test of 
Participant 1 was negative, which means that the signal of BZE from the participant could derive 
from the environmental contamination because of not wearing a glove after handwashing. It was 
therefore concluded that natural sweating after handwashing would not be the right choice in this 
study. Therefore, wearing gloves was chosen as an after-handwashing protocol for the further 
study.       
5.4.3 Preliminary environmental exposure cut-off level 
Clearly, the results in the previous sections show that the detection of cocaine and BZE in a 
fingerprint can be observed after normal environmental exposure. Setting cut-offs for conventional 
drugs is readily carried out for hair, sweat, and oral fluid to reduce the chances of false positives 
due to environmental exposure of a substance [42, 189]. Therefore, in this study, the possibility of 
setting an environmental cut-off level using a fingerprint was explored.    
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In case of this study, neither cocaine nor BZE were detected from fingerprint samples of non-drug 
users in “after handwashing” study. This implies that the limits of detection of the method are 
suitable for distinguishing drug use from normal environmental exposure.    
In contrast, for either washed or unwashed hands, cocaine was detected above the cut-offs.  
5.4.4 Comparison of fingerprints and oral fluid 
In order to explore the relationship between fingerprints and oral fluid, patients were also asked to 
take an oral fluid test using a Quantisal™ collection kit, Alere Toxicology, UK. Analysis of oral 
fluid samples were carried out by Claritest (Norwich, UK). The samples were screened for multiple 
drugs including cocaine using immunoassay testing. Positive immunoassay screening was 
confirmed using LC-MS/MS as a confirmation test. As explained in Section 5.2.1, patients were 
asked to take an oral fluid test to confirm the positive reaction of cocaine and compare with their 
fingerprint samples. Oral fluid testing for drug abuse has been accepted universally for many 
applications [36]. 
With comparison of fingerprints to oral fluid screening test for cocaine and BZE in “as presented” 
and “after handwashing” collected from patients treated in the rehabilitation clinic, Cocaine was 
not detected in the oral fluid of patients in 8, 9, and 25 as shown in Figure 37. However, cocaine 
and BZE were detected in the corresponding fingerprints of all three patients in the “as presented” 
scenario. Patient 25 had been hospitalised for a while, and the drug use of this patient was thought 
to be under control. The oral fluid test indicated that the patient did not take drugs other than 
prescribed methadone. It is therefore unlikely that the cocaine detected in this patent’s fingerprints 
arises from cocaine use, and BZE was not detected after handwashing.  
One interesting observation is comparing results of the fingerprint test to positive results of the 
oral fluid test, which were performed as a confirmation test. After handwashing, BZE detection 
was 83 %.  Additionally, if we specify that only one fingerprint sample is needed for BZE for 
detecting cocaine administration, the detection rate then rises to 89 %. It means that the method 
used to detect BZE offered more specificity after handwashing, which is less affected by any 
potential contamination. 
5.5 Summary  
Previously, studies into drug detection in fingerprints have never included fingerprint samples of 
drug users. They applied drug standards to a surface such as a glass slide and spiked fingerprints 
on them. By controlling the amount of standards, they set two different scenarios: handling and 
abuse [138]. However, they only showed imaging results of two different scenarios, not explaining 
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the significance of two different scenarios and how to distinguish them. Recently, Costa et al. 
[135], investigated fingerprint samples of drug users for cocaine detection using a paper spray 
mass spectrometry method. It introduced the paper spray mass spectrometry technique in detecting 
drugs in fingerprints and yielded 99 % true positive rate for cocaine detection. However, compared 
to the method validation of the study of Costa et al., the method of this study provided the similar 
sensitivity (20 pg per fingerprint) but better precision (33 % to below 20 %). This study also 
fulfilled the standard of other method validation parameters that SWGTOX requests for the further 
quantification (accuracy, linearity, matrix effect, carryover, and stability) [182]. These resulted in 
no false positives and 100 % cocaine detection rate, in accordance with the results of oral fluid 
tests (confirmation test) and the testimony of participants. Furthermore, this study also investigated 
the significance study/evidence dynamic such as persistence and effect of hand washing for 
cocaine removal from fingertips. The persistence study showed that 48 hours after contact, cocaine 
was no longer detected in a fingerprint by this method. The background study showed that provided 
hands are washed prior to giving a sample, cocaine was not normally detected in the fingerprints 
of non-drug users. Therefore, although the detection of cocaine in a fingerprint does not necessarily 
indicate it has been ingested, it does show either ingestion or recent contact with the drug. In 
contrast, provided hands were washed prior to giving a sample, BZE was ONLY observed in 
fingerprints of drug users whose oral fluid tested positive for cocaine. Even immediately after 
contact with cocaine that was contaminated with BZE, this metabolite was not observed after hands 
were washed. Similarly, BZE was not detected amongst the non-drug users, or the drug users who 
tested negative in their oral fluid (provided hands were washed prior to giving a sample). The 
presence of BZE was a good indicative to distinguish fingerprints after cocaine contact and 
ingestion. 
5.6 Discussion 
Using fingerprints as a biological matrix for drug testing is challenging due to high variability in 
both composition and volume. The number of endogenous compounds and target analytes excreted 
from fingerprints are different depending on donor’s characteristics (gender, age, or size of 
fingerprints). The absence of a commercial fingerprint sweat standard also made it difficult to set 
an ideal calibration curve for target analytes.  
This study used careful experimental control to minimise the variation between fingerprints. For 
example. 
 all paper substrates were washed with washing solvents;  
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 a kitchen scale was used to achieve a consistent fingerprint deposition force;  
 participants’ actions was controlled after handwashing not to minimise potential 
contamination. 
As a result of endeavour, the matrix effect test and stability test with the presence of fingerprints 
were not significantly different, the cocaine detection method gave high sensitivity (LOD: 20 
pg/fingerprint) and yielded a significance result that BZE is a good indicative to distinguish 
fingerprints after cocaine contact and ingestion.  
By matching the sample size between non-drug users and drug users (28 donors, 56 fingerprint 
samples), the levels of cocaine and BZE in fingerprints were directly compared between the two 
groups. The results from the persistence study agreed with those from the administration study 
although the sample size for the persistence study was limited (3 donors, 6 fingerprint samples) 
due to health and safety controls 
To increase the significance of these data in the future a larger number of participants there should 
be used with a greater difference in the amount of cocaine powder used for low dose (0.5 mg) and 
high dose (2 mg). Despite these limitations, the study is still significant in investigating the 
persistence of illicit substance (cocaine and BZE) using fingerprints after contact with powder 
residue for the first time.                    
Because of advantages of PS-MS (no sample preparation, simple deposition of fingerprints, and 
rapid analysis) and high detection rate of target analytes from fingerprint samples of drug users 
(with a distinguishable level of cocaine and BZE from the environmental cut-off level), this 
method could be considered as a screening test tool for practical application in the near future. One 
example is the driving under the influence (DUI) test. This term is normally used to describe 
driving during alcohol intoxication. However, according to the 2017 National Survey on Drug Use 
and Health (NSDUH, USA) [190], 11.8 million drove under the influence of illicit drugs in 2016 
and the number increased to 12.8 million in 2017. Cocaine, heroin, methamphetamine, and THC 
were the mostly selected drugs during driving under the influence according to the ROSITA 
project [292]. However, In order to apply this method to the DUI test, law enforcement officers 
obviously have to basic knowledge of operating principle of the paper spray technique and mass 
spectrometry interpretation. If law enforcement agencies would like to try this technique and 
method for the practical application, they can be test-used, and experts can instruct them how to 
use and interpret the result. If the agencies are satisfied with outcomes of practical application, this 
technique and method will be spread to be used in other related agencies. With this application, 
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law enforcement agencies could obtain more quick and accurate information if they apply this 
method to directly detect illicit substances at the scene using a potable mass spectrometry possibly 
conjugated with a paper spray source [293], which can be a huge advantage for the further 
investigation and crime reconstruction.   
The next chapter explains whether mass spectrometry imaging can be used as a confirmation test 
to demonstrate whether a donor has handled or administered cocaine. 
. 
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Chapter 6 Exploration of Parameters of Mass Spectrometry Imaging 
(MSI) Techniques 
This chapter tests the suitability of imaging mass spectrometry techniques to distinguish between 
fingerprints deposited after cocaine use and cocaine contact. Unlike the optimised the paper spray 
mass spectrometry method described in Section 4.1, the methodology for imaging analysis 
comprises only qualitative analysis of fingerprint images.  
Molecular imaging analysis using mass spectrometry emerged because it can provide not only 
molecular identification of each analyte as per conventional mass spectrometry techniques, but 
also spatial distribution of analytes on the sample surface. A group of imaging mass spectrometry 
imaging analysis techniques such as matrix-assisted laser desorption/ionisation (MALDI), 
desorption electrospray ionisation (DESI), and secondary ion mass spectrometry (SIMS) are now 
commercially available and are widely used for biological sciences, especially for biological tissue 
imaging [191, 192].  
These techniques have more recently been applied to fingerprint imaging. Initial applications 
included imaging of latent fingerprints or enhancement of fingerprints to observe minute ridge 
details for personal identification [171, 193-196]. Later, they were applied for detection of 
compounds of interest such as illicit drugs and other exogenous chemicals (cosmetics) in 
fingerprints [138, 197-200]. 
MALDI and SIMS are conventionally operated in a high vacuum system (10 e-6 mbar). SIMS is 
less destructive to the sample than MALDI and able to provide sub-micron resolution image [137]. 
However, the mass range of SIMS is relatively low because SIMS bombards the sample, and 
sputtering causes molecules to be broken down into fragments rather than detecting intact ions, 
which could make identification of the analyte (through its intact molecular ion) difficult. On the 
other hand, MALDI-MS can generate intact molecular ions, which can aid analyte identification. 
However, the resolution of MALDI-MS imaging is frequently more than 50 μm [137]. 
Additionally, identification of analyte can be affected by interferences with ions from the matrix 
which is applied to the sample prior to analysis.  
More recently, DESI-MS was invented [201]. Unlike the two techniques above which are operated 
typically under high vacuum with DESI, the sample is analysed under ambient conditions. 
Additionally, it does not require a matrix to enhance analyte ionisation, and this allows a broad 
spectrum of analytes to be simultaneously probed without making prior assumptions about the 
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sample. DESI-MS has been applied to imaging biological tissues [202-206] and fingerprints for 
observing either ridge details [207, 208] or detection of exogenous substances [131].  
Due to limited instrument access, only limited optimisation using DESI and MALDI took place. 
Therefore, the methodology applied in this study is based on parameters previously set by National 
Physical Laboratory (NPL), and the analytical conditions and method performance is described in 
this chapter. 
In contrast, ToF-SIMS was available at the University of Surrey and was more readily available 
for use. This chapter describes the method optimisation that took place for this research.   
6.1 Materials 
Drug standards (cocaine, benzoylegonine (BZE)) were obtained from Cerilliant (Dorset, UK). 
Cocaine hydrochloride powder (Sigma-Aldrich, UK) was donated by Dr. Alexis Bailey of 
University of Surrey. To prepare all solution and solvent mixtures, OtimaTM LC-MS grade solvents: 
methanol (MeOH), acetonitrile (ACN), and water (H2O) were used (Fischer Scientific, 
Leicestershire, UK).  
6.2 Sample Collection 
A favourable ethical opinion for collection and analysis of samples was granted from the National 
Research Ethics Service (NRES - REC reference: 14/LO/0346). 
Fingerprint sample (left thumb and index for DESI-MS and MALDI-MS on adhesion slide Super 
Frost Plus and middle and ring for ToF-SIMS on silicon wafer, and graphene oxide) from patients 
attending a drug rehabilitation clinic, who testified administration of cocaine within last 24 hours 
were collected following two different scenarios: “as presented” and “after handwashing”. For the 
“as presented” samples, participants deposited their fingerprints without any wiping or hand 
washing. For the “after handwashing” samples, participants washed their hands and dried them 
completely before wearing gloves for 10 minutes to induce sweating. Samples were collected on 
each substrate using a kitchen scale pressing down until a reading of 1000 to 1200 g of deposition 
was achieved to control the force.  
To investigate drug residues immediately after contact with cocaine, samples of cocaine seized by 
the Irish police and stored at Forensic Science Ireland (FSI) were used. A sample from the drug 
seizure had been previously analysed by FSI’s standard analysis protocol using gas 
chromatography – mass spectrometry and had been found to have a cocaine purity of 41%, with 
traces of benzoylecgonine, ecgonine methyl ester, caffeine, lignocaine and levamisole. Three 
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donors (non-drug users) were asked to touch 2 mg of the powder, spreading the powder over all 
their right-hand fingers for approximately 10 seconds. They then dusted the excess off to remove 
large particles, and deposited fingerprints (left index and middle fingers) on the adhesion slide 
Super Frost Plus adhesion glass slide before and after handwashing, as described in Chapter 5. 
To explore the image of cocaine contact residue using fingerprints, 3 donors (non-drug users) 
touched 0.5 mg cocaine hydrochloride powder (Sigma-Aldrich, UK, 99 %), as described in the 
previous paragraph.  
Analysis of oral fluid samples of patients who deposited fingerprints were carried out by Claritest 
(Norwich, UK) in order to explore the relationship between fingerprints and oral fluid. The 
procedure of collecting oral fluid samples has been explained in Section 3.2.3. 
6.3 Exploration of DESI-MS parameters for fingerprint imaging 
6.3.1 Instrumentation  
DESI-MS analysis of fingerprint samples were carried out at the National Physical Laboratory 
(NPL). The DESI 2D ion source (Prosolia) was coupled to a Waters SYNAPT G2-Si High 
Definition Mass Spectrometer (Waters, UK). All spectra were analysed using MassLynx software. 
The capillary voltage (5 kV), cone voltage (50 V), capillary temperature (100 °C), S-lens RF level 
(50.0), and mass range (m/z 100 to 1200) were previously optimised to the mass spectrometry in 
NPL. The target protonated ions (M+H)+ of analytes were cocaine (m/z 304.1539) and 
benzoylegonine (m/z 290.143). Samples were analysed in full scan mode.  
Drug standard containing cocaine and BZE were prepared into 100 % of ACN. 90:10/MeOH:H2O 
was used as a DESI spray solvent. 0.1% v/v of formic acid (Fischer Scientific, Leicestershire, UK) 
was added to all spray solvent to enhance protonation. 2.5 mL of the solvent was filled in a syringe 
(Hamilton 1000) with a solvent flow of 2.0 μL/min. They were optimised for the image resolution. 
Table 16 Fixed parameters of mass spectrometry coupled with DESI. 
Mass spectrometer parameters Value 
Mass range (m/z) 100 to 1200  
Ion mode Positive 
Mass resolution 20,000 
Cone voltage 50 V 
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Capillary voltage applied 5 kV 
Capillary temperature 100 °C 
 
The movement of the DESI stage was controlled using the Omnispray software [209]. The 
sampling size was measured using a scale prior to running the sample based on the size of a whole 
fingerprint (usually bigger than 10 × 10 mm2) to cover the whole fingerprint. The pixel size was 
optimised in order to produce the optimum spatial resolution of fingerprint images, and this will 
be described in Section 7.1.4.  
6.3.2 Data processing  
Data was acquired and saved as raw files. Raw data was converted to .mzml and .imzml files using 
MS convert software and imzml converter, respectively. Finally, data was manipulated and 
analysed using Spectral Analysis through MATLAB [210]. Spectral Analysis is a software that 
can be used for the entire analysis of spectral imaging techniques whose workflow goes from raw 
data through pre-processing (including a wide range of methods for smoothing, baseline correction, 
normalization, and image generation) to multivariate analysis, for data sets acquired from single 
experiments to large multi-instrument, multimodality, and multicentre studies [211].  
6.3.3 Mass spectrometer calibration  
In order to calibrate the mass spectrometer coupled to the DESI source, a polylactic acid (PLA) 
film deposited on a glass slide was used. By using polymeric materials for calibration, broad molar 
mass distribution of known peaks can be obtained [212]. 
6.3.4 DESI source optimisation  
Optimisation of the DESI source was conducted in order to obtain the best erosion rate and 
transmission into the mass spectrometer. In this case, rhodamine B (m/z 443.2333) was used as a 
target analyte for DESI source optimisation. The ink of a Sharpie pen contains rhodamine B, so a 
glass slide with multiple lines drawn with the pen was put on the DESI stage, and one of lines were 
targeted with the DESI spray. The distance between spray tips and surface, the impact angle, and 
the distance between source sprayer and capillary inlet were optimised based on the intensity of 
rhodamine B peak which was targeted to be at least 106 counts. Optimised parameters are shown 
in Table 17. 
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Table 17 Optimised parameters of DESI source to target surface. 
DESI parameters Value 
Distance between spray tip and surface 2 mm 
Impact angle 65 ° 
Separation between source sprayer and capillary inlet 5 mm 
Intensity of rhodamine B peak (counts) 106 
Pressure of N2 gas 80 psi 
Solvent composition 9:1 (MeOH:water) 
Solvent flow rate 2 μL/min 
Scan speed 0.985 sec/scan 
Binning  0.001 
Pixel size 100 x 100 µm 
 
6.3.5 Image resolution optimisation  
As explained in Section 2.3, the DESI-MS used here can operate down to a pixel size of 40 µm. 
However, as the pixel size becomes smaller, the duration of sample mapping increases for a given 
scan area, assuming a constant dwell time per pixel. In this work, the scan area was set to 
approximately 12 × 10 mm so that a fingerprint could be visualised alongside relevant standard 
spots to ensure that the correct compounds were being monitored. To reduce acquisition time, 
larger pixel sizes of 100 and 200 µm were tested.  
Two different fingerprints from drug users were deposited on a glass slide, and a 1 µL drop 
containing 50 pg of cocaine standard was spotted right next to the fingerprint for direct comparison 
for analytes of cocaine ions between the fingerprint sample and standard. The two fingerprint 
samples were mapped with different pixel size: 100 and 200 µm, respectively as shown in Figure 
40.  
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Figure 40 DESI-MS images of analytes of cocaine at m/z 304.1534 in drug user’s fingerprint with 50 pg of cocaine standard (upper 
right side) at pixel sizes of (A) 100 × 100 µm and (B) 200 × 200 µm. 
Figure 40 shows images of m/z 304.1534 which were acquired at different pixel sizes. Using a 100 
µm pixel size, it was possible to produce a signal for cocaine in both the partial fingerprint and the 
standard. On the other hand, for the 200 µm of pixel size, the standard spot and fingerprint were 
not visualised.  
As seen in the previous chapter, the levels of cocaine in fingerprints vary enormously from donor 
to donor and so optimising a technique based on a variable sample is not ideal. However, the 
images above clearly show that a 50 pg of cocaine standard can be visualised using a 100 micron 
pixel size, and not using the 200 micron pixel size. Based on the result, 100 µm of pixel size was 
chosen.  
Additionally, a fingerprint from non-drug user was analysed in order to test for any interferences. 
A fingerprint sample was deposited on a Super Frost Plus microscope glass slide, and 1 µL volume 
of different concentrations of cocaine standard (giving mass depositions of 50, 500, and 5000 pg) 
were spotted next to the fingerprint. As shown in Figure 41, a fingerprint image could be obtained 
by selecting the m/z range 304.3156 to 304.3274. Additionally, the 3 standard spots could be 
visualised using the m/z range 304.1515 to 304.155 (corresponding to the protonated mass of 
cocaine). The images show that cocaine was not detected in the fingerprints of this non-drug user 
and that no interferences were present.  Moreover, a 100 µm pixel size was capable of producing 
sufficient spatial resolution to provide a clear fingerprint image.  
By spotting different concentrations of standard, it was possible to test the sensitivity of the DESI 
method to test whether it was fit for purpose for this application or not. The image in Figure 41B 
also shows the ability to provide a clear image of the 50 pg standard. In Chapter 4, it was found 
that fingerprints from drug users contained 1-100 ng cocaine per fingerprint, falling by almost an 
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order of magnitude after handwashing. Measuring that the spot area of the standard is 
approximately 1/20 of the area of a fingerprint and based on the successful imaging of the 50 pg 
standard, DESI should be able to image at least 1 ng cocaine per fingerprint. As shown in Figure 
41, this should provide adequate sensitivity to image cocaine in most fingerprints collected before 
or after handwashing. 
 
Figure 41 Image of blank fingerprint corresponding to its peak at 304.2174 to 304.3156 (A and C) and the image of cocaine 
analytes from standards corresponding to its peak at m/z 304.1515 to 304.155 (B and D). Images were acquired by dragging the 
assigned peak width. From the top, spot of 5000, 500, and 50 pg of cocaine standard are imaged.   
6.4 Exploration of ToF-SIMS Parameters for Fingerprint Imaging 
The optimisation process of the sample preparation, data collection and processing parameters 
developed in this research is explained in following sections. 
6.4.1 Instrumentation 
ToF-SIMS analyses of fingerprints was carried out using an ION-TOF GmbH (Munster, Germany) 
TOF.SIMS.5 instrument. A 25 keV Bi3+ (extracted at 11 kV) primary ion beam was operated 
delivering 1.0 µA of current with the high current bunched mode, pulsed at 10 kHz and rastered 
over regions of 100 × 100 µm2 in positive mode. Table 18 shows all the operating parameters for 
liquid metal ion gun (LMIG) used in this study.  
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Table 18 Parameters of LMIG gun in ToF-SIMS. 
Parameters Value 
Beam type Bi3+ 
Energy 25000 (eV) 
Polarity + 
Emission current 1.0 µA 
Heating  2.7 V 
 
All spectra were analysed using “SurfaceLab 6.5” provided by IONTOF [213]. Cocaine and BZE 
standards were diluted with 100 % ACN.  
The protonated mass of cocaine (m/z 304.15) and its main fragments (m/z 182.1 and 82.06); the 
protonated  mass of benzoylegonine (m/z 290.13) and its main fragment mass, m/z 168.10 were 
selected for image acquisition along with other hydrocarbon ions, sodium, and potassium ions 
which are found from endogenous compounds. The chemistry of cocaine fragment is shown Figure 
42. 
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Figure 42 Chemistry of the fragmentation of cocaine. The red squared one is main fragment of cocaine (m/z 182) and BZE (m/z 
168). The m/z value of each substance is not protonated mass.  
In SIMS imaging, the ion beam is rastered across the sample to produce an image, but this area is 
limited to a few hundred microns. To generate larger images, the stage can be moved under the 
beam to build up a mosaic of sequential images. This imaging mode is called MacroRaster mode 
and it was used to acquire images of fingerprints. Imaging data were acquired using Bi3+ primary 
ions with 1 shot/pixel over 128×128 pixel resolution in regions of 500×500 µm2, 256 pixel point 
with 1 scan, and a cycle of 100 µs.     
Due to the complexity of a fingerprint sample, which contains many different compounds, accurate 
mass calibration is critical to ensure that the images correspond to the analytes of interest. This is 
particularly critical for ToF-SIMS, where the mass calibration can change from sample to sample, 
due to differences in conductivity of the sample, which affects the work function and therefore the 
kinetic energy of ions leaving the surface [214]. Unlike for other mass spectrometry methods, in 
ToF-SIMS the calibration does not carry from one sample to the next. Therefore, calibration must 
be applied to each sample, which can be difficult when the sample is unknown. The mass scale in 
this study was calibrated following the standard described in Green et al. [215]. The selected peaks 
for mass calibration in positive mode of analysis are in Appendix A.3.   
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It should be noted that the mass calibration was only carried out up to m/z 97, whereas the analytes 
of interest to this study (cocaine and BZE) appear at higher m/z values (up to m/z 304). This 
therefore could put an uncertainty on the peak assignment. Therefore, peak assignment was 
conducted using cocaine and BZE standards to investigate if peaks of target analytes are present 
at the right location.    
Figure 43 and Figure 44 show spectra in the region of the protonated mass of a hydrocarbon ion 
(C2H5+ at m/z 29.02), sodium ion at m/z 22.98, cocaine fragment ions at m/z 105.03 and 182.1, 
BZE fragment ion at m/z 168.1, BZE ion at m/z 290.1, and cocaine ion at m/z 304.15 in a 100 pg 
of cocaine standard (red) and a fingerprint of non-drug user (blue) on silicon wafer before and after 
calibration. Peaks of these assigned ions including target ions (cocaine, BZE, and their respective 
fragment ions) deviated considerably from their theoretical values before calibration. With 
calibration, each standard peak is detected at an m/z value within ≤ 20 ppm (definition in glossary) 
of the theoretical mass, as shown in Figure 44, which gave an initial indication that the calibration 
routine used is fit for purpose. 
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Figure 43 Peaks of corresponding to (A) CH3+ at m/z 15.03, (B) C2H5+ at m/z 29.02, protonated cocaine fragment ions at (C) m/z 
105.03 and (D) m/z 182.1, (E) BZE fragment ion at m/z 168.1, (F) BZE ion at m/z 290.13 and (G) cocaine ion at m/z 304.15 of a 100 
pg of cocaine and BZE standard (red) and blank fingerprint sample (blue) on the silicon wafer using mapping analysis before 
calibration. 
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Figure 44 Peaks of corresponding to (A) CH3+ at m/z 15.03, (B) C2H5+ at m/z 29.02, protonated cocaine fragment ions at (C) m/z 
105.03 and (D) m/z 182.1, (E) BZE fragment ion at m/z 168.1, (F) BZE ion at m/z 290.13 and (G) cocaine ion at m/z 304.15 of a 100 
pg of cocaine and BZE standard (red) and blank fingerprint sample (blue) on the silicon wafer using mapping analysis after 
calibration. 
6.4.2 Preliminary validation 
The aim of this analysis was to provide a qualitative method that could image the spatial 
distribution of cocaine and BZE in a fingerprint. A previous study by Bailey et al had shown a lack 
of sensitivity of ToF-SIMS to cocaine in drug users fingerprints [131]. Therefore, this study 
attempted to improve the sensitivity of the SIMS to the compounds of interest by reducing 
interference and enhancing analyte signals.   
6.4.2.1 Peak assignment and interferences 
Figure 43 and Figure 44 show that no interferences for the cocaine and BZE analytes were 
observed from the non-drug user fingerprint imaged here. It also shows that peaks for cocaine and 
BZE can be observed from a standard to within 20 ppm of their theoretical m/z value.  
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Figure 45 Peaks of protonated mass of (A) cocaine at m/z 304.15 and (B) cocaine fragment at m/z 182.10 from 1 μg of standard 
(blue) and a non-drug user’s fingerprint sample (red) on silicon wafer. 
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Figure 46 Peaks of protonated mass of (A) BZE at m/z 290.13 and (B) BZE fragment at m/z 168.10 from 1 μg of standard (blue) 
and a non-drug user’s fingerprint sample (red) on silicon wafer. 
6.4.2.2 Lowest detectable mass 
With paper spray mass spectrometry, limits of detection (LOD) were calculated based on the ratio 
analyte to internal standard (A/IS) through a calibration curve. In contrast, the purpose of mass 
spectrometry imaging was to provide qualitative result only, and therefore it was no critical to 
explore linearity of the method. However, to ensure that the method was fit for purpose, the lowest 
detectable mass was explored. This was done through serial dilution of standards containing 
cocaine and BZE. A stock solution (1000 ng/ml) containing cocaine and BZE was prepared in 
acetonitrile (100 %). 1 µl of each standard was spotted on a silicon wafer, so the mass of cocaine 
and BZE spotted on the substrate was 1000, 500, 100, 50, and 10 pg.    
The spectra (normalised to the total ion count) are overlaid in Figure 47, and show that the signals 
appear at the correct m/z value and are all at least 10 times the blank. However, there was no 
systematic rise in signal intensity as a function of cocaine analyte mass, and therefore the images 
were investigated.  
134 
 
 
 
Figure 47 Peaks of protonated mass of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1), (C) BZE at m/z 290.1 and 
(D) BZE fragment at m/z 168 from standards at different concentration after no pre-treatment. Spectra are normalised by total 
ion counts. Sky blue: 1000 pg, green: 500 pg, dark blue: 100 pg, pink: 50 pg, and red: blank (4 × 4 mm). 
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Figure 48 shows the image of the peak at m/z 168.1 (corresponding to the BZE fragment), along 
with the total ion image of the spot. However, as shown in Figure 47 A, B, C, and D the signal 
corresponding to cocaine (m/z 304.15) and BZE fragment (m/z 168.1) is more intense on the 
outside of the drop than inside, suggesting that either (a) the whole drop was imaged and isobaric 
interferences were present on the silicon wafer (which seems unlikely given that no spectral 
inferences were observed on either a blank silicon wafer or a silicon wafer with ACN deposited 
on it), or (b) that the cocaine and BZE moves to the edge of the drop upon evaporation (coffee ring 
effect [216]) and the entire area of the drop was not imaged in the 4 × 4 mm2 area. Either way, a 
satisfactory image showing cocaine, BZE, and their respective fragment ions ((M+H)+) in a single 
drop was not achieved.  
This pattern was observed regardless of whether the silicon wafer was wiped with a paper towel 
or with ACN prior to deposition of standards.  
 
Figure 48 Images of protonated mass of cocaine (m/z 304.15) of (A) 1000, (B) 50, (C) 100 pg and (D) BZE fragment (m/z 168.1, 
100 pg) ions, and (E) total ions (100 pg) on a silicon wafer. Regardless the concentration, the outside of the standard drop is 
brighter for both cocaine and BZE fragment unlike the image of total ion, which means more intense at the outside of drop for 
cocaine and BZE standard spotted.  
Spectra from inside and outside of the spot were directly compared to test whether any spectral 
difference could be observed between the inside and outside of the drop, to see if any isobaric 
interferences could be resolved. These spectra were extracted from 1 mm2 squares at the centre 
and at the edge of the spot as shown in Figure 49. Figure 49 shows the extracted spectra. In this 
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case, ions corresponding to cocaine (m/z 304.15), cocaine fragment (m/z 182.1), BZE (m/z 290.13), 
and BZE fragment (m/z 168.1) yielded a higher intensity on the outside of the spot. The spectra 
show some differences on between the inside and outside of the spot, in particular for the fragment 
ions. There are a number of possible explanations for this (a) as shown by the total ion image, the 
matrix composition of the outside of the spot is different to the inside of the spot and there could 
be a calibration shift; (b) the calibration is unaffected and the spectral differences are real. Given 
that the shape of the spectra changes on the inside vs outside of the spot, it would appear that a 
linear superposition of the calibration has not taken place and that (b) is the most credible option. 
The spectra from the outside of the spot contain peaks that are closer to the theoretical mass of the 
target ions than the inside of the spot. This can be explained by cocaine and BZE drying at the 
edge of the spot in a coffee ring effect and the existence of impurities from either the solvent or Si 
wafer (with slightly different mass) on the inside of the spot.  
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Figure 49 Spectra of 100 pg of standard at (A) cocaine fragment ion (m/z 182.1), (B) cocaine ion (m/z 304.15), (c) BZE fragment 
ion (m/z 168.1), and BZE ion (m/z 290.13). There is a triplet peak close to the mass of BZE fragment (m/z 168.1). 
6.4.2.3 Substrate compatibility test 
Four different substrates were tested for suitability for imaging cocaine and BZE in fingerprints: a 
silicon wafer, glass slide, gold coated silicon wafer, and graphene oxide coated silicon wafer. 
First, silicon wafer and glass slide were compared for interferences and sensitivity. 500 pg of 
cocaine standard (100 % in ACN) was spotted on each substrate. As a result, peak resolutions of 
hydrocarbons, cocaine, and the cocaine fragment on glass slide were not better than that of in 
silicon wafer. Even after calibration, a peak corresponding to the hydro-carbon (CH3+) on the glass 
slide was not placed in the right position, presumably due to charging on this insulating sample. 
Therefore, the flood gun was applied on glass slide to overcome charging, but it did not 
dramatically improve peak resolution and peak assignment. Additionally, cocaine and the cocaine 
fragment were detected only in silicon wafer sample, as shown in Figure 51. Therefore, silicon 
wafer was selected over the glass slide.   
 
Figure 50 Peaks of CH3+ (hydrocarbon) ion from cocaine standard (500 pg) on silicon wafer (grey) and glass slide (red) using 
point analysis. 
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Figure 51 Peaks of protonated mass of (A) cocaine at m/z 304.15 and (B) cocaine fragment ion at m/z 182.1 from cocaine 
standard (500 pg) on silicon wafer (green) and glass slide (purple) using point analysis. 
Next, a gold coated silicon wafer substrate was compared to a silicon wafer for sensitivity. Elsner 
et al. analysed latent fingerprints deposited on a gold-coated silicon wafer to enhance the 
respective ion images using MALDI-ToF-MS [217]. Additionally, gold deposition is known to 
greatly enhance the observed secondary molecular ion yields on silicon wafers [218, 219]. 1nm of 
thickness of gold was coated onto a silicon wafer using a K575X gold coating device (EMITECH). 
Fingerprints from drug users who tested positive for cocaine through an oral fluid test were 
deposited on a silicon wafer and gold-coated silicon wafer. As shown in Figure 52, no 
improvement in cocaine images was observed following the gold-coated silicon wafer. Admittedly, 
this was applied to two different drug users fingerprint’s, which does not give a consistent basis 
for comparison because drug user fingerprints are variable, as shown in Chapter 3 and 4. However, 
since no dramatic improvement was achieved, silicon wafer was selected due to the simplicity of 
sample preparation. 
In terms of image analysis, these fingerprints provided distinctive difference. As shown in Figure 
52, fingerprint ridge details and location of pores were observed on the uncoated silicon wafer 
substrate through the image of hydrocarbon (C5H11+) and gave a better image than for the coated 
sample. Neither sample gave any fingerprint-like features for cocaine-related analytes. In Figure 
51A, a fingerprint-like image of the cocaine fragment is observed for the sample deposited on a 
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silicon wafer, but this anti-correlates with the location of the ridges. Therefore, silicon wafer was 
chosen because of the ability to produce fingerprint images.  
 
 
 
Figure 52 Images of (A) cocaine fragment (m/z 182.1) and (B) BZE fragment (m/z 168.1), and (C) hydrocarbon (C5H11+) ion 
normalised to the total ion count on the uncoated silicon wafer and the gold coated silicon wafer substrate. 
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Finally, images from the silicon wafer substrate were compared to a graphene oxide layered 
substrate. According to Cai et al. [196], graphene oxide (GO) can increase the secondary ion yields 
of molecular ions of lipids (> 700 Da) and peptides (> 1000) in biological matrices using ToF-
SIMS. With the GO layer (2 mg/ml GO solution, 2 μm thickness), the sensitivity towards the target 
analytes (alkaloids and antibiotics) in a latent fingerprint was improved as secondary ion yields of 
intact molecular ions were enhanced. Additionally, better spatial resolution of latent fingerprints 
and sweat pores were observed because GO can form a homogenous layer which enhances 
ionisation in ToF-SIMS imaging [199].  
The preparation of the GO layer substrate followed the method described in Cai et al.,  a silicon 
wafer, pre-cleaned with methanol was immersed in 2 mg/ml of GO solution (GO graphene, UK) 
and dried in an oven at 60 °C for 6 hours [199]. Once the substrate was prepared, collection of 
fingerprint samples from a drug user (left thumb and left index) was conducted as described in 
Section 6.2.  
In order to determine which substrate provides better sensitivity to endogenous compounds of a 
fingerprint between silicon wafer and GO layer substrate, ion images of K+, hydro-carbon ion 
(C27H45+), and Si+ were acquired. Fingerprint ridge details were observed using the potassium 
signals on both substrates tested here. However, the enhancement of the signals of C27H45+ in the 
presence of graphene oxide layer, as shown in Figure 53, resulted in brighter ion images with better 
ridge detail than on untreated silicon wafer. 
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Figure 53 Images of potassium, hydrocarbon (C27H45+) in a fingerprint of non-drug users on the silicon wafer (A and C) and GO 
layer substrate (B and D).  
However, Figure 54 shows spectra from the same non-drug user fingerprint in the region 
corresponding to cocaine at m/z 304.15, cocaine fragment at m/z 182.1, BZE at m/z 290.13, and 
BZE fragment at m/z 168.1. Interferences with cocaine and cocaine fragment were detected in the 
non-drug user’s fingerprint sample on the GO layer substrate, but not on the silicon wafer substrate. 
For BZE and BZE fragment, no interferences were detected on silicon wafer substrate, but were 
present on the GO layer substrate. This suggests that despite GO layer substrate enhancing 
sensitivity, a silicon wafer is a more appropriate choice of substrate than the GO on silicon.  
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Figure 54 Mass spectra collected from a fingerprint of a non-drug user using a silicon substrate (purple) and a graphene oxide 
(gold) in the region for (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) BZE at m/z 290.13, and (D) BZE 
fragment at m/z 168.1. 
To test signal to noise ratio, a 300 pg standard containing cocaine and BZE were deposited on both 
silicon and GO layer silicon wafer substrates. The image acquisition parameters were the same as 
previously described. The corresponding spectra are shown in Figure 55 (on GO layer silicon 
wafer). It shows that when a graphene oxide layer is applied, a peak from non-drug user’s 
fingerprint sample still appears at cocaine and BZE related analytes. Therefore, a silicon wafer 
gives a better signal to noise ratio for cocaine. 
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Figure 55 Mass spectra in the region of (M+H)+ for (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) BZE at m/z 
290.13, and (D) BZE fragment at m/z 168.1 for a fingerprint from a non-drug user (purple) and a 300 pg standard of cocaine 
(grey) deposited on the GO layer silicon wafer (3×3 mm). 
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6.4.2.4 Mapping area 
In order to fully optimise the sensitivity, different mapping areas were explored. Smaller regions 
of fingerprint samples were tested to see if they contain enough information to distinguish between 
fingerprints deposited after drug contact and drug use. A whole fingerprint usually covers an area 
of > 10×10 mm2, which took more than 3 hours to acquire under the set parameters. On the other 
hand, a small scan area of 5×5 mm2 took less than 30 minutes to acquire under the same settings.  
Fingerprint samples of drug users and fingerprint samples of non-drug users who contacted cocaine 
hydrochloride powder were collected. Sample collection procedures followed the protocols 
described in the sample collection section in Chapter 6. Both samples were collected without 
washing hands for this optimisation process.  
Figure 56 shows the image of a fingerprint collected after cocaine use using the smaller scan area. 
The image still produced distinctive ridge details of the fingerprint via the hydrocarbon and silicon 
ions. Images of cocaine and cocaine fragment ions hardly provided any ridge details, compared to 
BZE (which spatially correlates with the silicon) and BZE fragment (which spatially correlates 
with the hydrocarbon). Figure 57 overlay images of the target analytes with hydrocarbon and 
silicon ions showed that the image of BZE fragment correlates with the fingerprint ridges. The 
uniformity of the analyte within the ridges supports the previous hypothesis that a drug user has a 
more uniform distribution of drug/metabolite in their fingerprint, due to the drug being excreted.  
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Figure 56 Images of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) fingerprint ridge at m/z 312.3, (D) BZE at 
m/z 290.1, (E) BZE fragment at m/z 168.1, and (F) silicon ions at 27.97 with fingerprint ridge and silicon ion from the fingerprint 
after drug use (5 x 5 mm). 
 
Figure 57 Overlay images of (A)cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) BZE at m/z 290.1, and (D) BZE 
fragment at m/z 168.1 with fingerprint ridge and silicon ion  from the fingerprint after cocaine use (small size: 5 × 5 mm). 
For the fingerprint samples deposited after contact, Figure 58 shows images of hydrocarbon and 
silicon ions did not produce distinctive fingerprint ridge details presumably because of the 
presence of cocaine particles in the fingerprint sample. However, intensities of target analytes were 
very high as expected, and the images of them showed that target analytes were concentrated in 
hot spots as described in the hypothesis. Besides, Section 4.2 already demonstrated that the pure 
cocaine hydrochloride powder contains BZE as well. However, the overlay images of the 
fingerprint sample deposited after contact to lay out target analytes on fingerprint ridges shown in 
Figure 59 did not provide enough fingerprint related information as it was not easy to visualise the 
fingerprint ridges. 
The small area size test of the fingerprint was able to be used to draw the characteristics of each 
cocaine contaminated fingerprint as described in the hypothesis. However, fingerprint samples 
produced after cocaine contact did not produce enough fingerprint related information such as 
fingerprint ridge details although signals of target analytes were very high. Therefore, larger area 
acquisition of fingerprint samples after contact was also conducted.        
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Figure 58 Images of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) fingerprint ridge at m/z 312.3, (D) BZE at 
m/z 290.1, (E) BZE fragment at m/z 168.1, and (F) silicon ions at m/z 27.97 with fingerprint ridge and silicon ion from the fingerprint 
after 0.5 mg of cocaine powder contact (small size: 5 × 5 mm). 
 
148 
 
Figure 59 Overlay images of (A)cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) BZE at m/z 290.1, and (D) BZE 
fragment at m/z 168.1 with fingerprint ridge and silicon ion from the fingerprint after 0.5 mg of cocaine powder contact (small 
size: 5 × 5 mm). 
As shown in Figure 60, the large region test covered the most of a whole fingerprint. At this 
increased scan area, it was possible to visualise fingerprint ridges. This is presumably because, the 
presence of cocaine particles disrupts image formation due to topography effects. In a larger image, 
there is a reduced chance of scanning only a region containing a high intensity of cocaine particles. 
Those factors may have led to acquire better sensitivity under this acquisition area. As shown in 
Figure 60, the image of fingerprint ridge was not interrupted by cocaine particles, and images 
derived from all target analytes still contained sufficient fingerprint information, so it was easy to 
confirm that drug analytes derive from fingerprint. In overlay images, as shown in Figure 61, target 
analytes were able to be much more distinguished from fingerprint ridges and silicon ions, and it 
still supported the hypothesis.  
 
Figure 60 Images of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) fingerprint ridge at m/z 312.3, (D) BZE at 
m/z 290.1, (E) BZE fragment at m/z 168.1, and (F) silicon ions at 27.97 of the fingerprint sample after 2 mg of cocaine hydrochloride 
powder contact (large size: 12 × 12 mm). 
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Figure 61 Overlay images of (A)cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) BZE at m/z 290.1, and (D) BZE 
fragment at m/z 168.1 with fingerprint ridge and silicon ion from the fingerprint after 2 mg of cocaine hydrochloride powder 
contact (large size: 12 × 12 mm). 
6.5 Exploration of MALDI-MS Parameters for Fingerprint Imaging. 
Unlike DESI-MS and ToF-SIMS above, detailed exploration for MALDI-MS parameters did not 
take place, due to limited access to instrumentation. Instead, only the choice of matrix was explored. 
A Waters Prototype μMALDI ion source was coupled to a Waters Synapt G2-Si Q-ToF mass 
spectrometer at the National Physical Laboratory. Spectra were acquired using MassLynx [220], 
and images were acquired using the same software described in Section 5.3.2. All parameters were 
previously set up by the National Physical Laboratory, which are typically used for acquiring 
images of drugs and small molecules in tissue. These are shown in Appendix A.4. 
Before applying to fingerprint samples, two matrices were prepared. One was 37.5 mg/mL of DHB 
(2,5-dihydroxybenzoic acid) in 5:5/ ACN: water, and the other was 5 mg/mL of CHCA (alpha-
cyano-4-hydroxycinnamic acid) in 8:2/ MeOH: water. These were tested for suitability for the 
detection of cocaine and BZE. To do this, 1 µL of standard containing 50 ng/mL (50 pg) cocaine 
and BZE (in 100 % ACN) were spotted on six different designated wells of a MALDI plate. Then, 
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1 μl of each matrix solution was applied to the three wells on top of the standard. Each matrix 
solution was also applied to empty wells as a blank sample. This procedure helped to find out not 
only the best matrix composition for the detection of cocaine and BZE, but also to test the peak 
assignment for cocaine and BZE using this mass spectrometer. Based on the result, the assigned 
peaks of cocaine and BZE were m/z 304.1557 and 290.1403, respectively.  
 
 
 
Figure 62 Spectra of standards analysed using MALDI in a mass range near the protonated molecular mass of (a) cocaine and (b) 
BZE DHB only (1st row), CHCA only (2nd row), cocaine or BZE with CHCA (3rd row), and cocaine or BZE with DHB (4th row). 
151 
 
As shown in Figure 62, neither matrix interfered with the peak of cocaine, but for CHCA, there 
was an interference near the BZE peak at m/z 290.1031. Therefore, DHB was chosen over CHCA 
as a matrix for cocaine and BZE analytes.  
To test fingerprint samples, DHB was applied. All prepared fingerprint samples were placed in the 
TM-Sprayer, which is a robotic MALDI matrix deposition system. Parameters for matrix 
deposition on fingerprint samples are shown in Appendix A.5.   
 
6.6 Summary  
In order to distinguish between fingerprints deposited after cocaine use and cocaine contact, 
parameters of DESI-MS, ToF-SIMS, and MALDI-MS were tested, which were as successful in 
detecting the level of cocaine and BZE as the PS-MS method. However, as mentioned in the 
beginning of this Chapter, these mass spectrometry imaging methods were used only for 
qualitative analysis, so they were not able to provide the calculated LOD value. Therefore, a serial 
dilution method was applied to detect LOD of cocaine and BZE for these methods. For DESI-MS, 
because it is an ambient analysis technique, the sample preparation was simple and rapid. It was 
possible to detect cocaine and BZE in standards spotted on a surface at 50 pg and produce an 
outline image of a fingerprint. ToF-SIMS was able to produce much clearer images of individual 
fingerprint ridges than DESI, which was expected since it is known for producing the lowest image 
resolution. On the other hand, because ToF-SIMS is highly fragmented and the resolving power 
of mass spectrometry was lower than that of DESI, it was unexpected to detect relevant peaks in 
as low 50 pg of standard containing cocaine and BZE as DESI-MS did. Fortunately, no spectral 
interferences were observed for a fingerprint deposited on silicon wafer. For MALDI imaging, 
only interferences from the matrix were explored due to a lack of instrument access. However, it 
was found that DHB gave a better signal to noise ratio. This method was also able to detect 50 pg 
cocaine and BZE. With a more sophisticated method optimisation process, MALDI-MS could 
detect lower than 50 g of cocaine and BZE.  
6.7 Discussion 
The previous chapters (Chapter 4 and 5) have revealed some limitations in using only the chemical 
profile of the fingerprint to distinguish cocaine ingestion and cocaine contact. In particular, the 
work in Chapter 5 has shown that cocaine persists on the fingers for some time after contact and 
is not easily removed. As an alternative approach, visualisation of target analytes and their spatial 
distribution within the fingerprint ridges was introduced in this study. Developing a molecular 
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imaging method could provide a confirmation test to distinguish between fingerprints deposited 
after contact and cocaine administration with different spatial distribution of the drugs and 
metabolites. 
The next chapter will show the images of fingerprint samples of drug use and drug contact to 
distinguish how the target analytes would spatially be different using these three different 
techniques.   
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Chapter 7 Results of Mass Spectrometry Imaging Analysis 
After exploration of parameters of each mass spectrometry imaging technique, fingerprints from 
drug users were compared to fingerprints from ingestion scenarios to see if contact with cocaine 
could be distinguished from ingestion. This chapter details the work. 
7.1 DESI-MS imaging of fingerprints 
7.1.1 As presented  
A fingerprint sample collected from contact with street cocaine was created, as described in 
Section 3.1.3. As shown in Figure 63, a peak matched to cocaine and BZE respectively. The peak 
of cocaine was in the range of m/z 304.1513 to 304.1705, and that of BZE was in the range of m/z 
290.1233 to 290.1569. Intensities of both analytes were high because of mg amount was handled 
for this experiment. Besides, multiple concentrated areas (hot spots) of cocaine and BZE were 
found in the fingerprint. An overlay image of cocaine and BZE with a peak at m/z 582.954 
(assumed to be a lipid) was acquired, as shown in Figure 64. Here there is no obvious correlation 
between the position of the fingerprint ridges and the location of ions assigned to cocaine and BZE. 
Peaks of relatively high intensity in fingerprints in lipid mass range (between m/z 500 and 1000) 
were selected and their images were acquired. Among them, the image which yielded the best 
fingerprint ridge details were chosen as a lipid. This method was applied to the subsequent samples.  
 
Figure 63 Image of (A) TIC, (B) cocaine, (C) BZE and their corresponding peaks: (D) cocaine at m/z 304.1538 and (E) BZE at m/z 
290.143 from the fingerprint sample after contact from FSI. The red point defines the selection of mass range for correspinding 
images of (B) cocaine and (C) BZE.   
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Figure 64 Overlay image of cocaine (red) and BZE (green) with lipid (m/z 582.954, blue) in the fingerprint after contact. 
Fingerprint samples were also taken from donors at the drug clinic who testified taking cocaine. 
Here, cocaine and BZE standards were spotted right next to the fingerprint sample to ensure that 
the peaks were assigned correctly. The total ion current (TIC) image of the fingerprint sample 
produced the location of the fingerprint and fingerprint ridge information. Cocaine analytes were 
picked up in both the standard and the fingerprint with lower intensity compared to the fingerprint 
sample after contact. However, it was somewhat difficult to distinguish the signal of cocaine in 
the fingerprint from that of noise in the off-fingerprint surface. BZE analytes were picked up in 
both the standard and the fingerprint and gave a clearer image as shown in Figure 65. The image 
of overlay proved that analytes of cocaine and BZE were spatially distributed more evenly over 
the whole fingerprint, as shown in Figure 66, unlike those analytes which were concentrated at 
certain regions of a fingerprint after contact.   
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Figure 65 Image of (A) TIC, (B) cocaine, (C) BZE and their corresponding peaks: (D) cocaine at m/z 304.1538 and (E) BZE at m/z 
290.143 from the fingerprint sample of a drug user. The red point defines the selection of mass range for correspinding images of 
(B) cocaine and (C) BZE. 
 
Figure 66 Overlay image of cocaine (red) and BZE (green) with lipid (m/z 566.986, blue) in the fingerprint of a drug user. 
In order to test whether the above finding was repeatable, another trial was conducted. This time 
with fingerprint samples produced (A) after contact with 0.5 mg of pure cocaine hydrochloride 
powder and (B) from a drug user, applying the same analysis parameters. 50 pg of standard 
containing both of cocaine and BZE was run to assign their peaks. Peaks were formed at m/z 
304.1534 and 290 1435 corresponding to the relevant protonated molecular ions. From this sample 
run, the standard was not spotted next to the fingerprint because the sample running time would 
take at least 1 hour longer to cover the larger mapping area. Therefore, the standard was simply 
analysed for peak assignment without generating an image of it.    
As shown in Figure 67, images of cocaine and BZE signal showed that these analytes could be 
spread out uniformly over the fingerprint, as shown in the fingerprint after cocaine use. However, 
intensities of them were much higher compared to the first trial of the fingerprint sample after 
contact. This may be because this second sample was pure cocaine (as opposed to 41 % purity in 
the previous run) despite a smaller amount handled. As shown in Figure 67, hot spots of those 
analytes were formed in all over the fingerprint. Moreover, the overlay image of cocaine and BZE 
support the result as shown in Figure 68. 
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Figure 67 Image of (A) cocaine, (B) BZE, and their corresponding peaks: (C) cocaine and (D) BZE ions from the fingerprint sample 
after contact with pure cocaine hydrochloride powder. The red point defines the selection of mass range for correspinding images 
of (A) cocaine and (B) BZE. 
 
Figure 68 Overlay image of cocaine (pink) and BZE (green) in the fingerprint after contact with pure cocaine hydrochloride powder. 
For the sample provided after cocaine use, the TIC image of the fingerprint was not as clear as the 
previous trial, highlighting the issue of generating a representative fingerprint sample. However, 
the location of the fingerprint and fingerprint ridges were somewhat distinguishable. The signal of 
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cocaine analytes was detected (m/z 304.1534), but unlike contact scenario, the image of them did 
not correlate with the fingerprint. The cocaine peak is derived from a small spot at the lower part 
of the image, as shown in Figure 69. This could be a particle of cocaine powder residue left in the 
fingerprint after the donor (drug user) administered it. Compared to the first trial, the image of 
BZE analytes was not as pronounced. BZE analytes were spread all over the fingerprint, which 
was consistent from the result of the first trial. The overlay image of BZE with lipid showed that 
BZE analytes were picked up relatively even distribution across the fingerprint. However, the 
image of noise became enhanced.  
 
Figure 69 Image of (A) TIC, (B) cocaine, (C) BZE and their corresponding peaks: (D) cocaine and (E) BZE ions from the fingerprint 
sample after cocaine use (second trial). The red point defines the selection of mass range for correspinding images of (B) cocaine 
and (C) BZE. 
 
Figure 70 Overlay image of cocaine (red) and BZE (green) with lipid (m/z 582.954, blue) in the fingerprint sample after cocaine 
use. 
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7.1.2 After handwashing  
Images of fingerprint samples from contact and cocaine use after handwashing were also acquired. 
The fingerprint sample after cocaine use after handwashing was prepared by the protocols 
described in Section 3.1.3.  
The acquired image of cocaine analytes provided the location of the fingerprint and analytes in the 
fingerprint although the intensity became lower after handwashing. A signal corresponding to BZE 
was also picked up with the similar intensity to cocaine analytes, but the signal did not correlate 
with the fingerprint, as shown in Figure 71. An overlay image of cocaine and lipid is shown in 
Figure 72. Similar to the data shown prior to handwashing, the cocaine image is more intense than 
that of corresponding to BZE.  
 
Figure 71 Image of (A) cocaine, (B) BZE, and their corresponding peaks: (C) cocaine and (D) BZE ions from the fingerprint after 
cocaine use sample after handwashing. The red point defines the selection of mass range for correspinding images of (A) cocaine 
and (B) BZE. 
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Figure 72 Overlay image of cocaine (grey) with lipid (m/z 598.92 dark green) in the fingerprint sample after cocaine use after 
handwashing. 
An intensity observation is that the relative intensity of the cocaine and BZE images are repeatedly 
different for the contact and ingestion scenarios. In each contact scenario, the cocaine produces a 
brighter image of the fingerprint area than BZE, whereas the reverse is true for each ingestion 
scenario. An attempt to relate the cocaine: BZE ratio by Ismail et al to distinguish drug use from 
drug administration failed [221]. Figure 68 B shows that fingerprints may contain a hot spot of 
cocaine that would skew a measurement of total cocaine content. In this sense, imaging mass 
spectrometry techniques may unlock the key to distinguishing a contact from ingestion scenario 
because powder hotpots can be decoupled from the rest of the fingerprint.        
7.2 ToF-SIMS imaging of fingerprints 
Fingerprint samples after contact with cocaine and cocaine use in as presented and after 
handwashing scenarios, respectively were analysed with the method optimised in the previous 
chapter.    
7.2.1 As presented  
In the method validation section, a relatively high dose of cocaine (2 mg) was used for the contact 
residue sample. Here, a fingerprint sample after contact with a lower dose of 0.5 mg cocaine 
hydrochloride powder is presented. Fingerprint ridge details derived from the overlay image of 
hydrocarbon and silicon ions were very distinctive allowing the fingerprint to be clearly visualised. 
Images acquired from peaks corresponding to cocaine and cocaine fragment ions were found to 
correlate with the fingerprint ridges, unlike the images shown in Figure 58 (previous chapter). 
Peaks corresponding to BZE and BZE fragment were detected in the spectra, but the images of 
them barely had any ridge details. Overlay images also supported these results as shown in Figure 
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74. Some hot spots of analytes of cocaine and cocaine fragment were observed in left side of the 
fingerprint.          
 
Figure 73 Images of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) fingerprint ridge at m/z 77.02, (D) BZE at 
m/z 290.1, (E) BZE fragment at m/z 168.1, and (F) silicon ions at m/z 43.01 of the fingerprint sample after 0.5 mg of cocaine 
powder contact. 
 
Figure 74 Overlay images of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) BZE at m/z 290.1, and (D) BZE 
fragment at m/z 168.1 with fingerprint ridge and silicon ion from the fingerprint after contact (large size). 
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A fingerprint sample was collected from a donor after cocaine use. The donor was confirmed 
positive for cocaine through oral fluid sample test, and cocaine and BZE were still detected in 
other fingerprints provided using paper spray mass spectrometry. Using ToF-SIMS, the intensities 
of target analytes were lower for this donor than for the fingerprint deposited after contact, which 
was also seen in Chapter 4. In Section 4.2, it was found that the fingerprint samples donated after 
drug contact contained 10 to 100 ng of cocaine, while the fingerprint samples from drug users 
contained from 0.1 to 100 ng of cocaine, therefore possibly giving a fingerprint with considerably 
less cocaine. As shown in Figure 75, the image fingerprint ridge details derived from hydrocarbon 
and silicon was still distinctive and allowed visualisation of the fingerprint ridges. Image 
corresponding to cocaine, cocaine fragment and BZE showed no correlation with the fingerprint 
ridges. In contrast, the BZE fragment ion image showed correlation with the fingerprint ridges and 
this is confirmed by the overlay image in Figure 76. Furthermore, the analytes were evenly 
distributed all over the fingerprint, which supported the hypothesis.   
 
Figure 75 Images of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) fingerprint ridge at m/z 184.2, (D) BZE at 
m/z 290.1, (E) BZE fragment at m/z 168.1, and (F) silicon ions at m/z 27.97 of the fingerprint sample after cocaine use. 
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Figure 76 Overlay images of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) BZE at m/z 290.1, and (D) BZE 
fragment at m/z 168.1 with fingerprint ridge and silicon ion from the fingerprint sample after cocaine use. 
7.2.2 After handwashing 
The cocaine contaminated fingerprint samples for the after handwashing scenario were also 
investigated.  
As shown in Figure 77, peaks corresponding to cocaine and the cocaine fragment were still 
detected with high intensity after handwashing, but the image (and overlay in Figure 78) shows 
that these analytes do not correspond with the fingerprint ridges. BZE and BZE fragment were 
also detected but with not as high intensity as cocaine, which follows the pattern of the sample of 
as presented.  
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Figure 77 Images of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) fingerprint ridge at m/z 77.02, (D) BZE at 
m/z 290.1, (E) BZE fragment at m/z 168.1, and (F) silicon ions at m/z 43.01 of the fingerprint sample after contact followed by 
handwashing. 
 
Figure 78 Overlay images of (A)cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) BZE at m/z 290.1, and (D) BZE 
fragment at m/z 168.1 with fingerprint ridge and silicon ion from the fingerprint after contact followed by handwashing. 
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The same donor who provided the drug user fingerprint imaged previously in Figure 75 also 
provided fingerprints after handwashing. Using paper spray mass spectrometry, it was still possible 
to see both BZE and cocaine in fingerprints from the other fingers of this donor. Figure 79 shows 
the spatial distribution of ions corresponding to silicon (Figure 78f), hydrocarbon (Figure 78c), 
which shows some ridge detail, but a general lack of sensitivity to the fingerprint compared with 
the other images. It is not clear if this is due to an instrument error (low primary ion beam current) 
or insufficient deposition of fingerprint sample. The intensity fluctuations seen in the image (with 
the top of the image being darker than the bottom) are indicative of changes in the primary ion 
beam current during the run. In any event, cocaine, BZE and their fragments were not detected in 
either the spectra or the images.  
 
Figure 79 Images of (A) cocaine at m/z 304.15, (B) cocaine fragment at m/z 182.1, (C) fingerprint ridge, (D) BZE at m/z 290.1, (E) 
BZE fragment at m/z 168.1, and (F) silicon ions of the fingerprint sample after cocaine use after handwashing. 
7.2.3 Exploration of calibration and selectivity  
Figure 77 shows peaks corresponding to cocaine being detected in the furrows (spaces between 
the ridges) of a fingerprint after contact with a drug and then handwashing. In contrast, Figure 73 
shows that the same analytes are detected in the ridges of a fingerprint directly after contact with 
0.5 mg of cocaine. Conversely again, Figure 60 (previous chapter) shows the same analytes 
detected in the furrows after contact with 2 mg cocaine. Due to the difficulty in accounting for 
these differences in spatial correlation with the fingerprint material, a further investigation was 
carried out into the selectivity and effectiveness of the calibration of the method.  
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Figure 80 shows images from a non-drug user. The fingerprint ridges can be seen via potassium 
image (Figure 79a) as well as the inverse of the fingerprint, through the silicon image (Figure 79b). 
The images of fingerprint at m/z near 304.15 and 182.1 shows that the region of intense ion comes 
out from silicon, not from the ridges.  
In the method validation section, spectra from a fingerprint of a non-drug user and cocaine/BZE 
standards were compared. No interferences were observed. However, Figure 80 shows that 
isobaric interferences can be observed using ToF-SIMS and it is unclear why this is the case. In 
order to understand this phenomenon more closely, the calibration was investigated in more detail.   
 
Figure 80 Images of peak at (a) potassium ion, (b) silicon ion, (c) cocaine ions at m/z 304.15 and (d) cocaine fragment ion m/z 
(182.1) of a non-drug user's fingerprint samples. The region of intense ion of target analytes comes out from silicon not from 
ridges. 
6.2.3.1 Presence of drug standard 
In order to explore the efficacy of the calibration routine, 100 pg of cocaine standard was spotted 
right above a fingerprint collected after cocaine use. It was hypothesised that the presence of a 
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cocaine standard could help to assign the cocaine, BZE, and respective fragment peaks within an 
image to reduce calibration errors and further test the peak assignment. 
Figure 81 shows images of a fingerprint sample of a drug user with 1 µL of standard containing 
cocaine and BZE standard (100 ng/mL 🡪 100 pg). Assigned peaks for cocaine, BZE, cocaine 
fragment (m/z 182.1), and BZE fragment (m/z 168.1) were detected in the spectra using the 
calibration protocol that was used throughout this work. Figure 80E shows that the fingerprint can 
be visualised, and also the location of the BZE (middle) and cocaine (left) standards. Despite 
deposition of a 100 pg cocaine standard, the cocaine spot is not visualised in the cocaine image.  
 
Figure 81 Images of (A) cocaine at m/z 304.15), (B) BZE at m/z 290.1, (C) cocaine fragment at m/z 182.1, (D) BZE fragment at m/z 
168.1, and (E) C2H5+ ions of the fingerprint sample from a drug user with the standard (100 pg) containing cocaine and BZE (8 × 
12 mm). 
Figure 82 is an overlay of spectra extracted from the region where the cocaine standard was 
deposited. The blue spectrum shows the region corresponding to the protonated ion of cocaine, 
calibrated according to the protocol used in this study. Whilst the calibration routine worked well 
for cocaine standards deposited on silicon wafers only, Figure 82 shows that when a fingerprint is 
present, the calibration routine is ineffective. This is presumably due to the complex fingerprint 
matrix making accurate calibration at the lower masses difficult to achieve. The spectrum was 
recalibrated using the data from only the area of the standard (in the absence of a fingerprint) and 
as shown in the red spectrum, and a different peak now appears at the theoretical mass of cocaine.   
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Figure 82 Reconstructed spectra of cocaine (m/z 304.15) from the region where the cocaine standard was deposited as shown in 
Figure 80. Blue spectrum is before recalibration and Red one is after recalibration. 
Figure 83 shows spectra extracted from the region where the cocaine standard was deposited (blue) 
overlaid with the whole area (red) after calibration. It is clear that isobaric interferences are present, 
even after calibration. This is due to the low mass resolution (W= up to 10,000) of the SIMS 
detector, and the lack of MS/MS capability which creates a lack of selectivity. Therefore, it would 
appear that even after optimisation, this SIMs system lacks the selectivity to confidently assign 
cocaine or BZE in a fingerprint.  
 
Figure 83 Spectra extracted from the region where the cocaine standard was deposited (blue) overlaid with the whole area (red) 
of Figure 80 after calibration. 
7.3 MALDI-MS imaging of fingerprints 
One fingerprint sample after contact and one fingerprint sample after cocaine use were prepared 
for as presented and after handwashing scenario, respectively. Collection methods of both 
scenarios followed the protocol described in the sample collection section in Chapter 6. For the 
fingerprint sample after contact, 0.5 mg of pure hydrochloride powder was applied. As shown in 
Section 6.3, peaks of cocaine and BZE were expected to be found at m/z 304.1557 and 290.1403 
respectively.  
7.3.1 As presented 
For the fingerprint sample after contact, the instrument did not finish mapping the whole 
fingerprint because of mechanical issues of the instrument. Nevertheless, the images of cocaine 
(m/z 304.155) and BZE (m/z 290.139) analytes contained the characteristics expected in the 
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hypothesis, which is forming hot spots with high intensity of cocaine and BZE analytes in the 
fingerprint as shown in Figure 84. As seen previously with DESI and SIMS, the cocaine image 
intensity is brighter than for BZE. Peaks of relatively high intensity in fingerprints in the lipid mass 
range (between m/z 500 and 1000) were selected and their images were acquired. Among them, 
the image which yielded the best fingerprint ridge details were chosen to show the location of the 
fingerprint. This method was applied to following samples. As seen in Figure 85, the overlay image 
of cocaine and BZE analytes with lipids (m/z 628.373) in the fingerprint emphasised the presence 
of hot spots.    
 
Figure 84 Images of (A) TIC, (B) cocaine at m/z 304.155, and (C) BZE at m/z 290.139 and their corresponding peaks: (D) cocaine 
and (E) BZE from the fingerprint sample after contact as presented. The red point defines the selection of mass range for 
corresponding to (B) cocaine and (C) BZE.  
 
Figure 85 Overlay image of cocaine (red: m/z 304.155) and BZE (green: m/z 290.139) with lipid (m/z 628.373, blue) in the 
fingerprint sample after contact in as presented. 
The total ion chromatogram (TIC) image of the fingerprint sample after cocaine use as presented 
produced a distinctive fingerprint image, including distinguishable ridge details. The greatest 
difference was that only BZE was detected, with no (M+H)+ peak detected for cocaine. When an 
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image of BZE (m/z 290.140) was acquired, the image of the fingerprint was less pronounced than 
for after contact. However, the background signal did not interfere the signal of BZE analytes in 
fingerprint as shown in Figure 86. The image of BZE analytes also proved that they were detected 
and spatially distributed all over the fingerprint as the overlay image with lipids supported. 
 
Figure 86 Images of (A) TIC and (C) BZE at m/z 290.139 and corresponding spectra from the fingerprint sample after cocaine use 
as presented. The image of (B) derived from the peak near cocaine analytes, but not cocaine. The red box in figure (D) shows where 
the cocaine peak is supposed to be. The peak of BZE is detected (E). The red point defines the selection of mass range for 
correspinding an image of (C) BZE. 
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Figure 87 Overlay image of BZE (green: m/z 290.139) with lipid (m/z 638.616, blue) in the fingerprint sample after cocaine use as 
presented. 
7.3.2 After handwashing  
The TIC image did not yield an image of the fingerprint, unlike those provided as presented. This 
may be because wearing gloves after handwashing results in more eccrine sweat, and which is not 
lipid rich. However, images derived from cocaine analytes was still able to show the location the 
fingerprint and the pattern of those analytes in the fingerprint. Compared to as presented, those 
analytes were relatively more spread over the fingerprint without forming distinctive hot spots as 
shown in the overlay image, Figure 88. The result could be confused with that of fingerprint sample 
after cocaine use in as presented. One difference shown in the image of this fingerprint sample is 
having less background signal compared to the fingerprint sample after cocaine use in as presented. 
On the other hand, BZE was not detected in the fingerprint sample after contact after handwashing.  
 
Figure 88 Images of (A) TIC, (B) cocaine at m/z 304.15 and its corresponding peak (D) from the fingerprint sample after contact 
after handwashing. The image of (C) derived from the peak near BZE analytes, but not BZE (m/z 290.117), and its corresponding 
spectra proves (E).The red point defines the selection of mass range for correspinding an image of (B) cocaine. 
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Figure 89 Overlay image of cocaine (red: m/z 304.155) with lipid (m/z 628.373, green) in the cocaine sample after contact in after 
handwashing. BZE was not part of this overlay because it was not detected.  
The image of fingerprint sample after cocaine use after handwashing was not acquired as well. 
The signals of cocaine and BZE were not detected in spectra which are expected to be found at 
m/z 304.155 and 290.140 respectively, so that corresponding images did not show fingerprint 
related information unlike the fingerprint sample after contact after handwashing. There was no 
pattern found in the fingerprint after cocaine use in the after handwashing scenario.    
 
Figure 90 Images of (A) TIC, images of (B) and (C) acquired from peaks near to (D) cocaine and (E) BZE respectively at m/z 304.179 
and m/z 290.17. However, they were not detected as spectra show. The red boxes in figure D and E show where cocaine and BZE 
peaks are respectively.  
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7.4 Summary 
Mass spectrometry imaging techniques have been previously applied to the study of fingerprints 
with a focus on enhancing ridge details to help personal identification [194,196, and 199] and 
chemical detection such as explosives [7] and drugs [293]. However, it is difficult to find a study 
using mass spectrometry imaging techniques to detect and analyse those chemicals in fingerprints 
using molecular images. Hinners et al. [294], analysed spatial distribution of cosmetic and food 
materials in fingerprints using matrix assisted laser desorption/ionisation mass spectrometry 
(MALDI-MS), but did not explored the significance of detecting these substances. For the further 
drug analysis using mass spectrometry imaging techniques, Groeneveld et al.[138], used technique 
to image fingerprints with spiked standards as described in Section 5.5. However, the authors failed 
to explore the significance of detecting these substances in fingerprints as they did not analyse 
samples collected from drug users. The study here described aimed at analysing target analytes in 
fingerprints of drug users using mass spectrometry imaging techniques and further distinguishing 
between fingerprints after contact and ingestion based on the spatial distribution of target analytes. 
Chapter 6 explored the parameters of each mass spectrometry techniques. In order to distinguish 
between fingerprints deposited after cocaine use and cocaine contact, parameters of desorption 
electrospray ionisation mass spectrometry (DESI-MS), time of flight secondary ion mass 
spectrometry (ToF-SIMS), and MALDI-MS were optimised, which were as successful in detecting 
the level of cocaine and BZE as the PS-MS method (50 pg) before handwashing (Chapter 6). 
After running fingerprint samples of drug users which were confirmed positive for cocaine 
(through the results of fingerprints using the paper spray method and oral fluid test) (confirmation 
test), images acquired from DESI-MS and MALDI-MS (as well as ToF-SIMS, with caution over 
the calibration) supported the hypothesis. Before handwashing, all techniques produced different 
patterns of analytes of both cocaine and BZE in a fingerprint as expected in hypothesis. DESI-MS 
and MALDI-MS did not provide as good fingerprint ridge details as ToF-SIMS did (Cai et al., 
2017a, Cai et al., 2017b), but they were able to distinguish between fingerprints deposited after 
drug contact and drug use via the pattern of cocaine and BZE analytes in fingerprints. In addition, 
images of BZE were obtained only from fingerprints provided after ingestion (prior to 
handwashing), and the BZE was found to have a qualitatively more uniform distribution across 
the ridges after contact than after ingestion. Images of fingerprints after drug contact and drug use 
after handwashing were also investigated. None of the imaging methods had sufficient sensitivity 
to image cocaine or its metabolites in fingerprints from a drug user deposited after handwashing 
unlike the results derived from the paper spray method. This could be because the size of a drop 
173 
 
of standards (1mm diameter) was too small to compare the size of fingerprints (10 x 10 mm). It 
means that the density of analyte was lower in fingerprints. Therefore, using standards was not 
ideal for method optimisation and validation for mass spectrometry imaging techniques (Chapter 
7). 
7.5 Discussion  
This study explored, for the first time, methods to distinguish fingerprints between contact and 
administration using fingerprint samples of drug users. However, these methods still had 
limitations to overcome to yield accountable results.  
First, a proper method optimisation and validation process is still required although only 
qualitative results are expected. However, the mass spectrometry imaging methods for this study 
did not have the process due to the limited access to the facility. Therefore, most of analysis were 
performed with non-optimised parameters of instruments which the facility (NPL) recommended, 
which resulted in not being able to distinguish those fingerprints and even detect target analytes 
after handwashing. Therefore, it cannot be considered being confirmation test tool to distinguish 
between fingerprints deposited after cocaine contact and cocaine administration until the methods 
improve the sensitivity. 
Second, the sample size is too small. For the paper spray method, 56 fingerprint samples of drug 
users were able to be analysed because it is a rapid process (2 minutes acquisition time). However, 
due to the characteristics of mass spectrometry imaging techniques, the acquisition time to scan a 
whole fingerprint took 4 to 5 hours. Limited access to the facility also affected on the reduced 
sample size (4 fingerprint samples per technique). Although all three imaging techniques/methods 
yielded hypothesis supporting results consistently which a drug user has a more uniform 
distribution of target anlaytes in their fingerprint, repeatability test must be performed with a bigger 
sample size. 
Nevertheless, this study, for the first time, provided proof of concept for distinguishing between 
fingerprints deposited after contact and cocaine administration with different spatial distribution 
of the drugs and metabolites using molecular images as shown in the result of the as presented 
study, which chemical profiling by itself is not capable of doing. This approach can become a 
significant implication in drug abuse cases or drug related crimes. However, since this method did 
not work after handwashing, this study needs to improve the sensitivity of the method to detect 
minute amount of residue after handwashing as paper spray method did (Chapter 5) and prove the 
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repeatability with a larger number of sample sizes (at least as many as for the paper spray method) 
to find accountable patterns through more sophisticated optimisation and validation processes. 
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Chapter 8 Method Optimisation and Validation of Paper Spray - 
Orbitrap Mass Spectrometry Method for the Detection of NPS in 
Fingerprints 
8.1 Introduction  
This chapter describes method optimisation and validation of a paper spray mass spectrometry 
method for the detection of a selection of novel psychoactive substances in fingerprints. The 
purpose of the study was to develop and validate a method that could be used to assess whether 
the use of certain novel psychoactive substances could be established by fingerprint testing. 
A few studies have investigated NPS detection using PS-MS method in blood [227] and urine 
[228], but none of these studies has ever presented NPS detection using PS-MS method in 
fingerprint. Therefore, there was no previous method which could be referenced or applied for 
optimisation for this NPS study using fingerprints. The method in this research was optimised for 
the Q-Exactive Plus Orbitrap mass spectrometer and then validated. 
The validation process of the instrumental/data processing parameters and sample preparation 
applied in this research is explained in following sections. 
8.1.1 Materials 
Standards of UR-144, XLR-11, AB-PINACA, PB-22, APINACA, AB-FUBINACA, 5F-PB-22, 
UR-144 5-Hydroxypentyl metabolite, UR-144 5-Pentanoic acid metabolite, XLR-11 4-
Hydroxypentyl metabolite, APINACA (AKB-48) 5-Hydroxypentyl metabolite, AB-PINACA 5-
Hydroxypentyl metabolite, AB-PINACA 5-Pentanoic acid metabolite, PB-22 4-Hydroxypentyl 
metabolite, PB-22 5-Pentanoic acid metabolite, 5-Fluoro PB-22 3-carboxyindole metabolite, UR-
144 5-Hydroxypentyl metabolite-D5, PB-22 5-Pentanoic acid metabolite-D5, UR-144 5-Pentanoic 
acid metabolite-D5, and APINACA (AKB-48) 5-Hydroxypentyl metabolite-D4 were obtained from 
Cerilliant (Dorset, UK). AB-FUBINACA-D4 was obtained from Cayman (Michigan, USA). In 
order to prepare all solution and solvent mixtures, LC-MS optima grade solvents: methanol 
(MeOH), acetonitrile (ACN), and water (H2O) were applied (Fischer Scientific, Leicestershire, 
UK). 0.1% v/v of formic acid was purchased from Fischer Scientific (Leicestershire, UK). 
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Table 19 List of NPS applied to this study (6 parent drugs and 9 respective metabolites). Asterisk means analytes with proper 
internal standards used to obtain Ratio A/IS. 
Analytes Protonated 
mass (M+H+) 
Fragment 
ions 
Internal standard applied 
UR-144 312.2322 214.1228 UR-144 5-Hydroxypentyl metabolite-D5 
XLR-11 330.22277 125.0963 UR-144 5-Hydroxypentyl metabolite-D5 
AB-PINACA 331.2128 215.1174 AB-FUBINACA-D4 
PB-22 359.1754 214.1228 PB-22 5-Pentanoic acid metabolite-D5 
APINACA 366.2539 135.1169 AB-FUBINACA-D4 
AB-FUBINACA* 369.1721 109.0452 AB-FUBINACA-D4 
5F-PB-22 377.166 232.1132 PB-22 5-Pentanoic acid metabolite-D5 
UR-144 5-Hydroxypentyl 
metabolite* 
328.22711 98.9848 UR-144 5-Hydroxypentyl metabolite-D5 
UR-144 5-Pentanoic acid 
metabolite* 
342.2064 81.0707 and 
95.0863 
UR-144 5-Pentanoic acid metabolite-D5 
XLR-11 4-Hydroxypentyl metabolite 346.21768 125.0963 UR-144 5-Hydroxypentyl metabolite-D5 
APINACA 5-Hydroxypentyl 
metabolite* 
382.2489 69.0708, 
81.0707, and 
95.0863 
APINACA 5-Hydroxypentyl metabolite-D4 
AB-PINACA 5-Hydroxypentyl 
metabolite 
347.20777 253.0199 and 
235.0095 
APINACA 5-Hydroxypentyl metabolite-D4 
AB-PINACA 5-Pentanoic acid 
metabolite 
361.18703 129.0187 APINACA 5-Hydroxypentyl metabolite-D4 
PB-22 4-Hydroxypentyl metabolite 375.17032 333.2497, 
84.9606, 
69.0709, and 
95.0863 
PB-22 5-Pentanoic acid metabolite-D5 
PB-22 5-Pentanoic acid metabolite* 389.14958 149.0238 PB-22 5-Pentanoic acid metabolite-D5 
5-Fluoro PB-22 3-carboxyindole 
metabolite 
250.12378 204.0819 PB-22 5-Pentanoic acid metabolite-D5 
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8.1.2 Samples 
For sample preparation and collection, A sample kit was provided by Intelligent Fingerprinting 
Limited (Cambridge, UK), and it was composed of a chromatography paper (Whatman Grade 1) 
and plastic paper holder as shown in Figure 91. An electronic kitchen scale (Salter) was used for 
fingerprint deposition. The paper substrate was made the same way as that for cocaine study as 
described in Chapter 3 (triangle: 1.6 x 2.1 cm, base × height). 
 
 
 
Figure 91 Figures of the fingerprint collection kit for NPS test. Kits are provided from Intelligent Fingerprinting. 
8.1.3 Instrumentation 
PS-MS analysis of fingerprint samples were carried out by a custom-made paper spray (PS) source 
built at the Surrey Ion Beam Centre. The PS source was coupled with a Q-Exactive Plus Orbitrap 
mass spectrometer (Thermo Fisher Scientific, UK) in University of Surrey Ion Beam Centre. Data 
of all spectra was analysed using Xcaliber [127, 135]. 
To establish the most optimum condition of the instrument for NPS detection, solvent composition, 
spray voltage, temperature, and RF level were optimised using paper spray with standards of parent 
 
Sample 
collection area 
 
 
Cover slip; slide up to 
close sample viewing 
area 
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drugs only: UR-144, AB-PINACA, PB-22, APINACA, AB-FUBINACA, and 5F-PB-22. 
Standards of metabolites were late to be delivered and therefore optimisation focused on the parent 
drugs. For all optimisation work, 10 µL of 100 ng/ml of parent drug standard mixture was spotted 
on each paper and dried for 2 minutes 
8.1.3.1 Solvent composition   
Acetonitrile (ACN) and methanol (MeOH) were selected as candidate spray solvents, and water 
was added to dilute them and provide a role in changing solubility/ionisation as well as blocking 
evaporation. A total of 13 types of spray solvent were investigated, ACN : water (10:0, 95:5, 9:1, 
8:2, 7:3, 6:4), MeOH : water (10:0, 95:5, 9:1, 8:2, 7:3, 6:4), and ACN : MeOH (5:5). 0.1% of 
formic acid was added into each solvent to enhance protonation. Each solvent was tested in 
triplicate.  
 
Figure 92 Peak intensity of parent drug standards for each solvent composition. The possible cause of error in different solvent 
composition includes pipetting error, degradation of standards due to aged stock solution, or less extraction of target analytes 
due to distorted geometry of paper substrates after depositing spray solvent. 
Figure 92 shows that solvent of 95:5/ACN: water and 95:5/MeOH: water provided the highest 
intensity of parent drugs. The presence of water optimised solubility of analytes and enhanced 
ionisation of them, which resulted in the highest peak intensity. However, the RSD was much 
lower for the solvent of 95:5/ACN: water. The possible cause of error with larger RSD in different 
solvent composition includes pipetting error, degradation of standards due to aged stock solution, 
or less extraction of target analytes due to distorted geometry of paper substrates after depositing 
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spray solvent. These causes can be applied to the following mass spectrometry optimisation and 
method validation process. Therefore, 95:5/ACN: water was selected as the spray solvent for 
further analysis. The possible cause of error in different solvent composition includes pipetting 
error, degradation of standards due to aged stock solution, or less extraction of target analytes due 
to distorted geometry of paper substrates after depositing spray solvent. These factors could also 
be possible causes of error (error bar) for following optimisation processes 
8.1.3.2 Spray voltage 
Spray voltage is applied in order to generate charged droplets, which can carry the extracted 
analytes to MS inlet. From 1 to 6 kV of spray voltage was investigated. Spray voltage from 1 to 6 
kV were tested in triplicate. 
 
Figure 93 Peak intensity of parent drug standards at various spray voltages. The possible cause of error in different spray voltage 
includes pipetting error, degradation of standards due to aged stock solution, or less extraction of target analytes due to 
distorted geometry of paper substrates after depositing spray solvent. 
As shown in Figure 93, 3 kV provided the highest peak intensity of parent drug standards. 
8.1.3.3 Temperature  
It is recommended that the temperature of the capillary must be optimised after the solvent choice 
as this will affect the response of the system because the temperature of the inlet capillary on a 
Thermo Exactive Mass Spectrometer is critical in ensuring the drying of sprayed droplets in paper 
spray. The capillary temperatures investigated were 200, 250, 300, 350, 400, and 450 °C. Each 
temperature tested in triplicate.  
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Figure 94 Peak intensity of parent drug standards for each capillary temperature. The possible cause of error in different 
temperature includes pipetting error, degradation of standards due to aged stock solution, or less extraction of target analytes 
due to distorted geometry of paper substrates after depositing spray solvent. 
At 400°C, the peak intensity of target analytes was highest, and the RSD of replicate measurements 
was also the lowest.  
8.1.3.4 RF level  
The RF levels tested for optimisation were 40,50,60,70, and 80.  
 
Figure 95 Peak intensity of parent drug standards for each RF level. The possible cause of error in different RF level includes 
pipetting error, degradation of standards due to aged stock solution, or less extraction of target analytes due to distorted 
geometry of paper substrates after depositing spray solvent. 
RF level of 70 and 80 produced the highest peak intensity of target analytes. However, RF level 
of 60 was chosen because the RSD of 70 and 80 were larger. Also, an increase in the RF level 
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generally results in more ions, including unrelated analytes, with same mass to enter the mass 
spectrometer. Therefore, a lower RF level was selected. 
The spray voltage (3 kV), capillary temperature (400 °C), and S-lens RF level (60.0) were 
optimised using paper spray, which produced the higher protonated ion counts of analyte with the 
lower RSD. MS/MS was performed to confirm peak assignment using fragment peaks shown in 
Table 19. These optimised parameters will be consistent for method validation process and further 
fingerprint sample analysis.  
8.1.4 Sample collection 
A favourable ethical opinion for collection and analysis of samples was granted from the National 
Research Council and Her Majesty’s Prison and Probation Service (NRC - HMPPS reference: 
2018-263). 
Fingerprint donors for this study were prisoners of HM Prison Rochester, which has a problem 
with drug use. Because of the prison’s policy, only prison officers can approach 
prisoners/participants. Sample kits were prepared in University of Surrey and sent to prison 
officers who were trained on how to collect their fingerprint samples. Once samples were collected, 
they were delivered back to University of Surrey. Sample analysis was conducted using paper 
spray mass spectrometry. 
Fingerprint samples were collected as explained in Section 4.1.3  
8.1.5 Paper spray method 
The workflow of this study is similar to the paper spray method used in the cocaine study reported 
in Chapter 4. A sample (either a fingerprint or 10 µL of standard) is spotted onto the paper and air 
dried for 2 minutes. Then, 10 µL of internal standard (100 ng/ml of isotopically labelled standard) 
is deposited and then air dried for 2 minutes. The sample is then placed on the top of a glass slide 
and placed in the middle of folded aluminium foil before being mounted on the spray source. The 
distance and direction of the paper tip relative to the MS inlet is manually controlled using a close 
view camera. Once the paper is set up on the paper spray source, 100 µL of spray solvent (95:5 (% 
v/v), ACN: water, 0.1% formic acid) is pipetted onto the paper, and a voltage (3 kV) is applied. 
The data acquisition is then carried out for a total of 0.7 minutes. The first 0.5 minutes of 
acquisition is carried out in the full scan mode (m/z 50 to 500) for quantitative analysis, followed 
by 0.2 minutes in MS/MS mode to confirm the identity of the target chemical components. 
8.1.6 Mass spectrometry method 
The operating parameters for full scan mode and MS/MS mode to Orbitrap are shown in Table 20. 
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Table 20 Parameters of full scan mode (upper) and MS/MS mode (lower) for NPS detection. 
Scan parameters Value 
Scan range 50 to 500 m/z 
Resolution 280,000 
Polarity Positive 
Micro-scan 1 
AGC target 1,000,000 
Maximum inject time 500 ms 
 
Scan parameters Value 
Resolution 17,500 
AGC  200,000 
Max inject time 50 ms 
Isolation window 1.0 m/z 
NCE/stepped 45 
 
8.1.7 Method validation 
The method validation included the evaluation of the following parameters: limits of detection 
(LOD) and limits of quantification (LOQ), precision (intra and inter-day), stability, and matrix 
effects. The results of the validation study are reported in the following sections. 
8.1.7.1 Limits of detection (LOD) and limits of quantification (LOQ)   
Each standard was prepared from stock solution which contained analytes shown in in ACN: 
MeOH (5:5) at 1000 ng/ml. The stock solution was made with 0.1 mg/ml of those standards. The 
standards were prepared at 10, 50, 100, 200, 400, 600 and 800 pg in the same solvent by diluting 
the stock solution. 10 µL of each standard was spotted on a separate paper substrate and air dried 
for 2 minutes. 10 µL of internal standard (100 ng/ml in ACN: MeOH (5:5)) was subsequently 
spotted on the same paper substrate and air dried for 2 minutes before carrying out the paper spray 
mass spectrometry method. Each calibration standard was analysed in triplicate. The ratio 
analyte/internal standard (A/IS) was obtained for each measurement, and the mean value is plotted 
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against concentration in Figure 96. The values of RSD tended to be higher for substrates which 
did not have isotopically labelled standard. 
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Figure 96 Calibration curves of UR-144 (A), XLR-11 (B), AB-PINACA (C), PB-22 (D), APINACA (E), AB-FUBINACA (F), 5F-PB-22 (G), 
UR-144 5-Hydroxypentyl metabolite (H), UR-144 5-Pentanoic acid metabolite (I), XLR-11 4-Hydroxypentyl metabolite (J), APINACA 
(AKB-48) 5-Hydroxypentyl metabolite (K), AB-PINACA 5-Hydroxypentyl metabolite (L), AB-PINACA 5-Pentanoic acid metabolite 
(M), PB-22 4-Hydroxypentyl metabolite (N), PB-22 5-Pentanoic acid metabolite (O), and 5-Fluoro PB-22 3-carboxyindole 
metabolite (P). 
The LOD and LOQ were calculated by the same method using Equation 2 applied to cocaine and 
BZE in Section 3.1.7.1. In the case of 5-F PB-22 3-carboxyindole metabolite, the acquired 
calibration curve was not linear, so only the qualification purpose study was performed without 
LOD and LOQ value. The values of LOD and LOQ of each target analyte are shown in Table 21. 
Table 21 LOD and LOQ values of UR-144, XLR-11, AB-PINACA, PB-22, APINACA, AB-FUBINACA, 5F-PB-22, UR-144 5-Hydroxypentyl 
metabolite, UR-144 5-Pentanoic acid metabolite, XLR-11 4-Hydroxypentyl metabolite, APINACA (AKB-48) 5-Hydroxypentyl 
metabolite, AB-PINACA 5-Hydroxypentyl metabolite, AB-PINACA 5-Pentanoic acid metabolite, PB-22 4-Hydroxypentyl metabolite, 
and PB-22 5-Pentanoic acid metabolite. Asterisks mean that only analytes which have their own isotopically labelled standards 
and normalised to them.  
Substance LOD (pg) LOQ (pg) 
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UR-144 55 186 
XLR-11 50 168 
AB-PINACA 45 151 
PB-22 59 197 
APINACA 33 112 
AB-FUBINACA* 45 151 
5-F-PB-22 49 163 
UR-144 5-hydroxypentyl metabolite* 41 137 
UR-144 5-Pentanoic acid metabolite* 24 82 
XLR-11 4-Hydroxypentyl metabolite 42 141 
APINACA 5-Hydroxypentyl metabolite* 58 195 
AB-PINACA 5-Hydroxypentyl metabolite 49 165 
AB-PINACA 5-Pentanoic acid metabolite 15 52 
PB-22 4-Hydroxypentyl metabolite 53 177 
PB-22 5-Pentanoic acid metabolite* 39 131 
 
8.1.7.2 Precision 
Precision was evaluated by analysis of analytes containing standards at two quality control (QC) 
samples: low (200 pg) and high (800 pg) based on the acceptable range of calibration curve. 
Intra-day precision (repeatability) was performed with a single day run, and inter-day precision 
(reproducibility) was evaluated over runs on three separate days. Five replicates were carried out 
for each QC level. The results of both precision tests were expressed by relative standard deviation 
(RSD). The acceptable criteria of RSD for precision is less than 20 % [185]. Tables in Appendix 
A4 present RSD of inter-day precision and intra-day precision, respectively. The inter-precision 
test was performed once in each week. Overall, RSD levels of most of analytes were below 20 % 
in both intra and inter precision. However, RSD levels at lower QC of most substances which do 
not have isotopically labelled standards were above 20 %.  
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8.1.7.3 Stability 
The standards of analytes spotted on paper substrates were evaluated at low and high QC 
concentration (200 and 800 pg) under two different conditions: 5°C for three weeks and at room 
temperature (20 °C) for three weeks. This test was performed with three replicates. In three weeks, 
cocaine and BZE did not show any considerable degradation on 5 °C or room temperature storage. 
The result is shown in Figure 97. 
 
Figure 97 Stability of NPS standards on low (200 pg) and high (800 pg) QC concentration in room temperature and 5°C (n=3).  
The level of each substance after 3 weeks regressed under both conditions, but levels of APINACA 
5-hydroxypentyl metabolite, AB-PINACA 5-Hydroxypentyl metabolite, and AB-PINACA 5-
Pentanoic acid increased. However, there was no statistically significant difference between the 
aged samples and non-aged samples. Besides, the RSD was also placed in the acceptable range.  
8.1.8 Matrix effects 
The definition of matrix effects and the aim of this experiment are explained in Section 4.1.9. In 
order to determine the presence of any matrix effects caused by endogenous compounds in a 
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fingerprint, a drug standard containing 400 pg of analytes standard was spotted on top of a 
fingerprint deposited paper, and compared with the same drug standard son papers with the 
absence of a fingerprint. A total of three non-drug users deposited all five of their fingerprints on 
separate pieces of paper. As a result, no substances were affected by fingerprint endogenous 
compounds, as shown in Figure 98, and the t-test proved that there was no matrix effect.   
 
Figure 98 Matrix effect of NPSs with and without the presence of fingerprints (n=5, 400pg applied).  
8.2 Summary 
After successful outcomes from cocaine detection using the paper spray method, a new paper spray 
method for NPS detection was developed. This chapter showed the procedure and results of 
method optimisation and method validation for analytes of parent NPS and their respective 
metabolites. As a result, the method fulfilled the standards of SWGTOX for method validation for 
most of analytes except for precision at lower QC standard on some of analytes due to lack of 
isotopically labelled standard. After method development, fingerprint samples of drug users who 
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have been sentenced in Rochester prison and non-drug users will be analysed qualitatively and 
quantitatively using the developed method. The results of them will be shown in the next chapter.   
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Chapter 9 Results of Paper Spray Mass Spectrometry for Novel 
Psychoactive Substances 
This chapter describes the analysis of fingerprint samples collected from drug users and naïve 
users, using the PS-MS method detailed in Chapter 8. As explained in the literature review, one 
aim of this research is to develop a method to detect NPS in fingerprints which has never been 
investigated yet using any techniques. 
Fingerprint samples from non-drug users and after drug use were collected. The levels of target 
analytes were expressed in ng/fingerprint applying ratio analyte to internal standard (Ratio A/IS) 
to the calibration curves shown in Figure 96. All detected substances were confirmed with 
respective assigned peak with MS/MS.  
9.1 Background Population  
Unlike cocaine and heroin study, information about NPS being environmental contaminants is still 
unknown due to lack of research. Therefore, fingerprint samples of non-drug users were collected 
to explore the level of NPS in their fingerprints to set the environmental cut-off level if necessary. 
Two fingerprint samples (right thumb and right index) were collected from 15 non-drug users from 
the University of Surrey respectively for both “as presented” and “after handwashing” scenarios 
to obtain the cut-off values of parent drugs and their respective metabolites as the cocaine study 
did although the level of environmental contamination of NPS are unknown. All preparation steps 
are same as for the cocaine study. These samples were run using the PS-MS method described in 
Section 8.1.5. The mass/fingerprint corresponding to each NPS is shown in Figure 99. The black 
line in the figure represents the limits of detection (LOD) for each substance.  
For the “as presented” fingerprint samples, there was no substance detected above the LOD from 
fingerprint samples of non-drug users except both AB-PINACA metabolites. 1 fingerprint sample 
each was detected above the LOD of AB-PINACA 5-Hydroxypentyl metabolite with 0.06 
ng/fingerprint and AB-PINACA 5-Pentanoic acid metabolite with 0.15 ng/fingerprint as shown in 
Figure 99. These were also confirmed by MS/MS. Therefore, these were set as the “environmental 
cut-off” value for each of AB-PINACA metabolite. For rest of substances, the “environmental cut-
off” was set as the value of LOD.   
For the “after handwashing” fingerprint samples, No NPS was detected above its LOD. 
This result tells that environmental contamination of NPS and their respective metabolites does 
not frequently happen as cocaine does.      
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Figure 99 Mass per fingerprint of AB-PINACA 5-Hydroxypentyl metabolite and AB-PINACA 5-Pentanoic acid metabolite in as 
presented. Only these two substances were found from a single non-drug user. Rest of NPS were not detected from non-drug user 
population.      
9.2 Drug Users 
Fingerprint donors for this study were prisoners who have been imprisoned in HM Prison 
Rochester. Fingerprints were collected as presented and after handwashing to compare the level 
for drug and non-drug users. 
9.2.1 As presented fingerprints 
Fingerprint samples (right thumb and right index) were collected from 12 participants (24 
fingerprints) in HMP Rochester.  
The mass of each substance per fingerprint is shown in Figure 100. The procedure to collect 
fingerprint samples was same as described above in collecting from non-drug users. 3 fingerprint 
samples could not be analysed due to failed spray. Possible reasons for failed spray are explained 
in Section 5.1.  
Figure 100 shows the result of each substance detected in fingerprints as presented from drug users. 
As mentioned in Section 2.2.2, some substances share structural similarity, which results in sharing 
metabolites as well. In fingerprints of Donor 10, XLR-11, AB-PINACA, PB-22. AB-FUBIMACA 
and 5F-PB-22 were detected. The metabolites of XLR-11 (XLR-11 4-hydroxypentyl metabolite) 
was also detected along its parent drug. Interestingly, UR-144 5-hydorxypentyl metabolite was 
also detected. Because XLR-11 is an analogue of UR-144, so the list of metabolites of XLR-11 
also contain those of UR-144, which are UR-144 hydroxyl product and UR-144 pentanoic acid. In 
case of PB-22, PB-22 4-hydroxypentyl metabolites matched the result of its parent drugs. PB-22 
along PB-22 4-hydroxypentyl metabolites with were detected from Donor 4, 6, and 10. Another 
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metabolite of PB-22 (PB-22 5-pentanoic acid was also detected from Donor 6. PB-22 4-
hydroxypentyl metabolites could be a metabolised product of 5F-PB-22 since it is an analogue of 
PB-22 (Donor 10). APINACA was detected from none of Donors, neither was its metabolite 
(APINACA 5-hydroxypentyl). AB-PINACA was detected from Donor 2 and 10, and AB-
PINACA 5-hydroxympentyl metabolite was also found in these donors. AB-FUBINACA was also 
found in 3 donors, but there were no specific metabolic substances studied in this research. 
However, because of structural similarity between AB-PINACA and APINACA and AB-
FUBINACA, the metabolic product of AB-FUBINACA could be found in that of either AB-
PINACA or APINACA. 
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Figure 100 Mass per fingerprint of UR-144 (A), XLR-11 (B), AB-PINACA (C), PB-22 (D), APINACA (E), AB-FUBINACA (F), 5F-PB-22 (G), 
UR-144 5-Hydroxypentyl metabolite (H), UR-144 5-Pentanoic acid metabolite (I), XLR-11 4-Hydroxypentyl metabolite (J), APINACA 
(AKB-48) 5-Hydroxypentyl metabolite (K), AB-PINACA 5-Hydroxypentyl metabolite (L), AB-PINACA 5-Pentanoic acid metabolite 
(M), PB-22 4-Hydroxypentyl metabolite (N), and PB-22 5-Pentanoic acid metabolite (O) from fingerprint samples of drug user in 
as presented. Only 5 substances (UR-144 (A), APINACA (E), APINACA (AKB-48) 5-Hydroxypentyl metabolite (K), and AB-PINACA 5-
Pentanoic acid metabolite (M)) were not detected in fingerprints of participants. 5-F PB-22 3-carboxyindole metabolite was not 
qualitatively detected. The uncertainty could derive from sample collection procedure, which was completely uncontrollable and 
unobservable due to the prison policy, resulting in many variabilities. 
Although the detection rate of NPS and their respective metabolites was low, they were still 
detected in fingerprints. Unlike cocaine study, participants were not asked to testify if they took 
NPS, and preliminary actions of participants were not monitored. Some donors may have taken 
NPS a longer time ago, others, on the other hand, may have had drug residue remaining on their 
fingertips due to preparation for administration before depositing fingerprints. Therefore, 
determining the mass of these parent drugs and their respective metabolites after handwashing is 
very significant to this investigation and considered in the next section. 
9.2.2 Fingerprints collected after handwashing 
All preparation steps for “After handwashing” was same as the cocaine study as described in 
Section 5.4.2. 24 fingerprint samples (12 patients) were collected for this study. 2 of samples could 
not be analysed due to a failed spray. The mass of each substance per fingerprint after handwashing 
is shown in Figure 101. 
After handwashing, the sensitivity to detect each substance decreased. Among parent drugs, only 
AB-FUBINACA was detected after handwashing, but it did not match with the donors whose 
fingerprints were detected positive as presented. Among metabolites, both of AB-PINACA 
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metabolites (5-hydroxypentyl metabolite and 5-pentanoic acid) and both of PB-22 metabolites (4-
hydroxypentyl and 5-pentanoic acid) were detected. However, none of them matched with donors 
who were detected positive as presented. In order to confirm if these detected substances derive 
from drug administration, urine test was conducted with participant samples as a confirmatory test.    
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Figure 101 Mass per fingerprint of UR-144 (A), XLR-11 (B), AB-PINACA (C), PB-22 (D), APINACA (E), AB-FUBINACA (F), 5F-PB-22 (G), 
UR-144 5-Hydroxypentyl metabolite (H), UR-144 5-Pentanoic acid metabolite (I), XLR-11 4-Hydroxypentyl metabolite (J), APINACA 
(AKB-48) 5-Hydroxypentyl metabolite (K), AB-PINACA 5-Hydroxypentyl metabolite (L), AB-PINACA 5-Pentanoic acid metabolite 
(M), PB-22 4-Hydroxypentyl metabolite (N), and PB-22 5-Pentanoic acid metabolite (O) from fingerprint samples of drug user in 
after handwashing. 5-F PB-22 3-carboxyindole metabolite was not qualitatively detected. The uncertainty could derive from 
sample collection procedure, which was completely uncontrollable and unobservable due to the prison policy, resulting in many 
variabilities 
9.2.3 Comparison of fingerprints and urine 
Fingerprint donors were required to take a urine test using a kit as a part of mandatory drug test 
protocol. Analysis of oral fluid samples were carried out by Abbott (Maidenhead, UK). The results 
of urine tests were applied as confirmation results to explore the relationship between fingerprints 
and urine. As a result, none of NPS which the method developed for in this study were detected 
positive from urine tests according to Abbott.   
9.3 Summary  
Because novel psychoactive substances (NPS) have recently been manufactured to replace the 
conventional drugs and the number of newly synthesised substances are still dramatically surging, 
information regarding NPS detection and their toxicological reports are still significantly 
insufficient. However, multiple research groups published their works to detect NPS in biological 
matrices including blood and urine [296,297]. They successfully developed validated methods to 
identify and quantify many types of NPS using liquid chromatography mass spectrometry. 
However, biometrical limitations (invasive and easy to contaminate) and technical limitations 
(longer running time and lower sensitivity) still remained.  
This study introduced a method to detect NPS in fingerprints for the first time using the paper 
spray method. This approach can overcome the disadvantages from previous studies. A detection 
method was developed using paper spray mass spectrometry. The method validation process was 
fulfilled the standard of SWGTOX for most of target anlaytes [182]. Moreover, the LOD of each 
analyte was similar to that of the cocaine method, which was sufficient for fingerprint analysis (40 
to 100 pg/fingerprint). However, because of an attempt to detect multiple drugs (16 analytes) 
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simultaneously and rapidly, a certain analyte (5-Fluoro PB-22 3-carboxyindole metabolite) was 
not detected possibly due to poor extraction or poor ionisation. (Chapter 8).  
After method development, fingerprint samples of NPS users were analysed. The data showed that 
none of substances were detected from fingerprint samples of non-drug users except AB-PINACA 
5-hydroxypentyl metabolite (environmental cut off: 0.06 ng/fingerprint) and AB-PINACA 5-
pentanoic acid metabolite (environmental cut off: 0.15 ng/fingerprint) for as presented. For after 
handwashing, none of substances were detected in fingerprints of non-drug users. Some of 
substances were detected in fingerprints of offenders for drug abuse, and their respective 
metabolites were also detected from same donors in as presented. However, after handwashing, 
the same parent drug and their respective metabolites were not detected from fingerprints of the 
same donors. Moreover, the confirmatory urine tests were negative for all donors, which supported 
results of fingerprints after handwashing. This means that the sensitivity of this developed method 
to detect NPS in fingerprints is still unknown (Chapter 9).  
9.4 Discussion  
Because of the rapid increase of NPS manufacture/synthesis and use, the necessity of toxicological 
study and forensic (detecting) study of NPS is highly required recent days. In agreement with the 
phenomenon, this study, for the first time, developed a method to detect and quantify NPS in 
fingerprints using paper spray mass spectrometry. However, some questions and challenges still 
remained in this study. 
First, as mentioned in Section 5.6, using a fingerprint sample as a biological matrix requires highly 
controlled conditions when samples are collected to obtain consistency. In this study, however, a 
control of sample collection was not successfully performed. Since fingerprint samples were 
derived from the prisoners, only prison officers were able to collect their fingerprint samples. 
Although they were trained how to collect them, it is unknown for them to fully control collecting 
conditions as requested, which could resulted in potential contamination of samples to affect 
results of further analysis of them. Moreover, prisoners were very sceptical to donate their 
fingerprints despite explanation of this study. Therefore, the sample size of this study (12 donors) 
was not enough to provide accountable results.   
Second, during the method development, this study was limited to access for NPS standards due 
to expiration of the drug license. Therefore, a recommended list of NPS standards which were 
mostly detected from drug offenders were not acquired. It means that this study may have missed 
what prisoners actually administered using wrong standards, which affects the detection rate of 
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target anlaytes. Besides, the absence of suitable internal standards for some of drug standards (also 
due to drug license issue) affected the linearity of calibration curves, which affected LOD of each 
analyte (sensitivity) and further detection rate as well. It is recommended to have retrospective 
study as shown in Chapter 10 when all samples are analysed to observe if this method could still 
detect and identify other NPS that prisoners actually administered. 
Third, the current acquisition time (full scan: 30 seconds) to analyse 16 substances simultaneously 
may have been too short. Full scan mode which is 280,000 resolution has 1.024 second per scan 
times (how long the ions spin around the Orbitrap). 30 seconds was required for the full scan mode 
in this method to obtain rapidity. This means that only about 30 scans are possible. Because 16 
substances were analysed at the same time, fewer than 2 scans/ion were achieved. It means that 
each scan still can detect all the ions, but with low accuracy and repeatability, which results in not 
having enough ions for a high quality measurement. However, if resolution is reduced, more ions 
can be obtained leading to having better data statistics, but isobaric interferences must be 
considered (lower precision) in case of reducing resolution [298]. Increasing acquisition time could 
increase the number of scans per ion, but solvent dies after 30 seconds due to high temperature of 
the cone. Therefore, increasing acquisition time is not the proper solution to have all target ions. 
Originally, this NPS detection method was developed to be ultimately used as a mandatory drug 
test (MDT) tool in prison, which is regularly performed to prevent drug abuse in prison. Although 
this method still have limitations to overcome, it can be a huge advantage for the further MDT test 
with rapid detection, non-invasive, and less contaminated environments once the method is fully 
optimised. Also, it can be applied to the DUI test since it has been reported that NPS is frequently 
detected. 
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Chapter 10 Retrospective Study: Heroin 
This chapter investigated if the detection method developed for cocaine and BZE detection could 
also detect heroin and its main metabolite, 6-acetylmorphine (6-AM) in fingerprints. Retrospective 
analysis of the dataset from Chapter 4 and 5 was carried out to explore the presence of makers for 
heroin use in fingerprints. Retrospective analysis of high resolution mass spectrometry data has 
been described previously [229]. Because the method was initially set up to target cocaine and 
BZE, the only isotopically labelled standards were for cocaine and BZE. Therefore, a cocaine-D3 
standard was used as an internal standard to normalise heroin and 6-AM and to account for 
differences in extraction and ionisation between different replicates since BZE-D3 has caused 
higher RSD with 6-AM. All process and materials from instrument optimisation to sample analysis 
are same as those described in the previous chapters for cocaine and BZE detection. The method 
performance was tested using heroin and 6-AM standards (Cerilliant (Dorset, UK)).  
10.1 Data Processing 
Each analyte was assigned based on the m/z ratio of the [M+H]+ ion (heroin (m/z 370.165) and 6-
AM (m/z 328.1543) from the full scan (0 to 0. 5 min) mass spectrum. Peak assignment was 
confirmed using certified reference materials with MS/MS mode (0.5 to 0.7 min) by detecting 
fragment ions corresponding to heroin (m/z 370.165>165.0697) and 6-AM (m/z 
328.1543>268.1332). For fingerprint samples of drug users, MS/MS was not able to be explored 
because those samples were originally analysed with MS/MS mode for cocaine only. 
10.2 Limits of Detection and Limits of Quantification  
The limits of detection (LOD) for heroin and 6-AM using the paper spray method was determined 
by running different concentration standards. Each standard was prepared from a stock solution 
which contained heroin and 6-AM in ACN (100 %) at 1000 ng/ml. The stock solution was made 
with 1 mg/ml of heroin and 6-AM standards. The standards were prepared at 10, 20, 30, 40, 60 
and 80 ng/ml in the same solvent by diluting the stock solution. 10 µL of each standard (100, 200, 
300, 400, 600, and 800 pg) was spotted on a separate paper substrate and air dried for 2 minutes. 
10 µL of internal standard (100 ng/ml of cocaine-D3 in ACN) was subsequently spotted on the 
same paper substrate and air dried for 2 minutes before carrying out the paper spray mass 
spectrometry method as described in Section 4.1.7. Each calibration standard was analysed in 
triplicate. The ratio analyte/internal standard (A/IS) was obtained for each measurement, and the 
mean value is plotted against concentration in Figure 102. 
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Figure 102 Calibration curve of heroin (A) and 6-AM (B) with cocaine-D3 standard. The possible cause of uncertainty in the 
concentration of standard and internal standard includes pipetting error, degradation of standards due to aged stock solution, 
or less extraction of target analytes due to distorted geometry of paper substrates after depositing spray solvent.     
The method is linear in the range up to 800 pg with R2 values of 0.9868 for both heroin and 6-AM, 
which are not as good as that of cocaine and BZE. That may be because, the internal standard used 
in this study was not isotopically labelled for heroin and 6-AM. The LOD and LOQ value 
corresponding to heroin and 6-AM based on the calibration curve are shown in Table 22. The LOD 
value of heroin and 6-AM is 77 and 57 pg, respectively.  
Table 22 Values of LOD and LOQ for heroin and 6-AM. 
Substance LOD (pg) LOQ (pg) 
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Heroin 77 258 
6-AM 57 190 
 
10.3 Background Population  
The data collection from same fingerprint samples of background population for the previous 
cocaine and BZE detection study were analysed retrospectively for heroin and 6-AM.  
Here, two fingerprint samples (right thumb and right index) had been collected from 28 non-drug 
users from the University of Surrey respectively for both “as presented” and “after handwashing” 
scenarios. Heroin was not detected above the LOD in any fingerprints from background donors 
before and after handwashing. On the other hand, 6-AM was detected in one fingerprint before 
handwashing and in two fingerprint samples after handwashing. The mass per fingerprint of heroin 
and 6-AM are plotted in Figure 103. 
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Figure 103 Mass per fingerprint of heroin and 6-AM of non-drug users. Only 6-AM was detected in a single right index fingerprint 
(donor 24) in as presented (A) and both right thumb and index fingerprints (donor 13) after handwashing (B).  
For “as presented” samples, the highest level of heroin observed in a fingerprint of non-drug user 
was below the LOD of heroin, so an “environmental cut-off” value for heroin was set to LOD, 
which is 77 pg. The highest level of 6-AM observed in a fingerprint of non-drug user was 75 pg, 
and so that is set as the “environmental cut-off” for 6-AM.  
Similarly, after handwashing, heroin was not observed in a fingerprint of a non-drug user, so the 
“environmental cut-off” value of heroin is 77 pg. The highest level of 6-AM observed in a 
fingerprint of non-drug user was 79 pg. These values will be applied as an “environmental cut-off” 
for heroin and 6-AM. 
Unfortunately, peaks above the LOD level cannot be confirmed for peak assignment of heroin and 
6-AM with MS/MS because the peak assignment for the method was originally set for only cocaine 
and BZE.   
10.4 Persistence Study  
The sample preparation and protocols were exactly same as the persistence study of cocaine except 
heroin powder (Sigma) which was obtained from Dr. Alexis Bailey in Faculty of Health and 
Medical Sciences (FHMS) in University of Surrey. In order to investigate how long heroin residue 
can stay on a fingertip with normal daily activities with handwashing by analysing fingerprints, 3 
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participants touched 2 mg (high dose) and 0.5 mg (low dose) of pure heroin powder. To minimise 
the toxicological effect, the dose of heroin that was touched was limited to 2 mg. 
Before the study commenced, the heroin powder that was going to be used to make contact with 
fingerprints was made into a solution (500 ng/ml) to confirm if it would contain heroin and its 
metabolites. In cocaine study using the paper spray method, the metabolites of cocaine were not 
detected after contact with cocaine powder before and after handwashing although they were 
detected in the solution, which was the key factor to distinguish from fingerprints after cocaine 
use. This study investigated if fingerprint samples with heroin contact yield the similar result with 
that of cocaine study, so fingerprint samples after heroin contact and ingestion could be 
distinguished in the same way. The mass spectra confirmed the presence of heroin (m/z 
370.1649🡪165.0697) and 6-AM (m/z 328.1543🡪268.1332) with MS/MS peak assignment [230, 
231]. The mass spectra of the heroin solution are shown in Figure 104. 
Participants deposited their fingerprints (right thumb and index) on prepared cut papers at different 
time points: T=3, 7, 12, 24, 30, and 48 hours after touching heroin powder with fingers of their 
right hand for 10 seconds. Then, they shook their hands to remove large particles. During each 
time period, participants carried out normal daily activities including handwashing. Samples were 
collected using the same collection kit described above, on paper with pressure applied for 10 
seconds to the fingers until a reading of 1000 to 1200 g was achieved on the scales. 
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Figure 104 Assigned peaks (M+H)+ of heroin (m/z 370.1649) and its main fragment (m/z 165.0697) and 6-AM (m/z 328.1543) and 
its main fragment (m/z 268.1332). 
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Figure 105 Mass per fingerprint of heroin (A) and 6-AM (B) at short term persistence up to 48 hours as presented derived from 
contact with heroin powder (low dose, 0.5 mg). The possible cause of uncertainly includes uncontrolled daily activities of 
participants and accidental contact with heroin before fingerprint deposition, or less extraction of target analytes due to distorted 
geometry of paper substrates after depositing spray solvent.  D1: Donor 1, RT: right thumb, RI: right index. 
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Figure 106 Mass per fingerprint of heroin (A) and 6-AM (B) at short term persistence up to 48 hours as presented derived from 
contact with heroin powder (high dose, 2 mg). The possible cause of uncertainly includes uncontrolled daily activities of 
participants and accidental contact with heroin before fingerprint deposition, or less extraction of target analytes due to distorted 
geometry of paper substrates after depositing spray solvent.  D1: Donor 1, RT: right thumb, RI: right index. 
Figure 105 and Figure 106 show the mass of heroin and 6-AM corresponding to each time period 
from three donors after touching a high dose (2 mg) and low dose (0.5 mg) respectively. At low 
dose, the heroin level from Donor 1 was still placed above the environmental cut-off level (77 pg) 
after 48 hours. The heroin level from Donor 2’s fingerprints was detected above the environmental 
cut-off level up to 30 hours. Donor 3 did not produce heroin residues even after 3 hours showing 
same variability between donors. For the high dose, heroin was still detected in the fingerprints of 
Donor 1 and 2 after 48 hours. In contrast, Heroin was detected in the fingerprints of Donor 3 after 
3 hours, but it disappeared after the time period. As described in Section 5.2 BZE, the main cocaine 
metabolite, was not detected from any donors although it was detected in the solution of cocaine 
hydrochloride powder. In contrast, 6-AM, the main heroin metabolite, was detected in the 
fingerprints after heroin powder contact. As shown in Figure 105 and Figure 106, 6-AM is detected 
sporadically at close to the “environmental cut-off” level (75 pg) at random time points, and did 
not provide systemic pattern. At low dose, 6-AM appeared only in the fingerprint of Donor 2 at 
the time point of after 7, 24, and 48 hours. At high dose, 6-AM was detected in the fingerprints 
from Donor 1 after 3 hours, but it did not reappear again. In case of Donor 2, it has never been 
detected until after 30 hours, but it reappeared after 48 hours.  
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Figure 107 Mass per fingerprint of heroin (A) and 6-AM (B) at long term persistence up to 12 days after contact with 2 mg of heroin 
powder. The possible cause of uncertainly includes uncontrolled daily activities of participants and accidental contact with heroin 
before fingerprint deposition, or less extraction of target analytes due to distorted geometry of paper substrates after depositing 
spray solvent. Taken from fingers “as presented”.  
Because heroin and 6-AM could still be detected above the cut-off level, time points for the 
persistence study was extended up to 12 days to monitor long term persistence. Donor 1 and 2 
participated in this study since the signal of heroin and 6-AM of Donor 3 disappeared before 12 
hours of contacting heroin powder. As shown in Figure 107, heroin was detected up to 4 days after 
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contact with heroin powder, but it happened only from Donor 2. Both fingerprint samples of Donor 
2 provided heroin level above the cut-off level.      
10.4.1 Handwashing  
“After handwashing” was also investigated for the persistence of heroin after touching a low dose 
(0.5 mg) and high dose (2 mg) of heroin powder. As shown in Section 4.2 for the cocaine study, 
the aim was to find a method that could reduce the persistence of cocaine residue after contact with 
heroin by non-drug users. 
 
 
Figure 108 Mass per fingerprint of heroin (A) and 6-AM (B) at short term persistence up to 48 hours after handwashing derived 
from contact with heroin powder (low dose, 0.5 mg). The possible cause of uncertainly includes uncontrolled daily activities of 
participants and accidental contact with heroin before fingerprint deposition, or less extraction of target analytes due to distorted 
geometry of paper substrates after depositing spray solvent. D1: Donor 1, RT: right thumb, RI: right index.  
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Figure 109 Mass per fingerprint of heroin (A) and 6-AM (B) at short term persistence up to 48 hours after handwashing derived 
from contact with heroin powder (high dose, 2 mg). The possible cause of uncertainly includes uncontrolled daily activities of 
participants and accidental contact with heroin before fingerprint deposition, or less extraction of target analytes due to distorted 
geometry of paper substrates after depositing spray solvent. D1: Donor 1, RT: right thumb, RI: right index. 
As shown in Figure 108 and Figure 109, the time during which heroin persisted on the fingers 
became shorter when fingerprint were donated after handwashing. The pattern of signal of heroin 
was relatively unsystematic compared to “as presented” study in both low and high dose cases. 
After 48 hours, heroin and 6-AM were not detected for any donors. At low dose (0.5 mg), heroin 
was no longer detected after 7 hours, except for a signal of heroin that reappeared at 24 hours from 
Donor 2. At high dose (2 mg), heroin was detected for Donor 1 at 3, 12, and 30 hours. The signal 
of heroin from Donor 2 was detected until 7 hours, and it reappeared at after 30 hours. The level 
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of heroin from Donor 3 was also detected until 7 hours. In the case of 6-AM, at low dose, 6-AM 
was detected only up to 3 hours, and it derived from only 1 donor (Donor 2). At high dose, 6-AM 
was also detected up to 3 hours in the same donor. After handwashing, the signal of 6-AM did not 
reappear.  
10.5 Street Heroin 
Our group also investigated drug residues in fingerprints immediately after contact with heroin. 
The data in this sub-section of the thesis was provided by Miss Laura Juskite for her final year 
project but is used here for comparison purposes. This data is important because it considers source 
of heroin of street purity.  
Samples of heroin seized by the Irish police and stored at Forensic Science Ireland (FSI) were used 
for this work. A sample from the drug seizure had been previously analysed by FSI’s standard 
analysis protocol using gas chromatography – mass spectrometry and had been found to have a 
heroin purity of 11%, with traces of 6-AM, phenacetin, and paracetamol. Three donors (non-drug 
users) were asked to touch 2 mg of the powder, spreading the powder over all their right-hand 
fingers for approximately 10 seconds. They then dusted the excess off to remove large particles, 
and deposited fingerprints (left thumb and index fingers) before and after handwashing, as 
described in Section 5.3. 
 
Figure 110 Mass per fingerprint of heroin and 6-AM after touching street heroin in both as presented and after handwashing. 
Analysed by paper spray mass spectrometry. 
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As shown in Figure 110, both heroin and 6-AM were detected in fingerprints provided as presented. 
Interestingly, both analytes were completely removed after handwashing unlike street cocaine. 
This was unexpected because the solubility of cocaine in water (1 g/600 ml) is lower than that of 
heroin (1 g/1,700 ml) [232].  In street cocaine, cocaine was still detected after handwashing, 
whereas BZE was not.  
10.6 As presented fingerprints 
As mentioned in Section 4.4.1, fingerprint samples (right thumb and right index) were collected 
from 28 patients (56 fingerprints) in a rehabilitation clinic, who testified administration of cocaine 
within last 24 hours, but did not specify whether they had taken heroin. 3 fingerprint samples right 
index of 10, right thumb of 11, and right thumb of 12) could not be analysed due to failed spray 
(explained in Section 5.1).  
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Figure 111 Mass per fingerprint of heroin (A) and 6-AM (B) from drug users collected as presented and compared to the 
environmental cut-off levels. AP: as presented, OF-: oral fluid test negative. 3 failed fingerprint samples: (right index of 10, right 
thumb of 11, and right thumb of 12).    
As shown in Figure 111, heroin and 6-AM were detected retrospectively in the fingerprints 
collected from those donors. Heroin was detected above the “environmental cut-off” level in 40 
out of 53 samples. 5 of them were still detected despite negative of the oral fluid result. 6-AM was 
detected above the “environmental cut-off” level in 42 out of 53 samples. 3 of them were still 
detected despite oral fluid test being negative. 
The data shows an interesting result. The street heroin was observed to have a different texture and 
particle size from the powdered heroin used in the persistence measurements. As well as the purity 
of the street heroin being low (11 %), the removal of all traces of heroin from the fingerprint 
following handwashing may be explained by the difference in particle size. It is possible that street 
heroin is more easily removed from the skin than powdered heroin due to the larger particle size 
of the former. This result follows the result of Bull et al. [9]. Smaller size of pollen grains (heroin 
particles) tend to be stuck in fabrics (fingerprint ridges) resulting in being hard to remove despite 
washing processes.  
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10.7 Fingerprints collected after handwashing 
The protocol for collecting fingerprints after handwashing was already explained in Section 5.4.2. 
42 fingerprint samples (21 patients) were collected for this study. 2 of samples (right index of 24 
and right index of 25) could not be analysed due to a failed spray. 
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Figure 112 Mass per fingerprint of heroin (A) and 6-AM (B) from drug users collected after handwashing and compared to the 
environmental cut-off levels. AH: after handwashing, OF-: oral fluid test negative. 2 failed spray: right index of 24 and right index 
of 25. 
The “Environmental cut-off” was set based on the highest mass/fingerprint detected from 
fingerprint samples of background population. The value was 77 and 79 pg for heroin and 6-AM, 
respectively. Heroin was detected above the “environmental cut-off” level in 27 out of 40 
fingerprint samples. 6-AM was detected above the “environmental cut-off” level in 29 out of 40 
fingerprint samples as shown in Figure 112. 
10.8 Comparison of fingerprints to oral fluid test  
The oral fluid test aimed at detecting opiates and 6-AM. The oral fluid test confirmed that opiates 
and 6-AM were not detected from these participants (3, 7, 11, 15, and 25). Among them, only one 
participant (7) testified to take heroin within 24 hours prior to the test.  
6-AM and heroin were still detected from fingerprint samples of whose oral fluid test turned out 
negative. In case of participant 3, mass of 6-AM and heroin was relatively higher from both 
fingerprints. Even after handwashing, those mass in fingerprint still remained and detected in 
fingerprints. In case of participant 11 and 25, they yielded neither 6-AM nor heroin detected 
fingerprints both before and after handwashing.  
On the other hand, in case of fingerprint samples of participant 16, neither 6-AM nor heroin were 
not detected in as presented, but interestingly, signals of them were detected after handwashing.  
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10.9 Summary 
In this study, heroin and 6-AM detection was investigated in fingerprints using the detection 
method originally developed to target cocaine and BZE. There is an example of a retrospective 
study for drug detection using mass spectrometry. Mollerup et al. [299], previously tried to analyse 
valproate (VPA), but it was poorly detected with a wrong ionisation source. However, they 
retrospectively analysed the last 4 years of data with new methods, which resulted in better 
sensitivity and specificity. However, this heroin retrospective study aimed to observe if heroin and 
6-AM can be detected and quantified under non-optimised conditions such as using inappropriate 
internal standard (cocaine-D3) and the lack of method validation process. Nevertheless, Both 
heroin and 6-AM gave fairly good limits of detection (75 and 77 pg, respectively) with the 
optimised method for cocaine detection. The detection rate of heroin and 6-AM was not as good 
as cocaine, but formed at 75%, in accordance with the result of oral fluid test (confirmation test) 
and the testimony of participants. Moreover, the significance study of heroin detection in 
fingerprints such as persistence and effect of handwashing was still carried out under the condition. 
The persistence study showed that 48 hours after contact, heroin was no longer detected in a 
fingerprint. However, unlike the result of cocaine persistence study, the heroin metabolite, 6-AM, 
was still detected after contact, which is in agreement with Costa et al [300]. 6-AM was not washed 
off the hands after contact. It means that the presence of 6-AM cannot be used to distinguish 
between fingerprints of subjects from either group (heroin contact or ingestion). Although the 
method was not ideally optimised and validated to detect heroin and 6-AM in fingerprints, it was 
still able to detect and quantify them along with cocaine.  
10.10 Discussion 
Because this study retrospectively analysed heroin and 6-AM in fingerprints, the conditions to 
detect and quantify them were not ideal. The instrument were not optimised to identify heroin and 
6-AM, and the internal standard used for this study was cocaine-D3, which affected linearity of 
calibration curve. Moreover, for the further quantification, required method validation steps for 
the further detection and quantification of them were missed. Compared to Ismail et al.(Ismail et 
al. 2018), which developed methods through a proper method validation process to detect both 
cocaine and heroin simultaneously in a single fingerprint of drug users using liquid 
chromatography mass spectrometry obtained 100 % of heroin detection rate. Whereas, the lack of 
a proper method validation process gave much lower detection rate of heroin in this study. 
Moreover, the sample size for the persistence study was too small (3 donors, 6 fingerprint samples) 
compared to the heroin administration study because of health and safety reasons although the 
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result was consistent. Also, the amount of heroin powder used for low dose (0.5 mg) and high dose 
(2 mg) study should be more distinguished. It needs to have a bigger sample size and more 
distinctive difference of amount of dose for the result to be more accountable in the future research. 
However, this study is still significant to investigate, for the first time, the persistence of heroin in 
fingertips along with cocaine using fingerprints after contact with drug powder residue. 
Furthermore, this study proved the concept for using paper spray mass spectrometry for the 
detection of heroin in fingerprints, and that future work should explore optimising the 
methodology for this analyte to improve sensitivity. 
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Chapter 11 Conclusions and Future Work 
This study not only developed paper spray mass spectrometry (PS-MS) methods to detect illicit 
substances: cocaine, heroin, NPS in fingerprints, but also investigated the evidence dynamic of 
detecting them in fingerprints such as effect of handwashing and various removal methods, 
persistence, and distinguish between fingerprint samples after drug use and fingerprint samples 
after drug contact using mass spectrometry imaging techniques: desorption electrospray mass 
spectrometry (DESI-MS), time of flight secondary ion mass spectrometry (ToF-SIMS), and matrix 
assisted laser desorption/ionisation mass spectrometry (MALDI-MS).     
11.1 Detection of Cocaine and Heroin in Fingerprint 
The method using paper spray mass spectrometry was developed to detect cocaine and its main 
metabolite, benzoylecgonine (BZE). Fingerprint samples of non-drug users (background 
populations) and drug users (participants who receive treatment for drug addiction at NHS Drug 
and Alcohol Services) were collected in two different scenarios: as presented and after 
handwashing. The analysis of fingerprint samples of background populations was proposed to set 
the “environmental cut-off” level of cocaine and BZE as cocaine could be easily found in 
environmental circumstances such as banknotes [15]. As a result, low mass of cocaine and BZE 
was detected from the small number of background populations, and its highest mass was set up 
as “environmental cut-off” level for the further persistence and drug use studies (Section 5.1). 
Persistence of a cocaine in fingerprint after contact was investigated to observe not only how long 
cocaine residue remain after contact, but also to compare with administration of a drug through 
chemical profiling. No matter how much participants touched cocaine powder (0.5 mg VS. 2.0 
mg), no difference was observed in the length of persistence (48 hours). BZE was never found 
from fingerprint samples in the persistence study, and even if immediately after contact with 
cocaine contaminated with BZE, this metabolite was not observed after hands were washed 
(Section 5.2). Analysis of fingerprint samples of drug users showed something different from the 
persistence study. BZE was observed, and it was ONLY observed in fingerprints of drug users 
whose oral fluid tested positive for cocaine. We conclude that this method can be used as a 
screening tool for cocaine detection, because it is not readily detected at environmental levels, and 
was detected 100% of the time in samples from drug users.  However, cocaine alone cannot be 
used to confirm drug ingestion, and BZE is a more appropriate candidate compound for 
distinguishing cocaine contact from cocaine ingestion. 
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Heroin and its main metabolite, 6-acetylmorphine (6-AM) were retrospectively investigated in this 
study using the method to detect cocaine and BZE. Fingerprint samples from the same background 
populations and same drug users were applied to detect level of heroin and 6-AM because of using 
the same method. Heroin is more likely to be degradable [233]. Low mass of only 6-AM was 
detected from the small number of background populations, and its highest mass was set up as 
“environmental cut-off” level for the further persistence and drug use studies (Section 10.2). 
Compared to cocaine, heroin residues remained much longer (4 days), and 6-AM was still detected 
after handwashing with no systematic pattern (Section 10.3), but street heroin washed off. Unlike 
results of cocaine and BZE from drug users, 6-AM was still observed in fingerprint of some drug 
users whose oral fluid tested negative for 6-AM, which means that this method cannot be indicative 
of testing heroin administration. This may be because, the method could not be robust enough for 
heroin and 6-AM detection. Nevertheless, for the patients whose oral fluid was positive for 6-AM, 
only 3 patients out of 17 did not return any fingerprints positive for 6-AM, giving a detection rate 
of 82 % (Section 10.5). 
Overall, the method was able to discriminate the level of cocaine and BZE of individuals from 
background populations from donors who had taken cocaine recently based on the presence of 
parent drug and its metabolite. However, chemical profiling still had some limitations to 
distinguish fingerprint samples after drug use to fingerprint samples after contact. Therefore, mass 
spectrometry imaging techniques were introduced as an alternative method to distinguish them.  
11.2 Mass Spectrometry Imaging Techniques to Distinguish Fingerprint Samples after 
Drug Users and after Drug Contact 
Previously, studies of method development for detecting illicit substances using fingerprints have 
been investigated. However, no studies explored the significance of detecting the substances using 
fingerprints. Cocaine study using the paper spray method shown in Chapter 5 showed that cocaine 
and the cocaine metabolites were detected together from fingerprint samples of drug users. Besides, 
recent data from our group showed that the cocaine metabolites can also arise from contact with 
the powder residue [127]. It means that chemical composition alone of a fingerprint cannot be used 
to distinguish between contact and administration. For example, someone who accidently touched 
an illicit drug could be wrongly accused of drug abuse if the drug and its metabolites are still 
detected in his or her fingerprint. Therefore, this study developed chemical and molecular imaging 
protocols to distinguish between fingerprints after drug use and drug contact based on the spatial 
distribution of drugs and metabolites in a fingerprint.  
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As the paper spray method was investigated, fingerprint samples of drug users and contact with 
cocaine powder of non-drug users were collected, but on different substrates (silicon wafer for 
ToF-SIMS and adhesion slide Super Frost Plus for DESI-MS and MALDI-MS) (Chapter 7). 
However, this study using mass spectrometry imaging techniques was only qualitatively explored 
in order to observe the presence and spatial distribution of cocaine and cocaine metabolites in 
fingerprint samples unlike the paper spray method. Besides, in case of DESI-MS and MALDI-MS, 
the access for the instrument was limited. Therefore, there was no analytical protocols conducted 
for the method validation as the paper spray method was done, but the preliminary method 
optimisation process was investigated (Section 7.1, 2, and 3). 
Each technique has different characteristics, but the results of analysing fingerprint samples after 
cocaine use and cocaine contact using it were very similar. In as presented, fingerprint samples of 
drug users and cocaine contact of non-drug users were distinguishable. Fingerprint samples after 
contact created hot spots (highly concentrated cocaine and BZE analytes detected) in multiple 
regions in fingerprints with both street cocaine and pure cocaine (not detected from the paper spray 
method). Whereas, fingerprint samples of drug users yielded patterns of analytes more spread and 
evenly distributed over a fingerprint. In after handwashing, fingerprint samples after contact was 
still distinguished from background signal, but hot spots were no more existed, which made similar 
to the images of fingerprint samples of drug users in as presented. However, fingerprint samples 
of drug users in after handwashing did not yielded images of target analytes due to lack of 
sensitivity of the method (Chapter 8).  
Based on the results obtained in this study, using mass spectrometry imaging techniques can be a 
good method to distinguish between fingerprint samples of drug users and drug contact with spatial 
distribution of drugs and metabolites in a fingerprint. However, the study to improve the sensitivity 
of methods and resolution of images must be developed in order to yield distinctive images of low 
amounts of analytes, which leads to become a robust method to discriminate those fingerprint 
samples.      
11.3 Detection of NPS in Fingerprint 
Currently, it is difficult to identify and detect NPS using current techniques because manufacturers 
tweak the chemical structure of existing conventional illicit drugs in order to mimic the effects of 
them and increasingly contort the chemical compositions and structures of the drugs to make them 
“legal”. Therefore, studies to identify parent drugs and their respective metabolites are being 
explored in the forensic toxicology field. However, these studies were started recently, and there 
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are many kinds of NPS in the market and newly manufactured, which result in limited information 
regarding their metabolising mechanism. As a result, it is uncertain what the main metabolites or 
bio markers of NPS administration are. This study, as a potential screening method to detect NPS, 
developed a detection method (Section 8.2) and applied it to detect NPS listed in synthetic 
cannabinoid as shown in Table 19. Fingerprint samples were collected from prisoners who had 
been sentenced for drug abuse in Rochester prison in before and after handwashing.  
In as presented, all substances except APINACA were detected in at least one of the donated 
fingerprints, which were confirmed by MS/MS peak assignment. In case of UR-144, PB-22, and 
AB-PINACA, they were detected from some donors, and their metabolites were detected from the 
same donor. After handwashing, the detection rate became lower compared to samples collected 
as presented. All substances detected in donors before handwashing disappeared. Since, the 
confirmation test confirmed that all donors were tested negative for all substances, the results 
shown from as presented could derive from contact with these substances or isobaric compounds 
(Section 9.2.3). 
Compared to conventional drugs, the toxicological research on NPS is still limited in order to find 
out what the main metabolites are as a biomarker, and there are much more NPS left in the world 
which need to be investigated other than those substances in this study. Therefore, the detection 
method must be constantly developed and improved to cover and identify as many NPS as possible.  
As a biological matrix to detect NPS, a fingerprint can be a robust screening tool with 
characteristics of using fingerprints such as simplicity and rapidity for sample 
collection/preparation and even provide identification of offender. As this study is not terminated 
yet, fingerprint samples of prisoners will continue to be collected. The person who succeeds this 
study will continue to explore this research.          
11.4 Implication of the research and Future Work   
This research has brought up challenges using of fingerprints as a biological matrix for drug testing. 
The biggest issue in using fingerprint was high variability. The number of endogenous compounds 
and target analytes excreted from fingerprints are different depending on donors’ age, gender, their 
biological characteristics, or size of fingerprints. The absence of fingerprint standard also made it 
difficult to set an ideal calibration curve for target analytes. Also, matrix effect test and stability 
test were conducted with the presence of fingerprints. As a result, there was fortunately no 
significant difference found.  
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On cocaine study, this study has first investigated the significance of drug detection in fingerprints, 
as well as developed methods compared to previous studies regarding drug detection in 
fingerprints. This study explored the persistence of cocaine, effect of handwashing, comparison of 
residue removing methods, and differentiation of cocaine administration and cocaine contact. With 
high detection rate (89 %) of fingerprint samples from cocaine users, they were successfully 
distinguished from who contacted pure cocaine powder with presence of the cocaine main 
metabolite, BZE. In order to distinguish them more distinctively, mass spectrometry imaging 
techniques were suggested and explored in this study.  
Application of mass spectrometry imaging techniques for the first time yielded the distinctive 
difference between fingerprint samples from cocaine users and cocaine contact, but only for as 
presented samples. After handwashing, cocaine and BZE were not detected and image of them 
were not acquired, which is against that the study already proved using the paper spray method 
that cocaine can still be detected after handwashing (100 % detection rate). Therefore, the method 
must be re-optimised to improve the sensitivity.    
For other conventional drugs such as heroin or methamphetamine which are still commonly used 
and found, the significance study of them must be done as well. In case of the heroin study, the 
method was not fully optimised for heroin and 6-AM because it was originally developed for 
cocaine and BZE detection. However, it still provided good detection rate (79 %) of fingerprint 
samples of drug users, and the main metabolite, 6-AM was also found from fingerprint samples 
who contacted pure heroin hydrochloride powder as well as in street heroin. Since this method 
using PS-MS with fingerprints can detect both cocaine and heroin obtaining advantages (no sample 
preparation, simple deposition of fingerprints, rapid analysis, and high detection rate), this method 
can be applied to the drug related DUI test. Law enforcement agencies could obtain more quick 
and accurate information if they apply this method to directly detect illicit substances, which can 
be huge advantage for the further investigation.         
Application of fingerprint testing for the detection of NPS was explored, which has never been 
conducted before. As mentioned in Section 2.4, NPS has been recently manufactured and 
introduced, and there are too many analogues tweaking chemical structures of original parent drugs. 
Therefore, toxicology studies on metabolism of NPS and follow up information is very limited as 
of yet. During the method development, this study was limited to access for NPS standards due to 
expiration of the drug license. Therefore, a recommended list of NPS standards which were mostly 
detected from drug offenders (supplied by Rochester prison) were not acquired. Besides, the 
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absence of suitable internal standards for some of drug standards (also due to drug license issue) 
affected the linearity of calibration curves. Nevertheless, method development to detect NPS in 
fingerprints were completed. Currently, because of lack of the sample size, it cannot be assured 
that the developed method could work on fingerprint samples who administered those drugs. 
Therefore, additional sample collection and analysis must be required to prove the method 
sensitive enough. Once it is proved, subsequent significant study of detection in fingerprints can 
be explored as done for the cocaine study. Besides, detection methods for other NPS must be 
consistently developed since newly manufactured synthetic drugs keep surging. 
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Appendix A 
A.1: The method to test whether there is significant difference or not for the matrix effect on two 
different sets of data for matrix effect of cocaine and BZE standards using equation of f test and t 
test. 
In order to determine the matrix effect for cocaine and BZE with the presence of fingerprints using 
the paper spray mass spectrometry method, f test was used before applying a t test. That is because, 
the matrix effect test contains two different sets of data. In this case, significant difference is 
figured out by comparing of two experimental means [183]. In order to calculate means, f test was 
used prior to t test to test whether two standard deviations differ significantly by comparing two 
different standard deviations. The f value of each donor was calculated to be compared with the f 
value of standard only sample. The calculated f value is compared to the value in f table. The value 
only depends on the degrees of freedom.   
In order to test whether the difference between two sample variances is significant, the f value is 
calculated with Equation 3.  
𝐹 =
𝑠12
𝑠22
 
Where the subscripts 1 and 2 are allocated in the equation so that F is 
always ≥1. 
- The number of degrees of freedom (df) of the numerator and denominator are 𝑛1 − 1 and 
𝑛2 − 1 respectively. 
- The test assumes that the populations from which the samples are taken are normal. 
Equation 3 Equation to acquire f value 
Because there were 3 replicates in each donor’s fingerprint samples and drug standard only 
samples, the value can be found df1=2 and df2=2, which is 39.00.  
As a result, the f value for cocaine and BZE between samples with each donor’s fingerprint and 
the sample with drug standard only was lower than 39.00 as shown in Table 23. 
Table 23 a) f value of each donor’s fingerprint sample to “no fingerprint” samples for cocaine, b) f value of each donor’s 
fingerprint sample to “no fingerprint” samples for BZE 
 
 
Cocaine 
 
Donor 
f value 
n=2,2 
(p=0.05
) 
239 
 
1 4.234 
39 
2 2.25 
3 27.04 
 
 
 
 
 
 
BZE 
 
Donor 
f value 
n=2,2 
(p=0.05
) 
1 4.356 
39 
2 2.741 
3 4.283 
 
 
 
 
 
Depending on the f value, the following equation applied to t test would be different. There are 
two equations to acquire t value in case of comparison of two experimental means shown in 
Equation 4.  
𝑡 = (𝑥1 − 𝑥2)/𝑠 × √(
1
𝑛1
+
1
𝑛2
) 
or 
𝑡 = (𝑥1 − 𝑥2)/√((
𝑠12
𝑛1
) + (
𝑠22
𝑛2
)) 
Where t has 𝑛1 + 𝑛2 − 2 degrees of freedom. 
Equation 4 Equation to acquire t value with f value 
240 
 
Because the f value for cocaine and BZE between the with donors’ fingerprint samples and without 
fingerprint samples was lower than the designated value in the table, the f value was considered 
not significantly different. Therefore, the first equation of Equation 4 was applied to acquire the t 
value. The t value of samples with each donor’s fingerprint to samples without fingerprints for 
cocaine and BZE was calculated with the equation and is shown in Table 24. 
Table 24 a) t value of each donor’s fingerprint sample to “no fingerprint” sample for cocaine, b) t value of each donor’s 
fingerprint sample to “no fingerprint” sample for BZE 
 
 
Cocaine 
 
Donor  
t value 
df=4 
(p=0.05
) 
1 0.006018128 
2.78 
2 -0.069141805 
3 -0.006868828 
 
 
 
BZE 
 
Donor 
t value 
df=4 
(p=0.05
) 
1 -0.002740105 
2.78 
2 -0.053452474 
3 -0.038721371 
 
All t values (|t|) for cocaine and BZE were lower than the designated value when degree of 
freedoms is 4 (3 + 3 − 2), which means that there is no significant difference in the presence of 
donors’ fingerprints. Therefore, there was no matrix effect found. 
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A.2: Parameters of analyser and MacroRaster in ToF-SIMS 
Parameters Value 
Extraction 2000 V 
Energy 2000 V 
Lens 4910 V 
Variable drift path (VDP) 140 V 
Reflector 20 V 
 
Parameters in MacroRaster mode Value 
ToF cycle time 100 us 
Number of scans 1 
Frames per patch 10 
Field of analysis 10 x10 mm 
Pixel density 300 pixel/mm 
Maximum patch side length 0.3 mm 
Patch resolution 89 x 89 pixel 
Total resolution 3026 x 3026 pixel 
Pixel resolution 128 x 128 
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A.3: List of peaks used for calibration for ToF-SIMS  
Peak m/z 
CH3 15.02 
Na 22.99 
C2H3 27.02 
Si 27.98 
C2H4 28.03 
CHO 29.00 
C2H5 29.04 
K 38.96 
C3H5 41.04 
C2H3O 43.02 
C3H7 43.05 
C4H5 53.04 
C3H3O 55.01 
C4H7 55.05 
C5H7 67.05 
C4H5O 69.03 
C5H9 69.07 
C6H5 77.04 
C6H11 83.08 
C7H7 91.05 
C7H9 93.0 
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C7H11 95.08 
C7H13 97.10 
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A.4: Parameters of mass spectrometry, MALDI, and image used for the MALDI method. 
Mass spectrometry parameters Value 
Mass range (m/z) 100 to 1200 
Polarity Positive 
Mass resolution 50,000 
Trap capillary electrophoresis (CE) 4 
Transfer CE 2 
Analyser Mode Sensitivity 
MALDI parameters Value 
Laser energy 350 
Laser repetition rate 2500 Hz 
Scan time 0.1 sec 
UV laser 355 nm 
Image parameters Value 
Pixel size 50 µm 
Raster speed 0.5 mm/sec 
Scan rate 10 scans/sec 
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A.5: Parameters of robotic matrix deposition system in MALDI-MS. 
Matrix deposition system parameters Value 
Temperature 75 °C 
Gas pressure 10 psi 
Gas flow rate 2 L/min 
Flow rate 0.08 mL/min 
Velocity 1200 mm/min 
Nozzle height  40 mm 
Number of passes 16 
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A.6:  Introduction of NPS other than synthetic cannabinoid. 
Aminoindanes 
Aminoindanes as known as “bath salts” were synthesised for medical use initially such as 
vasoactive, bronchodilatory, and analgesic properties [66]. The chemical structures of 
aminoindanes are very similar to that of amphetamine. The prototype aminoindane, 2-aminoindane 
(2-AI), is amphetamine cyclic analogue with a bridge between α-carbon and the aromatic ring. The 
aminoindane NPS are synthesised from the 2-AI structure modified to various chemical substances 
by addition of a methylenedioxy bridge (e.g. MDMA, MDA, MDAI, and MDMAI), aromatic ring 
substitution with a variety of functional groups (e.g. 5-IAI), and N-alkylation (e.g. MDMA, 
MDMAI, and NM-2AI) [234]. All of them are psychoactive substances and are sold as “legal highs” 
in the market [235]. According to United Nations Office on Drugs and Crime (UNODC), new 
aminoindanes derivatives such as NM-2AI, 1-AI, and ETAI were reported in 2015. However, the 
scientific information regarding their compounds are still unknown, and any aminoindanes are not 
under international control yet [66]. 
 
Figure 113 Chemical structure of amphetamine (A) and 2-aminoindane (2-AI) (B). The highlight in red shows the structural 
difference from amphetamine [66]. 
Aminoindanes act predominantly as stimulant, which are taken to produce sense of euphoria, or 
“high” by mediating enhancement of dopamine, norepinephrine, or serotonin, which mimics the 
effects of cocaine, amphetamine, and ecstasy [236]. According to Nicholas et al., [237] they 
defined new pharmacologic class, “entactogens”, and aminoindanes listed above such as MDMA, 
MDA, and MDEA are placed in the class. “Entactogens” are contrasted from hallucinogens and 
stimulants. People who take the latter are not capable of producing normal sensory experiences or 
powerful visionary experience causing distortion. On the other hand, “entactogens” were able to 
still allow communication and introspection [237]. 
Research for adverse effects of using aminoindanes has never been conducted on humans yet. 
However, some animal studies have shown locomotion activity and toxicity of aminoindanes. 
Paleniceket al., [238] investigated an acute toxicity including median lethal dose (LD50) of MDAI, 
which is known as a non-neurotoxic ecstasy replacement for recreational users, on Wistar rats 
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(outbred albino rat for laboratory use purpose). The LD50for subcutaneous injection and 
intravenous was 28.3 mg/kg and 35 mg/kg respectively. The highest dose (40 mg/kg) in rats 
showed better locomotion than lower dose (20 mg/kg) of them. However, all the rats given the 
highest dose died in 15 min of administration. However, all rats in oral administration survived 
after a dose of 40 mg/kg. They also found that MDAI rapidly increased body temperature with 
severe perspiration [238]. Aminoindanes have been used for recreational purposes, and they can 
be frequently found in the environment of clubs or parties to pursue stimulant effect. However, 
aminoindanes primarily act on the serotonin system, so stimulation is limited. As a result, users 
tend to take them in larger dose to increase the dopamine release or make drug cocktails with 
traditional stimulant drugs such as cocaine, amphetamine, or MDMA. This can cause unexpected 
neurotoxicity and cardiotoxicity [235]. Death related to aminoindanes after autopsy has been 
reported [39].             
 
Figure 114 Chemical structure modification of 2-AI (A), addition of methylendioxy bridge (MDAI) (B), aromatic ring substitution 
(5-IAI) (C), and N-alkylation (NM-2AI) (D) [66] 
Synthetic Cathinones 
Cathinones are plant based phenylalkylamine alkaloids which are present in the khat plant (catha 
edulis), mostly found in East Africa and South West Arabian Peninsula. There are two natural 
products in the khat plant, cathinone and cathine [239]. Cathinone is the most abundant and 
principal ingredient in the plant, and it is structurally a beta-keto analogue of amphetamine. 
Compared to amphetamine, ketone oxygen atom is present on the beta carbon position of amino 
alkyl chain [66]. In order to obtain effects of cathinone, chewing leaves of the khat plant is most 
common way to administer, which induces juices containing the alkaloid cathinone. Cathine is 
produced by metabolising action of cathinone in the plant, and it is less potent than cathinone [239]. 
Both cathinone and cathine are central nervous system (CNS) stimulants like amphetamine, as it 
can be seen based on the chemical structure. This means that the chemicals induce the release of 
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norepinephrine (noradrenaline) and epinephrine (adrenalin) and therefore increasing adrenergic 
effect. They also induce the release of dopamine, but to a lesser degree[240]. However, their 
potency is lower thanthat of amphetamine. Nevertheless, because of its high abuse and dependency, 
cathinone is classified as a Schedule I controlled substance in USA. On the other hand, cathine is 
classified as a Schedule III controlled substance. 
 
Figure 115 Chemical structure of cathinone (A), amphetamine (B), and methamphetamine (C). 
Synthetic cathinones, as known as bath salts, are chemical derivatives,beta-keto analogues of 
natural cathinone and synthesised with it as the prototype [66]. Because of not only their desired 
effects such as euphoria, empathy ,and alertness, but also low cost and easy procurement compared 
to conventional stimulants like amphetamine and cocaine, they have been frequently found in 
recreational purpose cocktail of drugs since mid-2000s [241]. They are usually found in pure white 
or brown powder form, and it is not difficult to purchase them via internet or blank markets [66].   
 
Figure 116 General structure of synthetic cathinones. 
Cathinone and most synthetic cathinonesare considered to be part of the phenethylamine family 
which includes amphetamine, methamphetamine, and MDMA. As explained for cathinone, its 
synthetic cathinone groups are differed by the presence of ketone functional group on beta carbon 
of alkylamines (secondary amines) and pyrrolidnes (tertiary amines) [239]. Those two functional 
groups, the ketone and the amine, can determine their chemical behaviour [242]. Cathinone 
derivatives exist in two stereo-isomeric forms, which can cause different potencies despite the 
same mass. The natural cathinone is S-enantiomers. On the other hand, most ring substituted 
derivatives (group 3 and 4) are racemic mixtures (equal amounts of two enantiomers of a chiral 
molecule) [239, 243]. These racemised synthetic cathinones are produced by keto-enol 
tautomerization by transforming cathinone to a dimmer (3,6-dimethyl-2,5-diphenylpyrazine) at 
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room temperature. Another way to produce cathinones derivatives is to rearrange with 
dihydropyrazine dimer to form iso-cathinones[239].  
 
Figure 117 Structure of 3,6-Dimethyl-2,5-diphenylpyrazine (A) and dihydropyrazine (B) 
There are four groups of synthetic cathinones based on their structures: group 1, 2, 3, and 4 [244]. 
Group 1 contains N-alkyl compounds at the alpha carbon or alkyl compounds or halogen 
substituted at the aromatic ring [244]. The majority of the first generation of synthetic cathinones 
fall in this group. The length of carbon substitution at the alpha carbon and nitrogen (N) terminus 
can be used to distinguish each synthetic cathinone. The addition of carbons at the N-terminus is 
called N-alkylation, and it is the key region where stimulant activity of phenethylamine analogues 
maintains [245].  
 
Figure 118 Synthetic cathinones of group 1, Buphedrone (A), Ethcathinone, ETCAT (B), Flephedrone, 4-FMC (C), Mephedrone,4-
MMC (D). 
Group 2 contains methylenedioxy-substituted compounds substituded at the aromatic ring [244]. 
Synthetic cathinones of this group are structurally similar to MDMA.  
 
Figure 119 Synthetic cathinones of group 2, Butylone, bk-MBDB (A), Ethylone, bk-MDEA (B), Methylone, bk-MDMA (C). 
Group 3 of synthetic cathinones includes natural cathinone analogues with N-pyrrolidine 
substituent at the alpha carbon [244]. Pyrrolidine, as known as terahydropyrrole, is a cyclic 
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secondary amine. Pyrrolidine derivatives are the most frequently found synthetic cathinones in 
seized dugs, and they are highly lipophilic and more potent [239].  
 
Figure 120 Synthetic cathinones of group 3, MPHP (A), α-PVP (B), pyrovalerone (C)[244]. 
Group 4 includes compounds containing both methylenedioxy and N-pyrrolidine substituent [244].   
 
Figure 121 Synthetic cathinones of group 4, MDPBP (A), MDPPP (B), MDPV (C)[244]. 
According to the UNODC 2016 report[246], synthetic cannabinoids take account the largest 
portion of the number of reported substances, followed by synthetic cathinones. The amount of 
seized synthetic cathinones has rapidly increased since 2011, and many legislative actions have 
been taken in many countries in order to regulate the drug abuse. However, because of the 
relatively easy alteration to their structures, numerous derivatives still keep emerging. The 
structure alteration can not only produce tremendous change of their psychoactive effects, but also 
help to circumvent the current legal standpoint [242]. Governmental legislative actions tend to be 
incapable of chasing the constant structure modification of them. The only cathinone derivatives 
listed in Schedule I of the UN convention in 1971 are cathinone and methcathinone, but many 
other derivatives are still not under international control [243].    
Synthetic cathinones act as central nervous system (CNS) stimulants by enhancing their stimulant 
effects through increasing synaptic concentration of dopamine, serotonin, and norepinephrine. 
Synthetic cathinones are less capable of crossing the blood-brain barrier than those of 
amphetamine, so that it has lower potency. That is because, a ketone functional group which results 
in increasing polarity is present. On the other hand, Group 3 and 4 synthetic cathinones containing 
pyrrolidine ring aremore able to cross the blood-brain barrier because the pyrrolidine ring 
decreases polarity of the molecules.This makes it more potent than Group 1 synthetic 
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cathinones[239, 243]. However, information regarding detailed pharmacology of them is still not 
sufficient.       
Current immunoassay tests targeting conventional stimulants cannot fully detect newly 
manufactured synthetic cathinones[247]. Therefore, more robust and selective methods using mass 
spectrometry have recently been. Because of its instability at room temperature, a method to 
identify synthetic cathinones under thermal degradation using GC-MS was developed [242]. Also, 
concentrations of methedrone and mephedrone were achieved from blood and hair samples in post-
mortem test using gas chromatography mass spectrometry (GC-MS)[248, 249]. By using liquid 
chromatography mass spectrometry (LC-MS) method, metabolic pathways of bk-MDBB, and bk-
MDEA though urinary system have been investigated [250].                     
Phencyclidine-type Substances 
Phencyclidine (PCP), also known as angel dust, falls into hallucinogens in the drug category 
causing dissociative and psychedelic effects [67]. PCP was invented by Parke-Davis Company 
with the trade name “Sernyl” in 1926, and it became commonly used as a general intravenous 
anaesthetics for surgery in 1950’s. However, patients suffered undesired delusions, anxiety, and 
agitation when the use was emerged. Therefore, usage of PCP on humans were regulated, and it 
became categorised into Schedule II controlled substance until now [251].  
PCP abuse has been emerged for recreational purposes since the late 1960s and subsequently 
reduced by the late 1980s and early 1990s because of the availability of crack cocaine [252]. 
However, PCP-type substances reappeared in 2010 and the abuse of PCP related substances rose 
back up as testified by the significantly increased number of emergency department (ED) visits 
between 2009 to 2011 due to PCP related accidents [252]. Besides, PCP and PCP analogues are 
not usually administered independently. It is often smoked with tabaco or marijuana [253]. It is 
also sold disguised as ecstasy, which containsa combination of PCP and other substances, but no 
MDMA [251].  
PCP and its first generation analogues arearylcyclohexylamine, which refers to a chemical class 
of compounds producing anaesthesia and hallucinogenic effects. It consists of acyclohexylamine 
moiety combined with an aryl moiety, which refers to any substituent derived from an aromatic 
ring [254], attached. Cyclohexane generally decreases N-methyl-D-aspartate receptor (NMDAR) 
affinity and PCP-like potency [255]. The amine is germinal (two atoms or two functional groups 
are conjugated with the same atom) to the aryl group. The amine can be either primary or secondary 
or tertiary, but most PCP analogues contain secondary and tertiary amines[256]. Phencyclidine is 
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also composed of tertiary amines. 14 PCP analogues were so far identified. As examples of first 
generation PCP analogues, there are ketamine, 1-Piperidinocyclohexanecarbonitrile (PCC), 1-[1-
(Thiophen-2-yl)cyclohexyl]piperidine (TCP), N-Ethyl-1-phenylcyclohexylamine (PCE), N-
Propyl-1-phenylcyclohexylamine (PCPr), N-isopropyl-1-phenylcyclohexylamine (PCiP), 1-(1-
Phenylcyclohexyl)pyrrolidine (PCPy), and so on[255].  All of these compounds have not found on 
the street drug market since between the late 1960s and 1990s in which they were initially 
synthesised and reported as major sources of drug abuse, but a number of them are still found in 
the online market manufactured by clandestine chemists.  
 
Figure 122 General structure to produce arylcyclohexylamine. 
Ketamine is the most well-known PCP-related drug. Since PCP had been reported to have severe 
side effects and is designated a Scheduled II substance because of them, ketamine was synthesised 
1960s and used for anaesthetics for human or animal surgery instead of PCP because it does not 
depress breathing or blood pressure [257]. It then started to appear in the market as a new 
psychoactive substance in the 1980s and 1990s, and illegal abuse of ketamine is still reported now. 
However, both the World Health Organisation (WHO) and the UN Office on Drugs and Crime 
reported that there is no sufficient information to warrant it to be scheduled, and the risk of fatal 
intoxication is very low unless high-dose abuse of ketamine [258]. Ketamine is also classified as 
an arylcycloalkylamine due to structural similarity to PCP.  
 
Figure 123 Structure of PCP (A), ketamine (B), and tiletamine (C). 
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Figure 124 First generation of PCP analogues and their structures[255]. 
A next generation of phencyclidine-type substances have recently appeared as NPSs in the market. 
Examples of them are amethoxy group conjugated with an aromatic ring of PCP, such as 3-MeO-
PCP, 4-MeO-PCP, 3-MeO-PCE, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (MXE), and 
2-MeO-deschloroketamine (2-MK)[255]. They were initially synthesised in 1965 [259], but the 
effects of them were actually reported in 1999 [255]. They tend to retain the hallucinogenic and 
dissociative effect, but are more euphoric and mentally clearer than conventional drugs. They have 
reduced potency, about 70 %, and reduced duration compared to PCP. MeO substitution would 
offer an opioid analgesic effect. Substituting from N-methyl to N-ethyl would provide longer 
duration and potency, and the presence of a keto group would provide some characters of ketamine 
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which could be more stable[255]. They are frequently found as research chemicals in white 
crystalline solid powder form. Unlike conventional PCP analogues likeeticyclidine (PCE), 
rolicyclidine (PHP), and tenocyclidine (TCP), which have been already listed in Schedule I 
controlled substance, they are not internationally under regulation yet, except MXE. Of these new 
phencyclidine-type substances, 4-MeO-PCP and 3-MeO-PCE are most commonly found[258].   
 
Figure 125 Next generation of PCP analogues and their structures[255]. 
PCP is an N-methyl-D-aspartate receptor (NMDA) antagonist.  NMDA receptor is the amino acid 
glutamate (Glu) receptor in central nervous system (CNS). Glu controls both normal and abnormal 
functions in CNS. It plays main role of excitatory neurotransmitter, on the other hand, it also can 
be excitotoxin destroying neurons in CNS by excessive activity of Glu receptors, which results in 
many neurodegenerative diseases [260]. There are two classes identified so far for Glu receptors: 
ionotropic and metabotropic. Ionotropic Glu receptor is recognised as causing excitotoxic 
activities by forming cation channel pores with the flow of K+, Na+ and sometimes Ca2+ when 
glutamate binds to the receptor. The NMDA receptor is one of ionotropic Glu receptors [261]. 
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The NMDA antagonist inhibits the action of the NMDA receptor. They are mostly used for 
anaesthetics for humans. NMDA antagonist can be used as treatment for neurodegenerative disease 
such as Alzheimer’s and Parkinson’s disease since they derive from over-activity of NMDA 
receptor inducing excitotoxicity in CNS. In order to inhibit the NMDA receptor activated, the 
antagonist binds the binding site of a NMDA receptor instead of Glu and glycine binding to the 
NMDA receptor. However, as explained above, NMDA receptors also function significantly in 
normal glutamatergic neurotransmission, so inhibiting the binding site with antagonists can cause 
side effects, such as hallucinations, delusions, dissociation, and learning and memory deficits [262]. 
The next generation of PCP analogues still have significant affinity for the PCP binding site of 
NMDAR [263]. 
Phenethylamines 
Phenethylamines are classified into either stimulants which stimulates the central nervous system 
(CNS) by mediating the secretion of dopamine, norepinephrine, and serotonin or hallucinogens, 
originally derived from the structure of mescaline [264, 265]. As examples of stimulants 
phenethylamines, conventional stimulants such as amphetamine, methamphetamine, and MDMA 
fall into the group [66, 266]. On the other hand, newly reported novel psychoactive substances as 
phenethylamine analogues fall into the hallucinogen category. Ring substituted substances such as 
the “2C series”, ring substituted amphetamine series such as the “D series”, and benzodifurans are 
examples of hallucinogenic phenethylamines [265, 266]. 
Amphetamine is a methyl group addition to the alpha carbon of phenethylamine which consists of 
primary amine attached to a benzene ring through ethyl group [267]. As explained in Section 
1.2.1.1, and 1.2.1.3 aminoindanes, cyclic analogues of amphetamine behaves mainly stimulant 
following characteristics of amphetamine. Methamphetamine and MDMA are both classical 
phenethylamine derivative as well. The structures of phenethylamine amphetamine are very 
similar.   
 
 
Figure 126 Chemical structure of phenethylamine (A), amphetamine (B), and cathinone (C). 
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Figure 127 Marked substitutional points of phenethylamine. 
Phenethylamines inducing hallucinogenic and psychedelic effect derive from the structure of 
mescaline. Figure shows that mescaline consists of addition of 3 methoxy groups with 
phenethylamine at 3, 4, 5 positions. The presence of these methoxy groups have a tremendous 
influence to induce hallucinogenic effect. Phenethylamine type substances are synthesised by 
replacing 4-methoxy group with larger alkoxy groups which are composed of single alkyl group 
bonded with oxygen, transposing the methoxy groups to different positions of benzene ring and 
substituting with halogens except fluorine,unbranched alkyl group, and alkylthio group to 4-
methoxy position, adding ethyl group on the alpha carbon in the side chain, and substituting 
dihydrofuran rings instead of 2,5-dimethoxy substituents [265]. These synthesised 
phenethylamines contain much higher potency than naturally occurring phenethylamine 
hallucinogenic effect from mescaline.   
 
 
Figure 128 Chemical structure of mescaline. 
Substances synthesised substances by substituting 4-methoxy group with larger alkoxy groups can 
result in significantly higher potency than that of mescaline. However, those substances are hardly 
found on the market because it is difficult for them to be synthesised and produced in large 
quantities [268].  
There are some ways to transpose each methoxy group to other positions. The most common way 
is to transpose 3-methoxy group of mescaline to the 2-position, which forms 2, 5-dimethoxy 
substitution pattern with changing the 4-substituent. This transposition can increase the potency of 
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hallucinogens. 2C-D, 2C-B, and 2CT-2 are examples of this type of phenethylamine substances. 
Moreover, addition of methyl group to the 2, 5-dimethoxy substitution on the alpha carbon of two-
carbon side chain can provide the most potency [269, 270]. As explained above, adding a methyl 
group on the alpha carbon is very similar to amphetamine. That is why, this type of phenethylamine 
is usually referred to “amphetamine hallucinogens” or “DOx series”.2,5-Dimethoxy-4-
methylamphetamine(DOM),Dimethoxybromoamphetamine (DOB), and 2,5-dimethoxy-4-
methylthioamphetamine (Aleph or DOT) are examples of amphetamine hallucinogens[271, 272]. 
One thing to note is that if an ethyl group is substituted instead of a methyl group on the alpha 
carbon of two carbon side chain, hallucinogenic activity will be completely eliminated [265].       
 
Figure 129 Chemical structure of 2C-D (A), 2C-B (B), and 2CT-2 (C) [265]. 
 
Figure 130 Chemical structure of DOM (A), DOB (B), and DOT (C) [265]. 
Transposing 3- and 5-methoxy groups to the 2, 6-postions can be another way to synthesise 
phenethylamine type substances. However, this type of substances are challenging to synthesise 
and lower potent compared to 2, 5-dimethoxy substitution pattern, so they are assumed as not an 
newly emerging problems  [265]. 
Additionally, the dihydrofuran ring can be substituted on the 2, 5-dimethoxy substitution positon 
in order to increase potency. Furan refers to an aromatic ring consisting of four carbons and one 
oxygen. Dihydrofuran is defined as a monounsaturated (containing only one double bond) 
derivative of furans. Their manufactures are more complicated than those of previously introduced 
phenethylamines. Nevertheless, they can be found on the market due to their higher potency. 
Modification of side carbon chains can also lead to hallucinogenic active compounds. 2C-Bfly, 
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Br-Fly, or Br-Dragonfly are exemplified for this type of phenethylamine substances [265]. 
Especially, Br-Dragonfly reaches the potency of LSD, and it has a very long duration [273].     
 
Figure 131 Chemical structure of 2C-Bfly (A), Br-Fly (B), Br-Dragonfly (C), and TCB-2 (D) [265]. 
Furthermore, N-Benzylphenethylamines which are higher potency than previous phenethylamine 
type substances were recently recognised [274]. They are based on the structure of phenethylamine 
structure with secondary amine added instead of primary amine. The other R group conjugated 
with nitrogen atom is benzene ring. That is why, this type of substance is called N-
Benzylphenethylamines. The most common structure of N-Benzylphenethylamines are based on 
the “amphetamine hallucinogens”, “Fly” type phenethylamine substances, and “Dragonfly” type 
phenethylamine substances. Halogens except fluorine, alkyl, methoxy, or thiol group can be 
substituted at the 4- position to be active hallucinogens. Then, the benzene ring can be substituted 
one of hydrogen conjugated with nitrogen atom to become N-benzylphenethylamines, and they 
can contain variety forms of benzene ring substituents. The most popular forms of N-
benzylphenethylamines as recreation drugs are 5-dimethoxy-4-iodo and 2,5-dimethoxy-4-
chlorophenethylamines with N-(o-methoxybenzyl) groups[265].   
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Figure 132 Examples of possible combinations of N-benzylphenetylamines which could be active and appear as new NPS. 
The “2C series” has been replaced from not only mescaline and LSD which induce psychedelic 
effects, but also MDMA which is stimulants widely used until the 1990s [269]. When MDMA 
became banned in 1985, the “2C series” emerged as a legal alternative [275]. Especially, 2C-B 
was developed as an aphrodisiac [275]. However, many of 2C compounds are now classified as 
Schedule I substances because of their tremendous psychedelic effects and over misuse [276]. 
Nevertheless, synthesis of new version of this type of substances is still ongoing to avoid legal 
control [277].  Besides, the amount of research about “2C series” is limited, and the research 
targeted only certain compounds. As a result, there is no antidote developed for 2C intoxication, 
and the way for the treatment is also limited [269].     
The “DOx” series has total of 29 family members, according to Alexander Shulgin, who first 
synthesised phenethylamines [278]. These compounds have highly potency and their psychedelic 
effects last longer than “2C series” drugs. Nevertheless, only DOB and DOM are classified as 
260 
 
Schedule I controlled substances in the USA. Rest of them are either monitored under the Federal 
Analogue Act because of structural similarity with DOB and DOM or still not under control [279].          
Piperazines 
Piperazines are an organically synthesised chemical compound which present as small alkaline 
deliquescent crystals. They were originally developed by pharmaceutical industries as potential 
therapeutic agents, especially antidepressant drugs, but they were not successfully adopted in the 
market. Therefore, they currently are described as ‘failed pharmaceuticals’ [280]. They have been 
widely used since 1990s, and now, they are more found as amphetamine and MDMA (ecstasy) 
alternatives due to their similar effects [281]. 
1,4-hexahydropyrazine as known as piperzine consists of two nitrogen atoms at opposite positions 
in the 6 membered heterocyclic ring. Piperazine itself cannot appear as a psychoactive effect 
inducing substance. Piperazine plays a role of backbone to manufacture the various piperazine 
derivatives. Mostly, an aromatic ring is a typical substituent [282]. 
 
Figure 133 Structure of piperazine. 
Piperazine derivatives can be broken down into two groups in terms of their chemical structure, 
namely benzyl-piperazines and phenyl-piperazines. Benzyl-piperazines can be described by the 
presence of methyl group bridges to an aromatic ring substituents.  Phenyl-piperazines can be 
described by the presence of a phenyl group conjugated with piperazine moiety [282]. Piperazine 
derivatives have not been as popular as other NPSs which are previously described in Section 1.2.1, 
but a number of N-substituted piperzines appeared in the market. Besides, there may be many ways 
left to synthesise variety of new piperazine derivatives with aromatic ring substituents, which can 
result in increased potency [265]. Piperazine derivatives are quite often claimed to be herbal 
products by suppliers, but pieprazine and all of its derivatives are synthetic substances [276].       
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Figure 134 Examples of benzyl-piperzine derivatives: 1-Benzylpiperzine (A), 4-methyl-1-benzylpiperazine (B), 1-(4-Bromo-,5-
dimethoxybenzyl)piperazine (C), 1,4-Dibenzylpiperazine (D), and 1-(3,4-methylenedioxybenzyl)piperazine (E)[282]. 
 
Figure 135 Examples of phenyl-piperazine derivatives: Trifluoromethylphenylpiperazine (A), 1-(3-Chlorophenyl)piperazine (B), 1-
(2-Methoxyphenyl)piperazine (C), 1-(4-Methoxypheynl)piperazine (D), 1-(3-Methylphenyl)piperazine (E), 1-(4-
Methylphenyl)piperzine (F), and 1-(4-Fluorophenyl)piperazine (G)[282] 
The most widely known and used piperazine derivatives are N-benzylipiperazine (BZP), 1,3-
trifluoromethylphenylpiperazine(TFMPP), and 1-(3-chlorophenyl)piperazine (mCPP).  
BZP is one of synthetic benzyl-piperzine analogue groups. It is usually found as BZP 
dihydrochloride presented in either tablets or capsules. It was originally developed as potential 
antidepressant therapeutic drugs in the 1970s. However, clinical trials of BZPwere abandoned 
because of amphetamine-like effects derived from structural similarity. BZP was liable to abuse 
with one tenth of its potency, which resulted in lower intensity of toxic effects [276]. Once 
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administered in human body, BZP acts as locomotor simulants with release of dopamine, serotonin, 
and noradrenaline [283]. In Europe, the abuse of BZP was widespread from 2004 until 2008, when 
it became regulated by European Union. In USA, it has been classified as a Schedule I controlled 
substance since 2002 [66].  
TFMPP is fluorinated phenyl-piperazine derivative. It is also commonly available either as a base 
or the hydrochloride salt. The base form is yellowish viscous liquid, and the hydrochloride salt is 
a white powder [284]. TFMPP is usually taken in combination with BZP. TFMPP is also found to 
act as stimulants. It is a direct serotoninergic antagonist, which stimulates the release of 
endogenous serotonin (5-HT) receptor in a similar way to MDMA. However, it does not contain 
properties of dopamine or adrenaline in contrast to BZP [282]. In the USA, It had been federally 
classified as a Schedule I hallucinogen drug because of its abuse potential in 2002, but it was 
released back to uncontrolled substances in 2004 through scientific and medical evaluation by 
Food and Drug Administration (FDA) and the National Institute on Drug Abuse (NIDA). However, 
a few States of USA and some of nations still strongly regulate this substance [284].  
mCPP can be found as an active metabolite of antidepressants such as trazdone, nefazadone, 
etoperidone, and mepiprazole[285]. It is structurally similar to TFMPP with chloro-moiety 
replacing the trifluoromethyl group, which results in similar effects of abuse. There are also two 
positional isomers available, 1-(4-chlorophenyl)piperazine (pCPP, para-CPP) and 1-(2-
chlorophenyl piperazine, (oCPP, ortho-CPP). However, most research has been focussed on mCPP, 
and it has been mainly used as an alternative to MDMA [282]. Due to structural similarity with 
TFMPP, mCPP also does not contain dopaminergic properties. It plays a role of serotoninergic 
antagonist, except being likely to be indirect [283]. Nevertheless, mCPP also has as high affinity 
as TFMPP does and even for wider range of 5-HT receptors [282]. Besides, it has affinity at 
adrenergic receptors unlike TFMPP [286]. Compared to the previous two piperazine derivatives, 
mCPP tends to be less desired for recreational purpose because of adverse side effects such as 
dysphoria, weakness, dizziness, anxiety, nausea, and even heart attack [236]. Nonetheless, the 
abuse of BZP has increased since 2006 according to the European monitoring centre for drugs and 
drug addiction (EMCDDA)[243].  
Plant-based substances 
NPSs do not always derive from a synthesising process. There are also natural organic substances 
causing drug effects produced from plants. The top three among plant-based substances on NPS 
are khat, kratom, and salvia divinorum according to UNODC [66]. 
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Khat was introduced in Section 1.2.1.3, synthetic cathinones. Khat contains principal active 
components, cathinone and cathine (norpseudoephedrine). They can be released from the leaf of 
khat into saliva by the action of chewing and cause amphetamine like pharmacological effects due 
to structural similarity. However, cathinone and cathine are less potent than amphetamine is. Khat 
is regulated in UK, and cathinone and cathine were classified as Schedule I and III Psychotropic 
Substances respectively by the UN Drug Conventions in 1971 [287].  
Kratom is a tree whose original name is Mitragyna specioseKorth. It contains many alkaloids. The 
main psychoactive components among them includes mitragynine, mitraphylline, and 7-
hydroxymitragynine. They can be administered by chewing leaves or making them into tea. 
Mitragynine and 7-hydroxymitragynine are the main components responsible for psychoactive 
effects from kratom. Generally, at a low dose, kratom produces ‘cocaine-like’ stimulation effect, 
so it was consumed for euphoria. On the other hand,at a large dose, kratom produces ‘morphine-
like’ sedative-narcotic effects, so it was used as an opium alternative. Nevertheless, none of 
alkaloids and kratom itself are classified scheduled substances of the UN Drug Conventions [288].  
 
Figure 136 Structure of mitragynine [288]. 
 
Figure 137 Structure of 7-hydroxymitragynine [288]. 
Salvia divnorum is a psychoactive plant which traditionally Mazatec Indians used for the religious 
ceremony or medical purpose. However, medical use of this substance is not currently approved. 
The principal component causing psychoactive effects is salvinorin A, which mainly induces 
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intense hallucinogenic effects and is comparable to those of LSD (an example of a synthetic 
tryptamine) and dimethoxybromoamphetamine (DOB) (an example of a synthetic 
phenethylamine). One thing to note is that salvinorin A does not contain nitrogen atom unlike other 
conventional or synthetic hallucinogenic substances. Salvia divnorum was traditionally 
administered by sucking and chewing fresh leaves, or crushing into powder to drink it with water. 
Nowadays, the vaporised salvinorin A extract is inhaled, or dried leaves are smoked. Both Salvia 
divinorum and salvionrin A are not listed in any of Schedules of the UN Drug Conventions [289]. 
However, according to UNODC, this plant is recognised as the most common plant-based 
psychoactive substance in 2009, and the use of it as a new psychoactive substance has increased 
since then. Therefore, the necessity of regulation for salvia divnorum and salvinorin A is increasing, 
and several countries have already conducted legislation to control them [66].      
 
Figure 138 Structure of Slavinorum A [289]. 
Tryptamines 
Tryptamines are natural compounds originating from the enzymatic decarboxylation of tryptophan 
which is an amino acid functioning to bio-synthesise proteins. Tryptamine itself is a monoamine 
alkaloid [290]. They are found in plants (teterahydroharmine (THH) and N,N-dimethyltryptamine 
(DMT)) , fungi (psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) and psilocin (4-hydroxy-
N,N-dimethyltryptamine)), and animals (bufotenine, 5-hydroxy-N,N-dimethyltryptamine (5-OH-
DMT), and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT))[276]. Synthetic tryptamines are 
organic compounds derived from structural modification of natural tryptamines. One major 
example is LSD. LSD is synthesised by modification of ergine as known as d-lysergic acid amide 
(LSA) which are produced by some species of fungi [290]. 
All tryptamines share the basic structural formation with amino acid tryptophan, which consists of 
two cyclic indole rings with an amino-ethyl group attached at the 3-position. [265].  
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Figure 139 Structure of tryptamine (A) and tryptophan (B). 
Based on the structural modification, tryptamines are broken down into two groups: simple 
tryptamines and ergolines. The simple tryptamines are broken down into 3 subgroups: 1) an 
addition of alpha-alkyl substituent without modification of the indole ring; 2) modification on the 
4-position on the indole ring; 3) modification on the 5-position on the indole ring [227]. Chemicals 
with the indole nucleus is responsible for inducing hallucinogenic effects. Substitution with the 
hydroxyl and methoxy groups on the 4 and 5 position are only considered because they enhance 
the drug potency. On the other hand, substitution on the 6 and 7 position reduced the hallucinogenic 
activity [276]. Examples of each subgroup of simple tryptamines are shown in Figure 139.       
 
Figure 140 Substituted positions of tryptamines. 
 
 
Figure 141 Examples of simple tryptamines subgroup 1: DMT (A), AMT (B), and DPT (C). 
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Figure 142 Examples of simple tryptamines subgroup 2): 4-HO-MET (A), psilocin (B), Psilacetin (C), and 4-HO-DiT (D). 
 
Figure 143 Examples of simple tryptamines subgroup 3): 5-MeO-DiPT (A), 5-MeO-DMT (B), 5-MeO-AMT (C), and 5-MeO MiPT 
(D). 
Ergolines are chemical compounds synthesised from a fungus called ergot. Compared to simple 
tryptamines, ergolines are composed of more complicated structure around an indole and 
tetracyclic ring. LSD is one example of them. LSD is one of the most potent hallucinogenic 
compounds, so any novel synthetic structural analogues of which maintain its potency and duration 
could be very problematic. As mentioned above, LSD is derived from modification of ergine 
(LSA). It is easier to produce LSA than diethylamide in LSD, but no analogues were reported yet. 
Besides, it is theoretically possible that the methyl group conjugated with nitrogen can be replaced 
with ethyl group or a halogen component to produce a quite potent LSD derivative [265].        
 
Figure 144 Examples of ergolines: LSD (a), mitragynine (b), and ergine (c). 
This study focuses on analysing and detecting substances of synthetic cannabinoids including UR-
144, AB-PINACA, PB-22, APINACA, AB-FUBINACA, 5-F-PB-22, and their metabolites since 
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synthetic cannabinoids account for the largest portion of NPS usage [258]. Besides, current routine 
cannabinoid immunoassay tests are not capable of detecting synthetic cannabinoids [291]. 
 
 
 
 
 
 
 
 
 
 
A.7: Inter and intra precision of NPS substances used for this study.  
Table 25 Intra-precision for NPS (n=5) 
Analyte Concentration of QC (pg) RSD (%) 
UR-144 200 25 
800 17 
XLR-11 200 23 
800 36 
AB-PINACA 200 26 
800 7 
PB-22 200 16 
800 8 
APINACA 200 31 
800 20 
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AB-FUBINACA 200 31 
800 14 
5F-PB-22 200 14 
800 10 
UR-144 5-Hydroxypentyl 
metabolite 
200 18 
800 13 
UR-144 5-Pentanoic acid 
metabolite 
200 31 
800 3 
XLR-11 4-Hydroxypentyl 
metabolite 
200 18 
800 21 
APINACA (AKB-48) 5-
Hydroxypentyl 
metabolite 
200 24 
800 8 
AB-PINACA 5-
Hydroxypentyl 
metabolite 
200 34 
800 25 
AB-PINACA 5-Pentanoic 
acid metabolite 
200 23 
800 18 
PB-22 4-Hydroxypentyl 
metabolite 
200 13 
800 13 
PB-22 5-Pentanoic acid 
metabolite 
200 8 
800 7 
 
Table 26 Inter-precision for NPS (n=5) 
Analyte Concentration of QC (pg) RSD (%) 
UR-144 200 23 
800 16 
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XLR-11 200 23 
800 14 
AB-PINACA 200 24 
800 18 
PB-22 200 21 
800 17 
APINACA 200 23 
800 17 
AB-FUBINACA 200 26 
800 18 
5F-PB-22 200 21 
800 15 
UR-144 5-Hydroxypentyl 
metabolite 
200 22 
800 16 
UR-144 5-Pentanoic acid 
metabolite 
200 22 
800 13 
XLR-11 4-Hydroxypentyl 
metabolite 
200 27 
800 15 
APINACA (AKB-48) 5-
Hydroxypentyl 
metabolite 
200 17 
800 15 
AB-PINACA 5-
Hydroxypentyl 
metabolite 
200 32 
800 27 
AB-PINACA 5-Pentanoic 
acid metabolite 
200 28 
800 23 
200 15 
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PB-22 4-Hydroxypentyl 
metabolite 
800 16 
PB-22 5-Pentanoic acid 
metabolite 
200 22 
800 12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
271 
 
Appendix B 
B.1: Standard operating procedure for oral fluid sample collection.  
 
 
 
272 
 
B.1 continued…   
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B.1 continued…   
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B.1 continued…   
 
 
 
 
 
275 
 
B.2: Standard operating procedure for fingerprint sample collection  
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B.2 continued…   
 
 
 
 
 
277 
 
B.2 continued… 
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B.2 continued… 
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B.3: Hazardous substances risk assessment form for cocaine 
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B.3 continued… 
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B.4: Hazardous substances risk assessment form for BZE 
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B.4 continued… 
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B.5: Hazardous substances risk assessment form for heroin 
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B.5 continued… 
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B.6: Training pack for Rochester prison officers to collect fingerprint samples for NPS study. 
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B.6 continued… 
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B.6 continued… 
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B.6 continued… 
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B.6 continued… 
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B.6 continued… 
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B.6 continued… 
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B.6 continued… 
 
 
 
 
 
 
 
 
 
 
 
 
 
293 
 
 
B.6 continued… 
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B.6 continued… 
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B.7: Instruction sheet for Rochester prison officers to collect fingerprint samples for NPS study. 
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B.7 continued… 
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B.7 continued… 
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B.8 Hazardous substances risk assessment form for NPS 
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B.8 Continued… 
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